Unique_ID,Arm.Name,Randomized,KM_Curves,Rand_Group,N_Patient,OS,OS_Comp,OS_pval,OS_events,OS_KM,OS_Note,TTP,TTP_Comp,TTP_pval,TTP_KM,TTP_events,TTP_Note,PFS,PFS_Comp,PFS_pval,PFS_KM,PFS_events,PFS_Note
ABRAM0199_T1,160 mg,Yes,Yes,,123,27.8,,,,ABRAM0199_OS_160.xml,Overall p-value 0.54,8.3,,,ABRAM0199_TTP_160.xml,123,,,,,,,
ABRAM0199_T2,800 mg,Yes,Yes,,124,24.4,,,,ABRAM0199_OS_800.xml,,7,,,ABRAM0199_TTP_800.xml,124,"\Not of statistical significance\""""",,,,,,
ABRAM0199_T3,1600 mg,Yes,Yes,,119,28.6,,,,ABRAM0199_OS_1600.xml,,8.1,,,ABRAM0199_TTP_1600.xml,119,"\Not of statistical significance\""""",,,,,,
ACKLA0201_T1,CEF,Yes,Yes,,223,20.1,"HR 0.87 [0.7, 1.1] p=0.23",,,ACKLA0201_OS_CEF.xml,,8.7,"HR 0.73 [0.59, 0.92]",,ACKLA0201_TTP_CEF.xml,,,,,,,,
ACKLA0201_T2,CMF,Yes,Yes,,237,18.2,,,,ACKLA0201_OS_CMF.xml,,6.3,,,ACKLA0201_TTP_CMF.xml,,,,,,,,
AHMAD0614_T1,Taxotere,Yes,,,23,,,,,,,,,,,,,,,,,,
AHMAD0614_T2,NDLS,Yes,,,49,,,,,,,,,,,,,,,,,,
AHMAN0174_T1,methyl-CCNU,Yes,,,22,,,,,,,,,,,,,,,,,,
AHMAN0174_T2,Multiple drugs alone,Yes,,,11,,,,,,,,,,,,,,,,,,
AHMAN0174_T3,Multiple drugs with vincristine,Yes,,,10,,,,,,,,,,,,,,,,,,
AHMAN0177_T1,Dianhydrogalactitol,Yes,,,18,3.27,,,,,Nothing more reported,,,,,,,,,,,,
AHMAN0177_T2,ICRF-159,Yes,,,14,2.1,,,,,Nothing more reported,,,,,,,,,,,,
AHMAN0576_T1,VP-16-213,Yes,,,19,2.89,,,,,"Nothing more reported; in fact, this is mean, not median OS",,,,,,,,,,,,
AHMAN0576_T2,Cytembena,Yes,,,15,2.94,,,,,"Nothing more reported; in fact, this is mean, not median OS",,,,,,,,,,,,
AHMAN0691_T1,CFP,Yes,,,47,15.8,,0.77,39,AHMAN0691_OS_CFP.xml,,4.7,,,,,,,,,,,
AHMAN0691_T2,CAP,Yes,,,46,17.3,,,37,AHMAN0691_OS_CAP.xml,,6.6,"HR 0.91 [0.60, 1.38] p=0.65",,,,,,,,,,
AISNE0695_T1,CAF,Yes,,,165,14.83,,,152,AISNE0695_OS_CAF.xml,,,,,,,,,,,,,
AISNE0695_T2,VATH,Yes,,,164,17.15,,,153,AISNE0695_OS_VATH.xml,,,,,,,,,,,,,
AISNE0695_T3,VATH/CMFVP,Yes,,,162,17.39,,,146,AISNE0695_OS_VATHCMFVP.xml,overall p=0.1710,,,,,,,,,,,,
AISNE1087_T1,CMF,Yes,,,99,14.93,,-0.04,52,AISNE1087_OS_CMF.xml,,,,,,,,,,,,,
AISNE1087_T2,CAF,Yes,,,82,24.73,,,35,AISNE1087_OS_CAF.xml,,,,,,,,,,,,,
AISNE1087_T3,CAFVP,Yes,,,79,16.33,,-0.08,46,AISNE1087_OS_CAFVP.xml,,,,,,,,,,,,,
ALBA0710_T1,PLD,Yes,Yes,,78,24.8,"HR 0.86 [0.58, 1.27] p=0.435",,,ALBA0710_OS_PLD.xml,,8.4,"HR 0.54 [0.39, 0.76] p=0.0002",,ALBA0710_TTP_PLD.xml,,,,,,,,
ALBA0710_T2,Observation,Yes,Yes,,77,22,,,,ALBA0710_OS_OBS.xml,,5.1,,,ALBA0710_TTP_OBS.xml,,,,,,,,
ALBAI0808_T1,Gemcitabine / Paclitaxel,Yes,Yes,,261,18.6,"HR 0.82 [0.67, 1.00] p=0.0493",,,ALBAI0808_OS_GT.xml,,6.14,"HR 0.70 [0.59, 0.85]",,ALBAI0808_TTP_GT.xml,,,5.9,"HR 0.73 [0.61, 0.87] p=0.0005",,,,
ALBAI0808_T2,Paclitaxel,Yes,Yes,,260,15.8,,,,ALBAI0808_OS_T.xml,,3.98,,,ALBAI0808_TTP_T.xml,,,3.9,,,,,
ALBAO0704_T1,A --> T,Yes,,,75,,,,,,,,,,ALBAO0704_TTP_A-T.xml,,,,,,,,
ALBAO0704_T2,AT,Yes,,,69,21.8,,,,,,9.2,,,ALBAO0704_TTP_AT.xml,,,,,,,,
ALLEG0685_T1,Mitoxantrone,Yes,,,113,,,,,,,,,,,,,,,,ALLEG0685_PFS_MITOXANTRONE.xml,,
ALLEG0685_T2,Doxorubicin,Yes,,,107,,,,,,,,,,,,,,,,ALLEG0685_PFS_DOXORUBICIN.xml,,
ALONS0495_T1,CAF,Yes,,,50,18,,,,ALONS0495_OS_CAF.xml,,,,,,,,,,,,,
ALONS0495_T2,CNF,Yes,,,50,19,,,,ALONS0495_OS_CNF.xml,,,,,,,,,,,,,
ALONS0588_T1,Tamoxifen,Yes,,,34,,,,,,,,,,,,,,,,,,
ALONS0588_T2,Tamoxifen plus aminoglutethimidine,Yes,,,34,,,,,,,,,,,,,,,,,,
ALONS0588_T3,Aminoglutethimidine,Yes,,,33,,,,,,,,,,,,,,,,,,
AMADO0513_T1,Pemetrexed-carboplatin,Yes,,,69,,,,,,,5.1,,,AMADO0513_TTP_pem.xml AMADO0513_TTP_pem_censor.xml,48,Also have counts at various months,,,,,,
AMADO0513_T2,Vinorelbine-gemcitabine,Yes,,,66,,,,,,,5.6,,,AMADO0513_TTP_vin.xml AMADO0513_TTP_vin_censor.xml,46,,,,,,,
AMADO0698_T1,DOX,Yes,,,68,24,,,,,no additional information,6.5,,,,,no additional information,,,,,,
AMADO0698_T2,DOX + LND,Yes,,,69,23,,,,,no additional information,6,,,,,no additional information,,,,,,
ANDER0111_T1,Docetaxel + Trastuzumab,Yes,,,143,35.7,,,,,,12.4,,,,,,,,,,,
ANDER0111_T2,Vinorelbine + Trastuzumab,Yes,,,141,38.8,"HR 1.01 [0.71, 1.42] p=0.98",,,,,15.3,"HR 0.94 [0.71, 1.25] p=0.67",,,,,,,,,,
ANDER0199_T1,CAF+TAM,Yes,Yes,,161,20.8,,0.17,158,ANDER0199_OS_CAF.xml,,11.8,,,ANDER0199_TTP_CAF.xml,161,overall p=0.001; also have counts at various months,,,,,,
ANDER0199_T2,CMF+TAM,Yes,Yes,,180,17.4,,,180,ANDER0199_OS_CMF.xml,,6.5,,,ANDER0199_TTP_CMF.xml,180,,,,,,,
ANDER1086_T1,ADR,Yes,,,42,9.3,,,,,no additional information,5.2,,,,,no additional information,,,,,,
ANDER1086_T2,ADR + MMC,Yes,,,39,10.2,,,,,no additional information,7.7,,,,,no additional information,,,,,,
ANDRE0514_T1,Everolimus group,Yes,,,284,,,,,,,,,,,,,7,"HR 0.78 [0.65, 0.95] p=0.0067",,,,
ANDRE0514_T2,Placebo group,Yes,,,285,,,,,,,,,,,,,5.78,,,,,
ARPIN0203_T1,Idoxifene,Yes,Yes,,108,,,0.77,,ARPIN0203_OS_idoxifene.xml,,5.53,,,ARPIN0203_TTP_idoxifene.xml,108,overall p=0.32,,,,,,
ARPIN0203_T2,Tamoxifen,Yes,Yes,,111,,,,,ARPIN0203_OS_tamoxifen.xml,,4.67,,,ARPIN0203_TTP_tamoxifen.xml,111,,,,,,,
AUSTR0286_T1,TAM,Yes,,,113,21,,,,AUSTR0286_OS_TAM.xml,,,,,,,,,,,,,
AUSTR0286_T2,TAM + AC,Yes,,,113,20,,,,AUSTR0286_OS_TAMAC.xml,,,,,,,,,,,,,
AUSTR0286_T3,AC,Yes,,,113,18,,,,AUSTR0286_OS_AC.xml,,,,,,,,,,,,,
AWADA0414_T1,Endo + PAC,Yes,Yes,,55,13,,,,AWADA0414_OS_endopac.xml,Also reports patient counts,,,,,,,4.2,,,AWADA0414_PFS_endopac.xml,55,Also reports patient counts
AWADA0414_T2,Endo mono,Yes,Yes,,57,11.9,,,,AWADA0414_OS_endo.xml,,,,,,,,3.4,,,AWADA0414_PFS_endo.xml,57,
AWADA0414_T3,PAC mono,Yes,Yes,,28,13.1,,,,AWADA0414_OS_paclitaxel.xml,,,,,,,,3.7,,,AWADA0414_PFS_paclitaxel.xml,28,
AWADA1113_T1,Etirinotecan pegol 145 mg/m2 every 14 days,Yes,Yes,,35,8.8,,,27,AWADA1113_OS_14day.xml,Also reports patient counts,,,,,,,3.3,,,AWADA1113_PFS_14day.xml,32,Also reports patient counts
AWADA1113_T2,Etirinotecan pegol 145 mg/m2 every 21 days,Yes,Yes,,35,13.1,,,23,AWADA1113_OS_21day.xml,,,,,,,,5.6,,,AWADA1113_PFS_21day.xml,29,
AWADA1216_T1,Neratinib Plus Paclitaxel,Yes,,,242,,"HR 1.05 [0.76, 1.45] p=0.77",,,,,,,,,,,12.9,"HR 1.02 [0.81, 1.27] p=0.89",,,,
AWADA1216_T2,Trastuzumab Plus Paclitaxel,Yes,,,237,,,,,,,,,,,,,12.9,,,,,
BACHE0711_T1,XT,Yes,Yes,,33,36.4,,,17.49,BACHE0711_OS_XT.xml,53% of patients died by follow-up,,,,,,,12.4,,,BACHE0711_PFS_XT.xml,33,overall p=0.0404
BACHE0711_T2,ET,Yes,Yes,,35,26.6,,,18.02,BACHE0711_OS_ET.xml,,,,,,,,6.8,,,BACHE0711_PFS_ET.xml,34,
BACHE0812_T1,Tamoxifen Alone,Yes,Yes,,57,32.9,,,,BACHE0812_OS_T.xml,,4.5,,,BACHE0812_OS_T.xml,,,,,,,,
BACHE0812_T2,Tamoxifen Plus Everolimus,Yes,Yes,,54,,"HR 0.45 [0.24, 0.81] p=0.007",,,BACHE0812_OS_T+E.xml,,8.6,"HR 0.54 [0.36, 0.81] p=0.0021",,BACHE0812_OS_T+E.xml,,,,,,,,
BAIDA0700_T1,200 mg,Yes,,,14,,,,,,,,,,,,,,,,,,
BAIDA0700_T2,800 mg,Yes,,,14,,,,,,,,,,,,,,,,,,
BAJET0102_T1,OP-LAR and TAM,Yes,,,99,,,,,,,,,,,,,5.83,,,BAJET0102_PFS_OPLAR.xml,53,overall p=0.62
BAJET0102_T2,Placebo and TAM,Yes,,,100,,,,,,,,,,,,,6.28,,,BAJET0102_PFS_placebo.xml,56,
BAJET0299_T1,Letrozole 0.5 mg,Yes,,,22,,,,,,,3.13,,,,,not broken down by arm; no additional info,,,,,,
BAJET0299_T2,Letrozole 2.5 mg,Yes,,,24,,,,,,,3.13,,,,,not broken down by arm; no additional info,,,,,,
BAJET0794_T1,250 mg,Yes,Yes,,69,30,,,,BAJET0794_OS_250mg.xml,,8,,,BAJET0794_TTP_250mg.xml,69,,,,,,,
BAJET0794_T2,500 mg,Yes,Yes,,68,22,,,,BAJET0794_OS_500mg.xml,,9,,,BAJET0794_TTP_500mg.xml,68,,,,,,,
BAND1077_T1,Bleomycin,Yes,,,24,,,,,,,,,,,,,,,,,,
BAND1077_T2,CCNU,Yes,,,20,,,,,,,,,,,,,,,,,,
BAND1077_T3,Streptozotocin,Yes,,,20,,,,,,,,,,,,,,,,,,
BARRI0510_T1,Sunitinib,Yes,Yes,,238,15.3,"HR 1.17 [0.84, 1.63] p=0.350",,,BARRI0510_OS_SUN.xml,,,,,,,,2.8,"HR 1.47 [1.16, 1.87] p=0.002",,BARRI0510_PFS_SUN.xml,,
BARRI0510_T2,Capecitabine,Yes,Yes,,244,24.6,,,,BARRI0510_OS_CAP.xml,,,,,,,,4.2,,,BARRI0510_PFS_CAP.xml,,
BASEL0112_T1,Placebo plus Trasuzumab plus Docetaxel,Yes,,,406,40.8,,,,,,,,,,,,12.4,,,,,
BASEL0112_T2,Pertuzumab plus Trastuzumab plus Docetaxel,Yes,,,402,56.5,"HR 0.68 [0.56, 0.84] p<0.001",,,,,,,,,,,18.7,"HR 0.68 [0.58, 0.80] p<0.001",,,,
BASEL0212_T1,Everolimus and Exemestane,Yes,,,482,31,"HR 0.89 [0.73, 1.10] p=0.14",,,,,,,,,,,11,"HR 0.38 [0.31, 0.48] p<0.001",,BASEL0212_PFS_EV.xml,,
BASEL0212_T2,Placebo and Exemestane,Yes,,,238,26.6,,,,,,,,,,,,4.1,,,BASEL0212_PFS_PLACEBO.xml,,
BASEL0314_T1,MTP,Yes,,,181,33.6,"HR 0.793 [0.610, 1.031] p=0.083",,,,,,,,,,,16.1,"HR 0.837 [0.648, 1.082] p=0.174",,,,
BASEL0314_T2,TP,Yes,,,182,29,,,,,,,,,,,,14.5,,,,,
BASEL0512_T1,Sorafenib plus Capecitabine population,Yes,Yes,,115,22.2,"HR 0.86 [0.61, 1.23] p=0.42",,,BASEL0512_OS_SORA.xml,,6.8,"HR 0.56 [0.39, 0.80] p<0.001",,,,,6.4,"HR 0.58 [0.41, 0.81] p<0.001",,BASEL0512_PFS_SORA.xml,,
BASEL0512_T2,Placebo plus Capecitabine population,Yes,Yes,,114,20.9,,,,BASEL0512_OS_PLACEBO.xml,,4.1,,,,,,4.1,,,BASEL0512_PFS_PLACEBO.xml,,
BASEL0617_T3,RIDA 30 mg + DALO,Yes,Yes,,29,24.7,"HR 1.28 [0.65, 2.49] p=0.763",,,BASEL0617_OS_MK.xml,,,,,,,,4.99,"HR 1.00 [0.46, 2.19] p=0.5",,BASEL0617_PFS_MK.xml,,
BASEL0617_T4,Exemestane,Yes,Yes,,33,24.9,,,,BASEL0617_OS_Exe.xml,,,,,,,,5.67,,,BASEL0617_PFS_Exe.xml,,
BASEL0713_T1,Cisplatin plus cetuximab,Yes,,,115,12.9,"HR 0.82 [0.56, 1.20] p=0.31",,,,,,,,,,,3.7,"HR 0.67 [0.47, 0.97] p=0.032",,,,
BASEL0713_T2,Cisplatin alone,Yes,,,58,9.4,,,,,,,,,,,,1.5,,,,,
BASEL0717_T1,Buparlisib plus fulvestrant,Yes,,,576,,,,,,,,,,,,,6.9,"HR 0.78 [0.67, 0.89]",,BASEL0713_PFS_BUP.xml,,1-sided p-value also provided
BASEL0717_T2,Placebo plus fulvestrant,Yes,,,571,,,,,,,,,,,,,5,,,BASEL0713_PFS_PLACEBO.xml,,
BASEL0903_T1,20 mg,Yes,,,46,,,,,,,10.7,,,BASEL0903_TTP_20mg.xml,42,also has patient counts,,,,,,
BASEL0903_T2,50 mg,Yes,,,46,,,,,,,8.6,,,BASEL0903_TTP_50mg.xml,43,also has patient counts,,,,,,
BASTH0496_T1,Epirubicin Dose: 40 mg/m2,Yes,Yes,,75,13.6,,,,BASTH0496_OS_40mg.xml,,4.4,,,BASTH0496_TTP_40mg.xml,75,,,,,,,
BASTH0496_T2,Epirubicin Dose: 60 mg/m2,Yes,Yes,,66,14,,,,BASTH0496_OS_60mg.xml,,4.7,,,BASTH0496_TTP_60mg.xml,66,,,,,,,
BASTH0496_T3,Epirubicin Dose: 90 mg/m2,Yes,Yes,,64,14.6,,,,BASTH0496_OS_90mg.xml,,8.4,,,BASTH0496_TTP_90mg.xml,64,,,,,,,
BASTH0496_T4,Epirubicin Dose: 135 mg/m2,Yes,Yes,,58,11.3,,,,BASTH0496_OS_135mg.xml,,8.4,,,BASTH0496_TTP_135mg.xml,58,,,,,,,
BATIS0301_T1,MC,Yes,Yes,,142,19,,,,BATIS0301_OS_MC.xml,,5.1,,,BATIS0301_TTP_MC.xml,,,,,,,,
BATIS0301_T2,AC,Yes,Yes,,155,16,"HR 1.04 [0.77, 1.42] p=0.79",,,BATIS0301_OS_AC.xml,,5.5,"HR 1.03 [0.80, 1.33] p=0.82",,BATIS0301_TTP_AC.xml,,,,,,,,
BEEX0381_T1,EE2 group,Yes,,,29,31,,,,,not reported as single K-M curve,,,,,,,,,,BEEX0381_PFS_EE2.xml,,
BEEX0381_T2,Tamoxifen group,Yes,,,30,25,,,,,not reported as single K-M curve,,,,,,,,,,BEEX0381_PFS_TAM.xml,,
BEEX1206_T1,Continuous tamoxifen,Yes,Yes,,94,35.1,,,82,BEEX1206_PFS_continuous.xml,also reports patient counts,,,,,,,11,,,BEEX1206_PFS_continuous.xml,93,
BEEX1206_T2,Intermittent tamoxifen,Yes,Yes,,93,35.2,,,78,BEEX1206_PFS_intermittent.xml,also reports patient counts,,,,,,,8,,,BEEX1206_PFS_intermittent.xml,88,
BEEX1206_T3,Intermittent/alternated tam/MPA,Yes,Yes,,89,31.4,,,76,BEEX1206_PFS_TMPA.xml,also reports patient counts,,,,,,,10.8,,,BEEX1206_PFS_TMPA.xml,87,
BEEX1287_T1,Oral,Yes,,,56,12,,,,,no further information,,,,,,,,,,,,
BEEX1287_T2,Intramuscular,Yes,,,51,10,,,,,no further information,,,,,,,,,,,,
BELTR0791_T1,TAM group,Yes,,,60,22.01,,,,,reports p=0.004,7,,,BELTR0791_TTP_TAM.xml,54,p=0.019,,,,,,
BELTR0791_T2,TAM-MPA group,Yes,,,60,30.97,,,,,,15,,,BELTR0791_TTP_TAMMPA.xml,58,,,,,,,
BENNE1088_T1,CNF,Yes,Yes,,167,12.57,,,142,BENNE1088_OS_CNF.xml,,4.83,,,BENNE1088_TTP_CNF.xml,115,p=0.18,,,,,,
BENNE1088_T2,CAF,Yes,Yes,,164,12.83,,0.25,141,BENNE1088_OS_CAF.xml,,5.8,,,BENNE1088_TTP_CAF.xml,116,,,,,,,
BERGH0312_T1,Sunitinib + Docetaxel,Yes,Yes,,296,24.8,"HR 1.21 [0.91, 1.60]",,,BERGH0312_OS_SU+DOC.xml,1-sided p-value,,,,,,,8.6,"HR 0.92 [0.72, 1.19] p=0.265",,BERGH0312_PFS_SU+DOC.xml,,1-sided p-value
BERGH0312_T2,Docetaxel,Yes,Yes,,297,25.5,,,,BERGH0312_OS_DOC.xml,,,,,,,,8.3,,,BERGH0312_PFS_DOC.xml,,
BERGH0612_T1,Anastrozole plus fulvestrant,Yes,Yes,,258,37.8,"HR 1.00 [0.76, 1.32]",,,BERGH0612_OS_A+F.xml,,10.8,"HR 0.99 [0.81, 1.20] p=0.91",,,,,,,,BERGH0612_PFS_A+F.xml,,
BERGH0612_T2,Anastrozole,Yes,Yes,,256,38.2,,,,BERGH0612_OS_A.xml,,10.2,,,,,,,,,BERGH0612_PFS_A.xml,,
BERRU1002_T1,EPI,Yes,,,91,,,,,,,8.6,,,BERRU1002_TTP_EPI.xml,93,,,,,,,
BERRU1002_T2,EPI + CDDP,Yes,,,90,,,,,,,11,,,BERRU1002_TTP_EPICDDP.xml,92,,,,,,,
BERRU1002_T3,EPI + LND,Yes,,,92,,,,,,,10.1,,,BERRU1002_TTP_EPILND.xml,93,,,,,,,
BERRU1002_T4,EPI + CDDP + LND,Yes,,,90,,,,,,,11,,,BERRU1002_TTP_EPICDDPLND.xml,93,,,,,,,
BEUSE0710_T1,Paclitaxel,Yes,Yes,,33,13,,,,BEUSE0710_OS_paclitaxel.xml,,4.9,,,BEUSE0710_TTP_paclitaxel.xml,33,,,,,,,
BEUSE0710_T2,Docetaxel,Yes,Yes,,37,7.5,,,,BEUSE0710_OS_docetaxel.xml,,3,,,BEUSE0710_TTP_docetaxel.xml,37,,,,,,,
BEZWO0879_T1,CVMF,Yes,,,57,11.8,,,,,KM curve split by response,,,,,,,,,,,,
BEZWO0879_T2,CAMF,Yes,,,51,12.9,,,,,KM curve split by response,,,,,,,,,,,,
BEZWO0998_T1,Fadrozole 1 mg,Yes,,,46,19.1,,,,,,3.72,,,,,,,,,,,
BEZWO0998_T2,Megestrol acetate 40 mg,Yes,,,50,24.43,,,,,,3.9,,,,,,,,,,,
BEZWO1282_T1,Schedule A,Yes,,,24,,,,,,"KM curve split up, and MOS only given for responders",,,,,,,,,,,,
BEZWO1282_T2,Schedule B,Yes,,,28,,,,,,"KM curve split up, and MOS only given for responders",,,,,,,,,,,,
BIGAT0702_T1,AT,Yes,,,138,20.6,,,,BIGAT0702_OS_AT.xml,,,,,,,,6,,,,,BIGAT0702_PFS_AT.xml
BIGAT0702_T2,AC,Yes,,,137,20.5,"HR 0.90 [0.67, 1.21] p=0.49",,,BIGAT0702_OS_AC.xml,,,,,,,,6,"HR 1.06 [0.83, 1.35] p=0.65",,,,BIGAT0702_PFS_AC.xml
BISHO0899_T1,Paclitaxel,Yes,Yes,,107,17.3,,0.068,74.9,BISHO0899_OS_paclitaxel.xml,has patient counts; follow-up range 17-40,,,,,,,5.3,,,BISHO0899_PFS_paclitaxel.xml,107,p=0.25; has patient counts
BISHO0899_T2,CMFP,Yes,Yes,,102,13.9,,,81.6,BISHO0899_OS_CMFP.xml,,,,,,,,6.4,,,BISHO0899_PFS_CMFP.xml,102,
BLACK0310_T1,Lapatinib,Yes,Yes,,148,9.5,,,,BLACK0310_OS_L.xml,,,,,,,,1.89,,,BLACK0310_PFS_L.xml,,
BLACK0310_T2,Lapatinib Plus Trastuzumab,Yes,Yes,,148,14,"HR 0.75 [0.53, 1.07] p=0.106",,,BLACK0310_OS_L+T.xml,,,,,,,,2.59,"HR 0.73 [0.57, 0.93] p=0.008",,BLACK0310_PFS_L+T.xml,,
BLAJM0399_T1,FAC,Yes,Yes,,85,17.3,,,,BLAJM0399_OS_FAC.xml,,9,,,BLAJM0399_TTP_FAC.xml,85,p=0.1965,,,,,,
BLAJM0399_T2,,Yes,Yes,,85,17.8,,0.1584,,BLAJM0399_OS_NA.xml,,7.5,,,BLAJM0399_TTP_NA.xml,85,,,,,,,
BLOHM0710_T1,EC,Yes,Yes,,111,19.9,,,,BLOHM0710_OS_EC.xml,,10.1,,,,,,,,,BLOHM0710_PFS_EC.xml,,
BLOHM0710_T2,ED,Yes,Yes,,125,30,HR 0.663 p=0.21,0.21,,BLOHM0710_OS_ED.xml,,10.3,HR 0.98 p=0.38,,,,,,,,BLOHM0710_PFS_ED.xml,,
BLOMQ0393_T1,FEC Every 28 Days,Yes,Yes,,83,21.2,,0.01,,BLOMQ0393_OS_monthly.xml,,9.2,,,BLOMQ0393_TTP_monthly.xml,86,p=0.005,,,,,,
BLOMQ0393_T2,FEC Every 7 Days,Yes,Yes,,83,11.8,,,,BLOMQ0393_OS_weekly.xml,,5.4,,,BLOMQ0393_TTP_weekly.xml,84,,,,,,,
BOCCA1285_T1,Chemotherapy,Yes,Yes,,36,20,,,,BOCCA1285_OS_C.xml,patient counts given,10.6,,,,,,,,,BOCCA1285_PFS_C.xml,,
BOCCA1285_T2,Chemohormone therapy,Yes,Yes,,32,34,,,,BOCCA1285_OS_CH.xml,patient counts given,17.2,,,,,,,,,BOCCA1285_PFS_CH.xml,,
BOER0412_T1,Vandetanib 100 mg + docetaxel,Yes,,,33,,,,,,,,,,,,,8.17,"HR 0.69 [0.46, 1.04] p=0.25",,,,
BOER0412_T2,Placebo + docetaxel,Yes,,,29,,,,,,,,,,,,,5.6,,,,,
BONNE1004_T1,ET,Yes,Yes,,70,34,,,33,BONNE1004_OS_ET.xml,,7.8,,,BONNE1004_TTP_ET.xml,,,,,,,,
BONNE1004_T2,FEC,Yes,Yes,,72,28,,,41,BONNE1004_OS_FEC.xml,,5.9,,,BONNE1004_TTP_FEC.xml,,,,,,,,
BONNE1085_T1,500 mg,Yes,,,73,13.2,,,,,KM split by response,,,,,,,,,,,,
BONNE1085_T2,1000 mg,Yes,,,76,14.2,,,,,KM split by response,,,,,,,,,,,,
BONNE1100_T1,Anastrozole 1 mg,Yes,,,336,,,,,,,8.2,,,BONNE1004_TTP_ANA.xml,,,,,,,,
BONNE1100_T2,Tamoxifen 20 mg,Yes,,,329,,,,,,,8.3,HR 0.99 p=0.941,,BONNE1004_TTP_TAM.xml,,,,,,,,
BONNE1102_T1,Docetaxel,Yes,Yes,,86,16,,,51,BONNE1102_OS_DOC.xml,,6.5,,,BONNE1102_TTP_DOC.xml,,,,,,,,
BONNE1102_T2,FUN,Yes,Yes,,90,15,,,45,BONNE1102_OS_FUN.xml,,5.1,,,BONNE1102_TTP_FUN.xml,,,,,,,,
BONNE1288_T1,Placebo,Yes,,,80,,,,,,,,,,,,,,,,,,
BONNE1288_T2,Bromocriptine,Yes,,,71,,,,,,,,,,,,,,,,,,
BONTE0698_T1,Doxorubicin,Yes,Yes,,116,10.97,,0.2,95,BONTE0698_OS_DOX.xml,patient counts available,5.37,,,BONTE0698_TTP_DOX.xml,,,,,,,,
BONTE0698_T2,Epirubicin,Yes,Yes,,113,10.27,,,103,BONTE0698_OS_EPI.xml,,4.43,,,BONTE0698_TTP_EPI.xml,,,,,,,,
BONTE1005_T1,AT,Yes,Yes,,108,22.6,,,,BONTE1005_OS_AT.xml,,8,,,BONTE1005_TTP_AT.xml,,,,,,,,
BONTE1005_T2,FAC,Yes,Yes,,107,16.2,"HR 1.43 [1.06, 1.92] p=0.019",,,BONTE1005_OS_FAC.xml,,6.6,"HR 1.50 [1.13, 1.98] p=0.004",,BONTE1005_TTP_FAC.xml,,,,,,,,
BRAMB0178_T1,Therapy A,Yes,,,55,,,,,,,,,,,,,,,,,,
BRAMB0178_T2,Therapy B,Yes,,,55,,,,,,,,,,,,,,,,,,
BRAMB0286_T1,Doxorubicin,Yes,,,21,,,,,,,,,,,,,,,,,,
BRAMB0286_T2,Epirubicin,Yes,,,23,,,,,,,,,,,,,,,,,,
BRAMB0374_T1,Adriamycin + vincristine group,Yes,,,20,,,,,,,,,,,,,,,,,,
BRAMB0374_T2,Adriamycin + vincristine + prednisone group,Yes,,,22,,,,,,,,,,,,,,,,,,
BRAMB0476_T1,CMF,Yes,Yes,,53,17.5,,,32,BRAMB0476_OS_CMF.xml,,,,,,,,,,,BRAMB0476_PFS_CMF.xml,,
BRAMB0476_T2,AV,Yes,Yes,,52,22.5,,0.34,27,BRAMB0476_OS_AV.xml,,,,,,,,,,,BRAMB0476_PFS_AV.xml,,
BRATH0884_T1,10 mg bd,Yes,,,116,,,,,,,,,,,,,,,,,,
BRATH0884_T2,20 mg bd,Yes,,,121,,,,,,,,,,,,,,,,,,
BROWN0277_T1,FACO,Yes,,,72,,,,,,,,,,,,,,,,,,
BROWN0277_T2,FANO,Yes,,,60,,,,,,,,,,,,,,,,,,
BROWN0277_T3,FANOM,Yes,,,55,,,,,,,,,,,,,,,,,,
BROWN0676_T1,AO,Yes,,,20,,,,,,,,,,,,,,,,,,
BROWN0676_T2,ACO,Yes,,,27,,,,,,,,,,,,,,,,,,
BROWN0676_T3,FACO,Yes,,,34,,,,,,,,,,,,,,,,,,
BRUFM0297_T1,FEC100,Yes,,,212,18,,0.54,,BRUFM0297_OS_FEC100.xml,,7.6,,,,,,,,,,,
BRUFM0297_T2,FEC50,Yes,,,241,17,,,,BRUFM0297_OS_FEC50.xml,,7,,,,,,,,,,,
BRUFS0811_T1,PB,Yes,Yes,,94,25,,,,BRUFS0811_OS_PB.xml,,,,,,,,8.8,,,BRUFS0811_PFS_PB.xml,,
BRUFS0811_T2,PB+G,Yes,Yes,,93,24.3,"HR 0.84 [0.52, 1.35] p=0.475",,,BRUFS0811_OS_PB+G.xml,,,,,,,,11.3,"HR 0.82 [0.60, 1.14] p=0.247",,BRUFS0811_PFS_PB+G.xml,,
BRUNI0289_T1,Group A,Yes,,,25,,,,,,,,,,,,,,,,,,KM split by response status
BRUNI0289_T2,Group B,Yes,,,19,,,,,,,,,,,,,,,,,,KM split by response status
BRUNI0289_T3,Group C,Yes,,,27,,,,,,,,,,,,,,,,,,KM split by response status
BRUNN0677_T1,Premenopausal: Ovariectomy + chemotherapy,Yes,,A,19,19.9,,,,BRUNN0677_OS1_ovariectomy.xml,,,,,,,,,,,,,
BRUNN0677_T2,Premenopausal: Chemotherapy only,Yes,,A,23,13.2,,,,BRUNN0677_OS1_chemo.xml,,,,,,,,,,,,,
BRUNN0677_T3,Premenopausal with no prior hormone therapy: DES + chemotherapy,Yes,,B,48,26.7,,,,BRUNN0677_OS2_DES.xml,,,,,,,,,,,,,
BRUNN0677_T4,Premenopausal with no prior hormone therapy: chemotherapy only,Yes,,B,48,19.2,,,,BRUNN0677_OS2_chemo.xml,,,,,,,,,,,,,
BRUNN0677_T5,Postmenopausal with previous hormonal therapy: Depo-Provera + chemotherapy,Yes,,C,38,18.1,,,,BRUNN0677_OS3_depo.xml,,,,,,,,,,,,,
BRUNN0677_T6,Postmenopausal with previous hormonal therapy: chemotherapy only,Yes,,C,37,22.8,,,,BRUNN0677_OS3_chemo.xml,,,,,,,,,,,,,
BULL0578_T1,CAF,Yes,,,38,27.2,,0.13,14,BULL0578_OS_CAF.xml,,6.06,,,,,,,,,,,
BULL0578_T2,CMF,Yes,,,40,17,,,27,BULL0578_OS_CMF.xml,,10.08,,,,,,,,,,,
BURST0407_T1,Arm 1,Yes,,,21,,,,,,,2.1,,,BURST0407_TTP_ARM1.xml,,,,,,,,
BURST0407_T2,Arm 2,Yes,,,21,,,,,,,2.1,,,BURST0407_TTP_ARM2.xml,,,,,,,,
BURST0907_T1,Arm A,Yes,,,41,,,,,,,8.5,,,BURST0907_TTP_ARMA.xml,,,,,,,,
BURST0907_T2,Arm B,Yes,,,40,,,,,,,6,,,BURST0907_TTP_ARMB.xml,,,,,,,,
BURST1214_T1,Lapatinib Arm,Yes,,,146,30,"HR 0.91 [0.68, 1.21]",,,,1-sided p-value only,,,,,,,4.7,,,,,
BURST1214_T2,Placebo Arm,Yes,,,145,26.4,,,,,,,,,,,,3.8,,,,,
BUYUK1087_T1,CNF,Yes,,,30,,,,8,BUYUK1087_OS_CNF.xml,,,,,,,,,,,,,
BUYUK1087_T2,CAF,Yes,,,30,9,,,,BUYUK1087_OS_CAF.xml,,,,,,,,,,,,,
BUZDA0179_T1,FAC,Yes,,,132,21.4,,,49,BUZDA0179_OS_FAC.xml,,,,,,,,,,,,,
BUZDA0179_T2,FAI,Yes,,,60,23.5,,,20,BUZDA0179_OS_FAI.xml,,,,,,,,,,,,,
BUZDA0297_T1,Anastrozole 1 mg,Yes,Yes,,128,,"HR 0.96 [0.45, 2.08] p=0.91",,,BUZDA0297_OS_1.xml,Says 97.5% CI,5.67,,,BUZDA0297_TTP_1.xml,,,,,,,,
BUZDA0297_T2,Anastrozole 10 mg,Yes,Yes,,130,,"HR 0.50 [0.21, 1.21] p=0.08",,,BUZDA0297_OS_10.xml,Says 97.5% CI,4.77,,,BUZDA0297_TTP_10.xml,,,,,,,,
BUZDA0297_T3,Megestrol acetate,Yes,Yes,,128,,,,,BUZDA0297_OS_MEG.xml,,5.03,,,BUZDA0297_TTP_MEG.xml,,,,,,,,
BUZDA0303_T1,Arzoxifene 20 mg,Yes,,,55,,,,,,,4.59,,,,,,,,,,,
BUZDA0303_T2,Arzoxifene 50 mg,Yes,,,57,,,,,,,4.38,,,,,,,,,,,
BUZDA0502_T1,Droloxifene,Yes,Yes,,681,,"HR 0.871 [0.672, 1.129]",,,BUZDA0502_OS_DRO.xml,,6.1,,,,,,,,,,,
BUZDA0502_T2,Tamoxifen ,Yes,,,673,,,,,BUZDA0502_OS_TAM.xml,,7.6,,,,,,,,,,,
BUZDA0582_T1,L-PAM,Yes,,,28,,,,,,,,,,,,,,,,,,
BUZDA0582_T2,Peptichemio,Yes,,,28,,,,,,,,,,,,,,,,,,
BUZDA0696_T1,Protocol 03: Fadrozole HCL,Yes,Yes,A,195,27.13,,0.2492,,BUZDA0696_OS_3FAD.xml,,3.87,,,BUZDA0696_TTP_3FAD.xml,,,,,,,,
BUZDA0696_T2,Protocol 03: Megestrol Acetate,Yes,Yes,A,184,23.07,,,,BUZDA0696_OS_3MEG.xml,,3.8,,,BUZDA0696_TTP_3MEG.xml,,,,,,,,
BUZDA0696_T3,Protocol 06: Fadrozole HCL,Yes,Yes,B,150,25.77,,,,BUZDA0696_OS_6FAD.xml,,5.27,,,BUZDA0696_TTP_6FAD.xml,,,,,,,,
BUZDA0696_T4,Protocol 06: Megestrol Acetate,Yes,Yes,B,148,27.9,,0.6584,,BUZDA0696_OS_6MEG.xml,,5.8,,,BUZDA0696_TTP_6MEG.xml,,,,,,,,
BUZDA0701_T1,Letrozole 0.5 mg,Yes,Yes,,202,33.1,"HR 0.79 [0.62, 1.00] p=0.053",,,BUZDA0701_OS_LET0.5.xml,,5.6,,,BUZDA0701_TTP_LET0.5.xml,,,,,,,,
BUZDA0701_T2,Letrozole 2.5 mg,Yes,Yes,,199,28.6,"HR 0.92 [0.73, 1.17] p=0.492",,,BUZDA0701_OS_LET2.5.xml,,3.2,,,BUZDA0701_TTP_LET2.5.xml,,,,,,,,
BUZDA0701_T3,Megestrol Acetate 160 mg,Yes,Yes,,201,26.2,,,,BUZDA0701_OS_MEG.xml,,3.4,,,BUZDA0701_TTP_MEG.xml,,,,,,,,
BUZDA0712_T1,40 mg,Yes,,,60,,,,,,,3.5,,,BUZDA0712_TTP_40.xml,,,,,,,,
BUZDA0712_T2,80 mg,Yes,,,66,,,,,,,2.6,,,BUZDA0712_TTP_80.xml,,,,,,,,
BUZDA0712_T3,120 mg,Yes,,,19,,,,,,,3.7,,,BUZDA0712_TTP_120.xml,,,,,,,,
BYRNE0997_T1,TAM + MPA,Yes,Yes,,109,17.2,,,,BYRNE0997_OS_MPA+TAM.xml,,3,,,BYRNE0997_TTP_MPA+TAM.xml,,,,,,,,
BYRNE0997_T2,MPA,Yes,Yes,,106,18.4,,0.87,,BYRNE0997_OS_MPA.xml,,4.5,,,BYRNE0997_TTP_MPA.xml,,,,,,,,
CALAB0291_T1,FAC,Yes,,,128,,,,,,,6,,,CALAB0291_TTP_FAC.xml,,,,,,,,
CALAB0291_T2,FAC Plus LND,Yes,,,126,,,,,,,9,,,CALAB0291_TTP_FAC+LND.xml,,,,,,,,
CAMPO0513_T1,V+C,Yes,,,44,22.2,,,28.7,CAMPO0513_OS_VC.xml,90 deaths distributed evenly,,,,,,,7.2,,,,,
CAMPO0513_T2,V+C Sequential,Yes,,,46,19.4,,,30,CAMPO0513_OS_VCseq.xml,,,,,,,,3.4,,,,,
CAMPO0513_T3,D+C,Yes,,,48,24.2,,,31.3,CAMPO0513_OS_DC.xml,,,,,,,,8.9,,,,,
CANEL1176_T1,L-PAM,Yes,,,91,9,,,,CANEL1176_OS_LPAM.xml,,,,,,,,,,,,,
CANEL1176_T2,Triple therapy (CMF),Yes,,,93,12,,,,CANEL1176_OS_CMF.xml,,,,,,,,,,,,,
CANNE0988_T1,AG,Yes,,,106,15.8,,0.85,,,too fuzzy,,,,,,,,,,,,
CANNE0988_T2,MPA,Yes,,,112,15.7,,,,,too fuzzy,,,,,,,,,,,,
CAPOT0103_T1,FEC,Yes,Yes,,44,23.3,,,29.24,CAPOT0103_OS_FEC.xml,68% of patients died,12.7,,,CAPOT0103_TTP_FEC.xml,,,,,,,,
CAPOT0103_T2,FEC-G,Yes,Yes,,42,25.6,,-0.55,27.88,CAPOT0103_OS_FECG.xml,,12,,,CAPOT0103_TTP_FECG.xml,,,,,,,,
CAPOT0103_T3,MMM-G,Yes,Yes,,45,24.1,,-0.21,27.88,CAPOT0103_OS_MMMG.xml,,14.5,,,CAPOT0103_TTP_MMMG.xml,,,,,,,,
CAREY0712_T1,Arm 1,Yes,,,31,7.5,,,26,CAREY0712_OS_arm1.xml,report number of patients,1.4,,,,,,,,,,,
CAREY0712_T2,Arm 2,Yes,,,71,10.4,,,59,CAREY0712_OS_arm2.xml,,2.1,,,,,,,,,,,
CARLS0612_T1,Anastrozole plus gefitinib,Yes,,,74,30.3,,,40,CARLS0612_OS_anastrozole.xml,,,,,,,,5.3,,,,,
CARLS0612_T2,Fulvestrant plus gefitinib,Yes,,,74,23.9,,,45,CARLS0612_OS_fulvestrant.xml,,,,,,,,5.2,,,,,
CARMO0586_T1,Intensive Group,Yes,,,51,21,,,,CARMO0586_OS_intensive.xml,,,,,,,,,,,,,
CARMO0586_T2,Intermittent group,Yes,,,49,17,,,,CARMO0586_OS_intermittent.xml,,,,,,,,,,,,,
CARMO1081_T1,CMFP,Yes,,,26,22.4,,,,CARMO1081_OS_CMFP.xml,,,,,,,,,,,,,
CARMO1081_T2,VAC,Yes,,,25,18,,,,CARMO1081_OS_VAC.xml,,,,,,,,,,,,,
CARMO1087_T1,Regimen A,Yes,,,24,20,,0.004862,14,CARMO1087_OS_A.xml,,,,,,,,,,,,,
CARMO1087_T2,Regimen B,Yes,,,24,8,,,21,CARMO1087_OS_B.xml,,,,,,,,,,,,,
CARMO1280_T1,Study Group,Yes,,,68,16,,,49,CARMO1280_OS_study.xml,,,,,,,,,,,,,
CARMO1280_T2,Control group,Yes,,,67,6,,,67,CARMO1280_OS_control.xml,,,,,,,,,,,,,
CARPE0986_T1,CAF-levamisole,Yes,,,49,20.3,,0.798,36.37,,72/97 total events,,,,,,,,,,,,
CARPE0986_T2,CAF-placebo,Yes,,,48,17.7,,,35.63,,,,,,,,,,,,,,
CASSI0508_T1,Arm D,Yes,Yes,,107,21.4,,,81.52,CASSI0508_OS_D.xml,160/210 total events,,,,,,,8.7,,,CASSI0508_PFS_D.xml,,
CASSI0508_T2,Arm P,Yes,Yes,,103,27.3,,0.081,78.48,CASSI0508_OS_P.xml,,,,,,,,8,,,CASSI0508_PFS_P.xml,,
CASTI1193_T1,MAP,Yes,,,55,29.03,"HR 0.83 [0.54, 1.27]",,,,"the HRs of the two MAP arms against TAM-MAP, combined using inverse variance weighting -- From the HRs and Cis in the text, MAP-TAM has ln(HR) = -0.2357223 and Var(HR) = 0.09615277 and MAP-AGT has ln(HR) = -0.1392621 and Var(HR) = 0.09138973 ; the inverse-variance-weighted estimate is therefore ln(HR) = -0.1862673 and Var(HR) = 0.04685538",8.8,,,CASTI1193_TTP_MAP.xml,50,,,,,,,
CASTI1193_T2,TAM,Yes,,,64,20.95,,,,,KM curve split up ,5.4,,,CASTI1193_TTP_TAM.xml,61,,,,,,,
CAVAL0584_T1,Regimen A,Yes,,,91,17.17,,0.7086,,,,,,,,,,,,,,,
CAVAL0584_T2,Regimen B,Yes,,,93,17.27,,,,,,,,,,,,,,,,,
CAVAL1183_T1,Treatment I,Yes,,,74,23.5,,,,CAVAL1183_OS_A1.xml,,,,,,,,,,,,,
CAVAL1183_T2,Treatment II,Yes,,,70,27,,,,CAVAL1183_OS_A2.xml,,,,,,,,,,,,,
CAVAL1183_T3,Treatment III,Yes,,,72,30,,,,CAVAL1183_OS_A3.xml,,,,,,,,,,,,,
CECI0795_T1,Arm A,Yes,,,46,8.4,,,,,,3.27,,,,,,,,,,,
CECI0795_T2,Arm B,Yes,,,43,8.17,,,,,,2.33,,,,,,,,,,,
CHAN0409_T1,GD,Yes,Yes,,152,19.29,,0.983,119,CHAN0409_OS_GD.xml,,,,,,,,8.05,,,CHAN0409_PFS_GD.xml,151,
CHAN0409_T2,CD,Yes,Yes,,150,21.45,,,115,CHAN0409_OS_CD.xml,,,,,,,,7.98,,,CHAN0409_PFS_CD.xml,142,
CHAN1004_T1,MC,Yes,Yes,,76,18.3,,,,CHAN1004_OS_MC.xml,,7.7,,,CHAN1004_TTP_MC.xml,,,,,,,,
CHAN1004_T2,EC,Yes,Yes,,78,16,"HR 1.15 [0.77, 1.72] p=0.504",,,CHAN1004_OS_EC.xml,,5.6,,,CHAN1004_TTP_EC.xml,,,,,,,,
CHANN0899_T1,Docetaxel,Yes,Yes,,161,15,,0.4506,132,CHANN0899_OS_DOC.xlsx,,6.1,,,,,,,,,CHANN0899_PFS_DOC.xml,,
CHANN0899_T2,Doxorubicin,Yes,Yes,,165,14,,,134,CHANN0899_OS_DOX.xlsx,,4.9,,,,,,,,,CHANN0899_PFS_DOX.xml,,
CHAUV0978_T1,VCF,Yes,,,35,,,,,,,,,,,,,,,,,,
CHAUV0978_T2,DVM,Yes,,,35,,,,,,,,,,,,,,,,,,
CHIA0408_T1,Fulvestrant,Yes,,,351,,,,,,,3.7,,,CHIA0408_TTP_FUL.xml,,,,,,,,
CHIA0408_T2,Exemestane,Yes,,,342,,,,,,,3.7,,,CHIA0408_TTP_EXE.xml,,,,,,,,
CHIES1207_T1,TAM,Yes,,,32,47.4,,,21,CHIES1207_OS_TAM.xml,Very difficult to read event counts,13,,,,,,,,,,,
CHIES1207_T2,TAM + RA,Yes,,,34,38.2,,,21,CHIES1207_OS_TAMRA.xml,,12.5,,,,,,,,,,,
CHIES1207_T3,TAM + IFN-alpha-2a,Yes,,,33,45.1,,,21,CHIES1207_OS_TAMIFN.xml,,10,,,,,,,,,,,
CHLEB0883_T1,DOXO-CCNU,Yes,,,17,9.1,,,15.06,CHLEB0883_OS_AC.xml,31/35 deaths,,,,,,,,,,,,
CHLEB0883_T2,DOXO-CCNU-VCR,Yes,,,18,7,,,15.94,CHLEB0883_OS_ACV.xml,,,,,,,,,,,,,
CHLEB1081_T1,Intravenous,Yes,,,24,9.8,,,23.02,CHLEB1081_OS_iv.xml,47/49 deaths,,,,,,,,,,,,
CHLEB1081_T2,Oral,Yes,,,25,12.1,,,23.98,CHLEB1081_OS_po.xml,,,,,,,,,,,,,
CINIE0417_T1,NORCAP,Yes,,,49,30.2,,,31,CINIE0417_OS_NORCAP.xml,,,,,,,,7.6,,,,,
CINIE0417_T2,GEMPAC,Yes,,,50,29.6,,,37,CINIE0417_OS_GEMPAC.xml,,,,,,,,9,,,,,
CINIE0417_T3,GEMDOC,Yes,,,50,31,,,35,CINIE0417_OS_GEMDOC.xml,,,,,,,,11.4,,,,,
CLEME0115_T1,YM155 + Docetaxel,Yes,,,50,20.03,,,,,,,,,,,,8.4,,,,,
CLEME0115_T2,Docetaxel,Yes,,,51,21,,0.768,,,,,,,,,,10.5,,,,,
CLEMO0714_T1,Vandetanib,Yes,,,61,31,,,18,,KM only plotted within subgroups,,,,,,,5.8,,,,,
CLEMO0714_T2,Placebo,Yes,,,68,,,,23,,,,,,,,,4.8,,,,,
CLEMO1110_T1,Capecitabine + enzastaurin,Yes,,,42,9.9,"HR 1.770 [0.9, 3.5] p=0.392",,,,,,,,,,,2.8,,,CLEMO1110_PFS_ENZ.xml,,
CLEMO1110_T2,Capecitabine + placebo,Yes,,,43,14.9,,,,,,,,,,,,4.3,,,CLEMO1110_PFS_PLACEBO.xml,,
COBAU0296_T1,Megestrol Acetate,Yes,,,135,26,,,93,COBAU0296_OS_MEG.xml,,,,,,,,,,,,,
COBAU0296_T2,Premarin/megestrol acetate,Yes,,,131,25.9,,0.48,83,COBAU0296_OS_PRE.xml,,,,,,,,,,,,,
COCCO0190_T1,Continuation Arm,Yes,,,49,,,,39,COCCO0190_OS_CONT.xml,,,,,,,,,,,,,
COCCO0283_T1,CMF,Yes,,,71,25.9,,0.25,39,,,,,,,,,,,,,,
COCCO0283_T2,CMF + T,Yes,,,62,18.2,,,37,,,,,,,,,,,,,,
COCCO0491_T1,CMF,Yes,,,65,17.5,,0.86,45,COCCO0491_OS_CMF.xml,,7.47,,,,,,,,,,,
COCCO0491_T2,PE,Yes,,,65,17.73,,,46,COCCO0491_OS_PE.xml,,7.23,,,,,,,,,,,
COCCO0692_T1,AG + HC,Yes,,,79,34.2,,,,,,8.1,,,,,,,,,,,
COCCO0692_T2,AG,Yes,,,74,36.3,,0.56,,,,6.3,,,,,,,,,,,
COLE0573_T1,C,Yes,,,30,17.3,,,,,mean instead of median survival,,,,,,,,,,,,
COLE0573_T2,N,Yes,,,26,10,,,,,mean instead of median survival,,,,,,,,,,,,
COLE0573_T3,C+N,Yes,,,22,10,,,,,mean instead of median survival,,,,,,,,,,,,
COLEM0506_T1,ARM A (60 q 6),Yes,,,57,,,,,,,5.8,,,,,,,,,,,
COLEM0506_T2,ARM B (50 q 4),Yes,,,59,,,,,,,5.4,,,,,,,,,,,
COLLE0206_T1,Arm A (C+M),Yes,,,90,18.2,,0.98,,,,3.8,,,,,,,,,,,
COLLE0206_T2,Arm B (C+M+T),Yes,,,88,17.1,,,,,,4.1,,,,,,,,,,,
CONTE0387_T1,CEF,Yes,Yes,,59,14.7,,,25.61,CONTE0387_OS_CEF.xml,,,,,,,,8.83,,,CONTE0387_PFS_CEF.xml,,
CONTE0387_T2,DES-CEF,Yes,Yes,,57,18.6,"HR 0.838 [0.491, 1.429] p=0.5",,28.39,CONTE0387_OS_DESCEF.xml,HR from reported O and E,,,,,,,9.2,,,CONTE0387_PFS_DESCEF.xml,,
CONTE0796_T1,CEF,Yes,Yes,,128,17.3,,,112.64,CONTE0796_OS_CEF.xml,,,,,,,,9.4,,,CONTE0796_PFS_CEF.xml,,
CONTE0796_T2,DES-CEF,Yes,Yes,,130,20,,0.7,114.4,CONTE0796_OS_DESCEF.xml,,,,,,,,11,,,CONTE0796_PFS_DESCEF.xml,,
CONTE0804_T1,Concomitant arm A,Yes,Yes,,106,20,,,,CONTE0804_OS_armA.xml,,,,,,,,11,,,CONTE0804_PFS_armA.xml,,
CONTE0804_T2,Sequential arm B,Yes,Yes,,92,26,,,,CONTE0804_OS_armB.xml,,,,,,,,10.8,,,CONTE0804_PFS_armB.xml,,
COOK1196_T1,Epirubicin,Yes,,,18,9.5,,,,,,,,,,,,,,,,,
COOK1196_T2,Mitozantrone,Yes,,,22,8,,,,,,,,,,,,,,,,,
CORKE0882_T2,Tamoxifen - Aminoglutethimidine,Yes,,,11,,,,,,,,,,,,,,,,,,
CORKE0882_T3,Tamoxifen only,Yes,,,9,,,,,,,,,,,,,,,,,,
CORTE0311_T1,Eribulin,Yes,,,508,13.1,,,274,,,,,,,,,3.7,,,,,
CORTE0311_T2,TPC,Yes,,,254,,,,148,,,,,,,,,,,,,,
CORTE1215_T1,Afatinib alone,Yes,Yes,,40,13.46,,,,CORTE1215_OS_A.xml,"HR only reported against investigator choice group, which was removed",,,,,,,2.78,,,CORTE1215_PFS_A.xml,,
CORTE1215_T2,Afatinib plus vinorelbine,Yes,Yes,,38,8.7,,,,CORTE1215_OS_A+V.xml,,,,,,,,2.87,,,CORTE1215_PFS_A+V.xml,,
COWAN0891_T1,Doxorubicin,Yes,,,117,10.5,,,103,COWAN0891_OS_doxorubicin.xml,,,,,,,,,,,,,
COWAN0891_T2,Bisantrene,Yes,,,128,9.7,,,110,COWAN0891_OS_bisantrene.xml,,,,,,,,,,,,,
COWAN0891_T3,Mitoxantrone,Yes,,,120,5.9,,,112,COWAN0891_OS_mitoxantrone.xml,,,,,,,,,,,,,
CREAG1184_T1,CFP,Yes,Yes,,41,18.2,,,,CREAG1184_OS_CFP.xml,,9.2,,,CREAG1184_TTP_CFP.xml,,,,,,,,
CREAG1184_T2,CAP+CFP,Yes,Yes,,45,,,,,CREAG1184_OS_CAP+CFP.xml,,,,,CREAG1184_TTP_CAP+CFP.xml,,,,,,,,
CREST0304_T1,Combination schedule,Yes,,,41,34,,,,,,8.4,,,,,,,,,,,
CREST0304_T2,Alternated schedule,Yes,,,42,34,,,,,,7.93,,,,,,,,,,,
CRIST0310_T1,Anastrozole plus gefitinib,Yes,,,43,,,,22,,,,,,,,,14.7,,,CRIST0310_PFS_GEF.xml,,
CRIST0310_T2,Anastrozole plus placebo,Yes,,,50,,,,32,,,,,,,,,8.4,,,CRIST0310_PFS_PLACEBO.xml,,
CROWN0813_T1,Sunitinib plus capecitabine,Yes,,,221,16.4,"HR 0.99 [0.76, 1.30]",,,,1-sided p-value,,,,,,,5.5,,,,,
CROWN0813_T2,Capecitabine,Yes,,,221,16.5,,,,,,,,,,,,5.9,,,,,
CUMMI0785_T1,CMFP,Yes,,,76,15.8,,,,CUMMI0785_OS_CMFP.xml,,,,,,,,,,,,,
CUMMI0785_T2,CAF,Yes,,,79,18.6,,0.86,,CUMMI0785_OS_CAF.xml,,,,,,,,,,,,,
CUMMI0981_T1,AV,Yes,,,92,8.3,,,74,CUMMI0981_OS_AV.xml,,,,,,,,,,,,,
CUMMI0981_T2,AVD,Yes,,,94,7.1,,,76,CUMMI0981_OS_AVD.xml,,,,,,,,,,,,,
CUMMI0981_T3,AVI,Yes,,,44,7.4,,,39,CUMMI0981_OS_AVI.xml,,,,,,,,,,,,,
CUNA0478_T1,Therapy A,Yes,,,50,,,,,,,,,,,,,,,,,,
CUNA0478_T2,Therapy B,Yes,,,51,,,,,,,,,,,,,,,,,,
CURIG1013_T1,Sunitinib,Yes,,,110,9.4,,,,,,,,,,,,2,,,,,
DELEN0290_T1,TAM,Yes,Yes,,31,,,,,DELEN0290_OS_TAM.xml,,12,,,DELEN0290_TTP_TAM.xml,,,,,,,,
DELEN0290_T2,TAM/MPA,Yes,Yes,,29,34,,,,DELEN0290_OS_TAMMPA.xml,,9,,,DELEN0290_TTP_TAMMPA.xml,,,,,,,,
DELMA0313_T1,Arm A,Yes,,,60,,,,,,,,,,,,,,,,,,
DELMA0313_T2,Arm B,Yes,,,64,,,,,,,,,,,,,,,,,,
DELMA0313_T3,Arm C,Yes,,,58,,,,,,,,,,,,,,,,,,
DELMA0313_T4,Arm D,Yes,,,59,,,,,,,,,,,,,,,,,,
DELMA0401_T1,CEF21,Yes,Yes,,74,32.7,,0.25,40,DELMA0401_OS_CEF.xml,,14.3,,,,,,,,,DELMA0401_PFS_CEF.xml,,
DELMA0401_T2,HD-CEF14,Yes,Yes,,77,27.2,,,44,DELMA0401_OS_HDCEF.xml,,12.8,,,,,,,,,DELMA0401_PFS_HDCEF.xml,,
DESHM1107_T1,Arzoxifene 20 mg,Yes,,,184,,"HR 1.55 [0.85, 2.82] p=0.157",,,,,,,,,,,4,,,DESHM1107_PFS_ARZ.xml,113,
DESHM1107_T2,Tamoxifen 20 mg,Yes,,,184,17.1,,,,,,,,,,,,7.5,,,DESHM1107_PFS_TAM.xml,94,
DICKL0816_T1,Letrozole + Bevacizumab,Yes,Yes,,173,47.2,"HR 0.87 [0.65, 1.18] p=0.19",,,DICKL0816_OS_L+B.xml,1-sided p-value,,,,,,,20.2,"HR 0.75 [0.59, 0.96]",,DICKL0816_OS_L+B.xml,,1-sided p-value
DICKL0816_T2,Letrozole,Yes,Yes,,170,43.9,,,,DICKL0816_OS_L.xml,,,,,,,,15.6,,,DICKL0816_OS_L.xml,,
DIERA0495_T1,Paclitaxel,Yes,Yes,,41,12.7,,0.15,,DIERA0495_OS_PAC.xml,I think the two KM curves were mislabeled based on the text,3.5,,,DIERA0495_TTP_PAC.xml,,,,,,,,
DIERA0495_T2,Mitomycin,Yes,Yes,,40,8.4,,,,DIERA0495_OS_MIT.xml,,1.6,,,DIERA0495_TTP_MIT.xml,,,,,,,,
DIERA0615_T1,Arm A Trebananib 10 mg/kg QW + Paclitaxel + Bevacizumab,Yes,,,56,,,,,,,,,,,,,11.3,,,,,
DIERA0615_T2,Arm B Trebananib 3 mg/kg QW + Paclitaxel + Bevacizumab,Yes,,,57,,,,,,,,,,,,,9.2,,,DIERA0615_PFS_B.xml,,
DIERA0615_T3,Arm C Placebo + Paclitaxel + Bevacizumab,Yes,,,58,,,,,,,,,,,,,12.2,,,DIERA0615_PFS_C.xml,,
DIERA0615_T4,Arm D Trebananib 10 mg/kg QW (Open-Label) + Paclitaxel,Yes,,,57,,,,,,,,,,,,,10,,,DIERA0615_PFS_D.xml,,
DIERA0915_T1,OBP,Yes,Yes,,63,14.7,"HR 1.36 [0.75, 2.46] p=0.316",,,DIERA0915_OS_OBP.xml,,,,,,,,7.3,,,DIERA0915_PFS_OBP.xml,,
DIERA0915_T2,OP,Yes,Yes,,60,13.4,"HR 1.92 [1.03, 3.59] p=0.038",,,DIERA0915_OS_OP.xml,,,,,,,,5.4,,,DIERA0915_PFS_OP.xml,,
DIERA0915_T3,BP,Yes,Yes,,62,17.4,,,,DIERA0915_OS_BP.xml,,,,,,,,7.2,,,DIERA0915_PFS_BP.xml,,
DILEO1208_T1,P + L,Yes,,,293,23.1,HR 0.86 p=0.216,,,,"Removed the CI both because it was rounded and also because it it clearly had a type --- it should have been [0.7, 1.1] instead of [0.7, 1.7].",6.8,,,,,,5.9,"HR 0.87 [0.72, 1.05] p=0.142",,,,
DILEO1208_T2,P + P,Yes,,,286,20.3,,,,,,5.3,,,,,,5.3,,,,,
DIRIX0308_T1,Exemestane,Yes,,,53,17.29,,,,,,4.67,,,DIRIX0308_TTP_EXE.xml,43,,,,,,,
DIRIX0308_T2,Exemestane + celecoxib,Yes,,,53,17.24,,,,,,5.46,,,DIRIX0308_TTP_COX2.xml,40,,,,,,,
DIXON0892_T1,Megesterol acetate,Yes,,,30,13,,,,DIXON0892_OS_MGA.xml,,5,,,,,,,,,,,
DIXON0892_T2,Mitozantrone,Yes,,,30,11,,,,DIXON0892_OS_mitoxantrone.xml,,5,,,,,,,,,,,
DOGLI0496_T1,EPI,Yes,,,104,25.3,,,60,,,10.6,,,,,,,,,,,
DOGLI0496_T2,EPI + LND,Yes,,,103,25,,,57,,,10.5,,,,,,,,,,,
DOMBE0298_T1,Letrozole 0.5 mg,Yes,,,188,21.5,,0.4,126,,,5.1,,,DOMBE0298_TTP_05.xml,,,,,,,,
DOMBE0298_T2,Letrozole 2.5 mg,Yes,,,174,25.3,,0.15,103,,,5.6,,,DOMBE0298_TTP_25.xml,,,,,,,,
DOMBE0298_T3,MA,Yes,,,189,21.5,,,128,,,5.5,,,DOMBE0298_TTP_MA.xml,,,,,,,,
DROOG1016_T1,HAT,Yes,Yes,,39,36.8,,,,DROOG1016_OS_HAT.xml,,,,,,,,19.8,,,DROOG1016_PFS_HAT.xml,,
DROOG1016_T2,HA-HAT,Yes,Yes,,45,54,,,,DROOG1016_OS_HAHAT.xml,,,,,,,,19.6,,,DROOG1016_PFS_HAHAT.xml,,
,20 mg,Yes,,,27,19.67,,0.05,,EBBS0689_OS_20.xml,,,,,,,,,,,,,
EBBS0689_T2,40 mg,Yes,,,26,9.87,,,,EBBS0689_OS_40.xml,,,,,,,,,,,,,
EISEN0498_T1,ECisF,Yes,,,21,10,,,,,MOS only for the subset with metastatic disease,7,,,,,,,,,EISEN0498_PFS_Cis.xml,,
EISEN0498_T2,ECycloF,Yes,,,38,13,,,,,,7,,,,,,,,,EISEN0498_PFS_Cyc.xml,,
EJLER0493_T1,18 months,Yes,,,157,23,,0.03,,,May have removed early failures in the p-value calculation,,,,,,,14,,,EJLER0493_PFS_18.xml,,
EJLER0493_T2,6 months,Yes,,,161,18,,,,,,,,,,,,10,,,EJLER0493_PFS_6.xml,,
EJLER0604_T1,Epirubicin,Yes,Yes,,194,18,,,156,EJLER0604_OS_E.xml,,,,,,,,8.2,,,EJLER0604_PFS_E.xml,,
EJLER0604_T2,VRL + Epirubicin,Yes,Yes,,193,19.1,,0.5,157,EJLER0604_OS_V.xml,,,,,,,,10.1,,,EJLER0604_PFS_V.xml,,
ELLAR0909_T1,Daily Schedule,Yes,,,33,,,,,,,,,,,,,,,,,,
ELLAR0909_T2,Weekly Schedule,Yes,,,16,,,,,,,,,,,,,,,,,,
ELLME0500_T1,TOR 20,Yes,,,90,,,,,,,6.87,,,ELLME0500_TTP_20.xml,,,,,,,,
ELLME0500_T2,TOR 40,Yes,,,81,,,,,,,6.3,,,ELLME0500_TTP_40.xml,,,,,,,,
ELLME0500_T3,TOR 60,Yes,,,89,,,,,,,6.53,,,ELLME0500_TTP_60.xml,,,,,,,,
ELMAW0891_T1,Group I,Yes,,,20,,,,,,,,,,,,,,,,,,
ELMAW0891_T2,Group II,Yes,,,20,,,,,,,,,,,,,,,,,,
ELOMA0503_T1,Group 1,Yes,,,26,26,,,,ELOMA0503_OS_group1.xml,,7,,,,,,,,,,,
ELOMA0503_T2,Group 2,Yes,,,24,23,,,,ELOMA0503_OS_group2.xml,,10,,,,,,,,,,,
ELOMA0503_T3,Group 3,Yes,,,10,16,,,,ELOMA0503_OS_group3.xml,,8,,,,,,,,,,,
ELOMA0588_T1,Single doxorubicin,Yes,,,22,8,,,,,"p=0.38, but unclear which arm is superior",,,,,,,,,,,,
ELOMA0588_T2,Doxorubicin + HD-MPA,Yes,,,21,8,,,,,,,,,,,,,,,,,
ENGEB0512_T1,Docetaxel alone,Yes,,,9,,,,,,,4.4,,,,,,,,,,,
ENGEB0512_T2,Gefitinib + docetaxel,Yes,,,9,,,,,,,3.1,,,,,,,,,,,
ENGEL0891_T1,Schedule A,Yes,,,125,17,,0.016,106,,,8.92,,,ENGEL0891_TTP_A.xml,,,,,,,,
ENGEL0891_T2,Schedule B,Yes,,,129,12,,,113,,,5.03,,,ENGEL0891_TTP_B.xml,,,,,,,,
ERKIS1297_T1,Group 1 Oral etoposide,Yes,,,30,16,,0.2,,,,,,,,,,,,,,,
ERKIS1297_T2,Group 2 FAC,Yes,,,30,14,,,,,,,,,,,,,,,,,
ESTAB1199_T1,CNF,Yes,,,72,11.99,,,71,,,7.7,,,,,,,,,,,
ESTAB1199_T2,CEF,Yes,,,73,17.36,,0.015,68,,,11.9,,,,,,,,,,,
ESTEV0303_T1,"Group 1, 200 mg/m2/d",Yes,,,33,,,,,,,2.12,,,ESTEV0303_TTP_12.xml,,,,,,,,
ESTEV0303_T2,"Group 1, 500 mg/m2/d",Yes,,,15,,,,,,,2.03,,,ESTEV0303_TTP_15.xml,,,,,,,,
ESTEV0303_T3,"Group 2, 200 mg/m2/d",Yes,,,32,,,,,,,2.01,,,ESTEV0303_TTP_22.xml,,,,,,,,
ESTEV0303_T4,"Group 2, 500 mg/m2/d",Yes,,,15,,,,,,,1.96,,,ESTEV0303_TTP_25.xml,,,,,,,,
ESTEV0303_T5,"Group 3, 200 mg/m2/d",Yes,,,36,,,,,,,2.24,,,ESTEV0303_TTP_32.xml,,,,,,,,
ESTEV0303_T6,"Group 3, 500 mg/m2/d",Yes,,,15,,,,,,,1.94,,,ESTEV0303_TTP_35.xml,,,,,,,,
ETTIN0486_T1,Megestrol Acetate,Yes,,,94,,,,,,,9.57,,,,,,,,,,,
ETTIN0486_T2,Tamoxifen,Yes,,,103,,,,,,,12.1,N/A,,,,,,,,,,
FALAN0809_T1,Celecoxib + exemestane,Yes,,,74,,,,,,,,N/A,,,,,9.8,,,FALAN0809_PFS_C.xml,,
FALAN0809_T2,Placebo + exemestane,Yes,,,83,,,,,,,,,,,,,9.8,,,FALAN0809_PFS_P.xml,,
FALKS0293_T1,M,Yes,,,37,7.8,,,,FALKS0293_OS_M.xml,,FALKS0293_TTP_M.xml,,,,,,,,,,,
FALKS0293_T2,MMPA,Yes,,,39,9.7,,0.31,,FALKS0293_OS_MMPA.xml,,FALKS0293_TTP_MMP.xml,,,,,,,,,,,
FALKS0785_T1,Stratum A DAT,Yes,,A,61,9.7,,0.25,,,,,,,,,,,,,,,
FALKS0785_T2,Stratum A MT,Yes,,A,52,7.6,,,,,,,,,,,,,,,,,
FALKS0785_T3,Stratum B MT,Yes,,B,38,4.6,,,,,,,,,,,,,,,,,
FALKS0785_T4,Stratum B MTF,Yes,,B,38,5.9,,0.78,,,,,,,,,,,,,,,
FALKS0796_T1,Fadrozole,Yes,,,40,30.4,,,,,,FALKS07992_TTP_FAD.xml,,,,,,,,,,,
FALKS0796_T2,Tamoxifen,Yes,,,40,33.7,,0.866,,,,FALKS07992_TTP_TAM.xml,,,,,,,,,,,
FALKS0888_T1,MPA and MMC,Yes,,,21,11.2,,,,,,,,,,,,,,,,,
FALKS0888_T2,MPA and vindesine,Yes,,,19,12.7,,,,,,,,,,,,,,,,,
FALKS0992_T1,1 mg daily,Yes,,,38,22.3,,,,FALKS0992_OS_1mg.xml,,,,,,,,,,,,,
FALKS0992_T2,4 mg daily,Yes,,,42,26.3,,0.36,,FALKS0992_OS_4mg.xml,,,,,,,,,,,,,
FALKS1174_T1,Group I: calusterone,Yes,,,10,,,,,,,,,,,,,,,,,,
FALKS1174_T2,Group I: fluoxymesterone,Yes,,,11,,,,,,,,,,,,,,,,,,
FALKS1174_T3,Group II: calusterone,Yes,,,18,,,,,,,,,,,,,,,,,,
FALKS1174_T4,Group II: fluoxymesterone,Yes,,,20,,,,,,,,,,,,,,,,,,
FAN0513_T1,TP arm,Yes,,,27,32.8,"HR 0.41 [0.18, 0.92] p=0.027",,,,,,,,,,,10.9,,,,,
FAN0513_T2,TX arm,Yes,,,26,21.5,,,,,,,,,,,,4.8,,,,,
FEHER0605_T1,Gemcitabine,Yes,,,198,11.8,,,97,,,3.4,,,FEHER0605_TTP_GEMI.xml,,,,,,,,
FEHER0605_T2,Epirubicin,Yes,,,199,19.1,,4.00E-04,68,,,6.1,,,FEHER0605_TTP_EPI.xml,,,,,,,,
FINN0115_T1,Palbociclib plus letrozole,Yes,,,84,37.5,"HR 0.813 [0.492, 1.345] p=0.42",,,,,,,,,,,20.2,,,,,
FINN0115_T2,Letrozole,Yes,,,81,34.5,,,,,,,,,,,,10.2,,,,,
FINN1116_T1,Palbociclib-letrozole,Yes,,,444,,,,,,,,,,,,,24.8,,,FINN1116_PCF_PA.xml,,
FINN1116_T2,Placebo-letrozole,Yes,,,222,,,,,,,,,,,,,14.5,,,FINN1116_PCF_PL.xml,,
FOCAN0793_T1,Group A,Yes,,,70,27.1,,,,,,19.2,,,FOCAN0793_TTP_A.xml,,,,,,,,
FOCAN0793_T2,Group B,Yes,,,71,23.6,,,,,,8,,,FOCAN0793_TTP_B.xml,,,,,,,,
FORER0615_T1,TIG/nab-PAC,Yes,,,42,,,,,,,,,,,,,2.8,,,FORER0615_PFS_TIG.xml,,
FORER0615_T2,nab-PAC,Yes,,,22,,,,,,,,,,,,,3.7,,,FORER0615_PFS_NAB.xml,,
FOUNT0401_T2,Group B,Yes,,,90,20,,,,FOUNT0401_OS_B.xml,,8.5,FOUNT0401_TTP_GRPB.xml,,,,,,,,,,
FOUNT0509_T1,PCb,Yes,,,136,29.9,"HR 0.91 [0.65, 1.28]",,,FOUNT0509_pcb_OS.xml,Converted from 98.34% CI to 95% CI,11.5,,,,,,,,,,,
FOUNT0509_T2,GDoc,Yes,,,144,26.9,,,,FOUNT0509_GDOC_OS.xml,,10.4,,,,,,,,,,,
FOUNT0509_T3,Pw,Yes,,,136,41,"HR 0.67 [0.47, 0.95]",,,FOUNT0509_pw_OS.xml,Converted from 98.34% CI to 95% CI,11.4,,,,,,,,,,,
FOUNT0713_T1,Group A (3-weekly),Yes,,,32,26,,,15,FOUNT0713_groupA_OS.xml,,,,,,,,9,,,,,
FOUNT0713_T2,Group B (weekly),Yes,,,32,,,,10,FOUNT0713_groupB_OS.xml,,,,,,,,12,,,,,
FOUNT1004_T1,Group A (P-E),Yes,,,162,22.4,,,83,FOUNT1004_OS_groupA.xml,,,,,,,,,,,,,
FOUNT1004_T2,Group B (P-Cp),Yes,,,160,27.8,,0.25,77,FOUNT1004_OS_groupB.xml,,,,,,,,,,,,,
FOUNT1297_T1,Group A,Yes,Yes,,81,14.6,,,52,FOUNT1297_OS_groupA.xml,,7.2,,,FOUNT1297_TTP_A.xml,,,,,,,,
FOUNT1297_T2,Group B,Yes,Yes,,86,14.9,,0.4483,53,FOUNT1297_OS_groupB.xml,,7.4,,,FOUNT1297_TTP_B.xml,,,,,,,,
FRASC1087_T1,Group 1,Yes,,,53,,,,,,,,,,,,,,,,,,
FRASC1087_T2,Group 2,Yes,,,62,,,,,,,,,,,,,,,,,,
FRENC0291_T1,FEC 50,Yes,,,126,18.7,,,,FRENC0291_OS_FEC50.xml,,,,,,,,,,,,,
FRENC0291_T2,FEC 75,Yes,,,127,21.3,,,,FRENC0291_OS_FEC75.xml,,,,,,,,,,,,,
FRENC0291_T3,Epirubicin,Yes,,,125,17.3,,,,FRENC0291_OS_epirubicin.xml,,,,,,,,,,,,,
FRENC0488_T1,FAC,Yes,Yes,,120,17.7,,,,FRENC0488_OS_FAC.xml,,9,,,FRENC0488_TTP_FAC.xml,,,,,,,,
FRENC0488_T2,FEC,Yes,Yes,,124,15,,,,FRENC0488_OS_FEC.xml,,7.3,,,FRENC0488_TTP_FEC.xml,,,,,,,,
FRENC0900_T1,Arm A,Yes,Yes,,139,17.9,,,119,FRENC0900_OS_groupA.xml,,10.3,,,FRENC0900_TTP_groupA.xml,,,,,,,,
FRENC0900_T2,Arm B,Yes,Yes,,145,18.9,,,126,FRENC0900_OS_groupB.xml,,8.3,,,FRENC0900_TTP_groupB.xml,,,,,,,,
FRENC0900_T3,Arm C,Yes,Yes,,133,16.3,,,115,FRENC0900_OS_groupC.xml,,6.2,,,FRENC0900_TTP_groupC.xml,,,,,,,,
FREUE0200_T1,Formestane,Yes,,,276,18.7,,,,FREUE0200_OS_formestane.xml,,5.6,,,,,,,,,,,
FREUE0200_T2,Megestrol acetate,Yes,,,271,19.9,,,,FREUE0200_OS_MGA.xml,,5.6,,,,,,,,,,,
FRITZ1282_T1,VAC/FMC Without C. parvum,Yes,,,76,21.1,,,,FRITZ1282_OS_withoutCP.xml,,,,,,,,,,,,,
FRITZ1282_T2,VAC/FMC With C. parvum,Yes,,,74,22.2,,,,FRITZ1282_OS_withCP.xml,,,,,,,,,,,,,
FRONT1104_T1,TXT,Yes,,,36,,,,,,,,,,,,,,,,,,
FRONT1104_T2,TXT + CBG,Yes,,,34,,,,,,,,,,,,,,,,,,
FUJIM0473_T1,Testosterone propionate,Yes,,,40,,,,,,,,,,,,,,,,,,
FUJIM0473_T2,10275-S,Yes,,,42,,,,,,,,,,,,,,,,,,
GALE0194_T1,AG,Yes,,,108,24.5,,,98,GALE0194_OS_AG.xml,,,,,,,,,,,,,
GALE0194_T2,TAM,Yes,,,108,21.6,,,94,GALE0194_OS_TAM.xml,,,,,,,,,,,,,
GALLA1287_T1,Low dose,Yes,,,66,13,,,,GALLA1287_OS_lowdose.xml,,,,,,,,,,,,,
GALLA1287_T2,High dose,Yes,,,58,11,,,,GALLA1287_OS_highdose.xml,,,,,,,,,,,,,
GARCI0292_T1,Ag,Yes,,,131,17.1,,,,GARCI0292_OS_AG.xml,,8.8,,,,,,,,,,,
GARCI0292_T2,MPA,Yes,,,119,19.6,,,,GARCI0292_OS_MPA.xml,,6.8,,,,,,,,,,,
GASPA0291_T1,Epirubicin,Yes,,,22,12,,,14,GASPA0291_OS_epi.xml,,,,,,,,,,,,,
GASPA0291_T2,Doxorubicin,Yes,,,21,11,,,14,GASPA0291_OS_dox.xml,,,,,,,,,,,,,
GASPA0307_T1,Arm A,Yes,Yes,,60,,,,,GASPA0307_OS_Phase1175.xml,,6.8,,,GASPA0307_TTP_A.xml,,,,,,,,
GASPA0307_T2,Arm B,Yes,Yes,,63,,,,,GASPA0307_OS_Phase1150.xml,,10,,,GASPA0307_TTP_B.xml,,,,,,,,
GEBBI0103_T1,"Phase II, 75 mg/m2/21 days",Yes,,,16,,,,,,,,,,,,TTP not reached,,,,,,
GEBBI0103_T2,"Phase II, 50 mg/m2/15 days",Yes,,,32,,,,,,,,,,,,TTP not reached,,,,,,
GEBBI0103b_T1,EC,Yes,,,18,,,,,,,,,,,,,,,,,,
GEBBI0103b_T2,ET,Yes,,,20,18,,,,,,,,,,,,,,,,,
GEBBI0103b_T3,AT,Yes,,,20,,,,,,,,,,,,,,,,,,
GELMO0515_T1,LTax/L,Yes,,,326,,"HR 1.28 [0.95, 1.72] p=0.11",,,,,,,,,,,9,,,,,
GELMO0515_T2,TTax/L,Yes,,,326,,,,,,,,,,,,,11.3,,,,,
GELMO1099_T1,P,Yes,,,20,,,,,,,,,,,,,,,,,,
GELMO1099_T2,P + A,Yes,,,20,,,,,,,,,,,,,,,,,,
GENNA0787_T1,AG + HC,Yes,,,25,,,,,,,,,,,,,,,,,,
GENNA0787_T2,AG + HC + F,Yes,,,25,,,,,,,,,,,,,,,,,,
GENNA0806_T1,Paclitaxel,Yes,Yes,,109,28,"HR 1.12 [0.72, 1.73] p=0.62",,,GENNA0806_OS_pAC.xml,"Says RR, not HR",8,,,,,,,,,GENNA0806_PFS_P.xml,,
GENNA0806_T2,Control,Yes,Yes,,106,29,,,,GENNA0806_Cont_OS.xml,,9,,,,,,,,,GENNA0806_PFS_C.xml,,
GERSH0698_T1,Letrozole 0.5 mg,Yes,,,192,21,HR 0.86 p=0.28,,,GERSH0698_LET0.5_OS.xml,"Says RR, not HR",3.3,,,,,,,,,,,
GERSH0698_T2,Letrozole 2.5 mg,Yes,,,185,28,"HR 0.64 [0.49, 0.85] p=0.002",,,GERSH0698_LET2.5_OS.xml,"Says RR, not HR",3.4,,,,,,,,,,,
GERSH0698_T3,Aminoglutethimidine,Yes,,,178,20,,,,GERSH0698_AMINO_OS.xml,,3.2,,,,,,,,,,,
GERSH0997_T1,TOR60,Yes,Yes,,157,25.4,"HR 1.04 [0.78, 1.39] p=0.802",,,GERSH0997_TOR60_OS.xml,Flipped the HRs,4.9,,,GERSH0997_TTP_TOR60.xml,,,,,,,,
GERSH0997_T2,TOR240,Yes,Yes,,157,23.8,"HR 0.98 [0.74, 1.32] p=0.854",,,GERSH0997_TOR240_OS.xml,Flipped the HRs,6.1,,,GERSH0997_TTP_TOR240.xml,,,,,,,,
GERSH0997_T3,TAM40,Yes,Yes,,149,23.4,,,,GERSH0997_TAM40_OS.xml,,6,,,GERSH0997_TTP_TAM40.xml,,,,,,,,
GEYER1206_T1,Lapatinib plus Capecitabine,Yes,,,163,17.5,"HR 0.92 [0.58, 1.46] p=0.72",,,GEYER1206_LAP_OS.xml,,8.4,,,,,,8.4,,,,,
GEYER1206_T2,Capecitabine Alone,Yes,,,161,15.1,,,,GEYER1206_CAP_OS.xml,,4.4,,,,,,4.1,,,,,
GHOSN1211_T1,Arm A (NAVCAP),Yes,Yes,,41,35,,,,GHOSN1211_OS_CAP.xml,,10,,,GHOSN1211_TTP_A.xml,,,,,,,,
GIANN0210_T1,Arm A,Yes,,,41,,,,,,,1.42,,,GIANN0210_ARMA_TTP.xml,,,,,,,,
GIANN0210_T2,Arm B,Yes,,,37,,,,,,,1.42,,,GIANN0210_ARMB_TTP.xml,,,,,,,,
GIANN0513_T1,Docetaxel Plus Trastuzumab,Yes,,,206,38,,,,,"\MOS exceeded 38 months\""""",,,,,,,13.7,,,GIANN0513_PCF_D.xml,,
GIANN0513_T2,Bevacizumab Plus Docetaxel Plus Trastuzumab,Yes,,,215,38,"HR 0.94 [0.68, 1.30] p=0.7078",,,,"\MOS exceeded 38 months\""""",,,,,,,16.5,,,GIANN0513_PCF_B.xml,,
GILL0993_T1,Megace,Yes,,,60,15.46,,,,GILL0993_OS_MGA.xml,Has HR for one of the randomized comparisons,,,,,,,,,,,,
GILL0993_T2,Tamoxifen,Yes,,,58,19.78,,,,GILL0993_OS_T.xml,Has HR for one of the randomized comparisons,,,,,,,,,,,,
GILL0993_T3,Megace + Tamoxifen,Yes,,,62,21.94,,,,GILL0993_OS_MT.xml,Has HR for one of the randomized comparisons,,,,,,,,,,,,
GOCKE0985_T1,Weekly,Yes,,,24,,,,,,,,,,,,,,,,,,
GOCKE0985_T2,Every 3 wks,Yes,,,9,,,,,,,,,,,,,,,,,,
GOCKE1086_T1,DES,Yes,,,50,35,,,20,GOCKE1086_OS_DES.xml,,6,,,,,,,,,,,
GOCKE1086_T2,Tamoxifen,Yes,,,54,34,,,25,GOCKE1086_OS_TAM.xml,,5,,,,,,,,,,,
GOETZ1117_T1,Abemaciclib Plus Nonsteroidal AI,Yes,,,328,,,,,,,,,,,,,,"HR 0.54 [0.41, 0.72] p=0.000021",,GOETZ1117_PFS_Abemaciclib.xml,,
GOETZ1117_T2,Placebo Plus Nonsteroidal AI,Yes,,,165,,,,,,,,,,,,,14.7,,,GOETZ1117_PFS_PLACEBO.xml,,
GOLDE0169_T1,Oxylone Acetate,Yes,,,108,9,,,,GOLDE0169_OS_OA.xml,,,,,,,,,,,,,
GOLDE0169_T2,delta1-Testololactone,Yes,,,103,9,,,,GOLDE0169_OS_DT.xml,,,,,,,,,,,,,
GOLDE0169_T3,Medroxy progesterone acetate,Yes,,,108,6,,,,GOLDE0169_OS_MPA.xml,,,,,,,,,,,,,
GOLDS1214_T1,1/3 wk Treatment Arm,Yes,,,25,,,,,GOLDS1214_OS_13.xml,,3.1,,,,,,3.1,,,,,
GOLDS1214_T2,3/4 wk Treatment Arm,Yes,,,27,9.4,,,,GOLDS1214_OS_34.xml,,2,,,,,,2,,,,,
GOMEZ0216_T1,LC,Yes,,,51,19.6,,,26,,,,,,,,,9,,,GOMEZ2016_PFS_Cap.xml,,
GOMEZ0216_T2,LV,Yes,,,45,15,,,27,,,,,,,,,7,,,GOMEZ2016_PFS_Vin.xml,,
GOMEZ0216_T3,LG,Yes,,,46,11.9,,,27,,,,,,,,,7,,,GOMEZ2016_PFS_Gem.xml,,
GOSS0199_T1,Vorozole,Yes,Yes,,225,26,,,78,GOSS0199_OS_VOR.xml,,2.7,,,GOSS0199_TTP_VOR.xml,,,,,,,,
GOSS0199_T2,Megestrole Acetate,Yes,Yes,,227,28.7,,0.937,73,GOSS0199_OS_MA.xml,,3.6,,,GOSS0199_TTP_MA.xml,,,,,,,,
GOSS1107_T1,ATA + TOR,Yes,,,434,33.48,,,,,,11.2,,,GOSS1107_TTP_TOR.xml,,,,,,,,
GOSS1107_T2,Letrozole,Yes,,,431,36.12,"HR 0.98 [0.87, 1.11] p=0.76",,,,,11.2,,,GOSS1107_TTP_Let.xml,,,,,,,,
GRADI0113_T1,Sorafenib + Paclitaxel,Yes,Yes,,119,16.8,"HR 1.022 [0.715, 1.461] p=0.904",,,GRADI0113_OS_S.xml,,8.1,,,,,,6.9,,,GRADI0113_PFS_S.xml,,
GRADI0113_T2,Placebo + Paclitaxel,Yes,Yes,,118,17.4,,,,GRADI0113_OS_P.xml,,5.6,,,,,,5.6,,,GRADI0113_PFS_P.xml,,
GRADI0809_T1,300 mg/m2 q3w,Yes,,,76,27.7,,,41,GRADI1012_OS_A.xml,Survival data from GRADI1012,,,,,,,11,,,,,
GRADI0809_T2,100 mg/m2 Weekly,Yes,,,76,22.2,,,53,GRADI1012_OS_B.xml,Survival data from GRADI1012,,,,,,,12.8,,,,,
GRADI0809_T3,150 mg/m2 Weekly,Yes,,,74,33.8,,,39,GRADI1012_OS_C.xml,Survival data from GRADI1012,,,,,,,12.9,,,,,
GRADI0809_T4,Docetaxel 100 mg/m2 q3w,Yes,,,74,26.6,,,42,GRADI1012_OS_D.xml,Survival data from GRADI1012,,,,,,,7.5,,,,,
GRADI1105_T1,ABI-007,Yes,,,229,15.17,,0.374,,GRADI1105_OS_A.xml,,5.37,,,,,,,,,,,
GRADI1105_T2,Standard Paclitaxel,Yes,,,225,13,,,,GRADI1105_OS_P.xml,,3.94,,,,,,,,,,,
GREEN0696_T1,VAC,Yes,,,53,11.7,,0.47,48,GREEN0696_OS_VAC.xml,,,,,,,,,,,,,
GREEN0696_T2,VNC,Yes,,,55,12.1,,,52,GREEN0696_OS_VNC.xml,,,,,,,,,,,,,
GUAN0613_T1,Lapatinib Plus Paclitaxel,Yes,,,222,27.8,"HR 0.74 [0.58, 0.94] p=0.0124",,,,,,,,,,,9.7,,,,,
GUAN0613_T2,Placebo Plus Paclitaxel,Yes,,,222,20.5,,,,,,,,,,,,6.5,,,,,
GUNDE0190_T1,Awkly,Yes,,,81,14,,,,GUNDE0190_OS_Awkly.xml,,,,,,,,,,,,,
GUNDE0190_T2,EPIbiwkly,Yes,,,68,14,,,,GUNDE0190_OS_EPI.xml,,,,,,,,,,,,,
GUNDE0292_T1,Chemotherapy,Yes,,,70,13,,,,GUNDE0292_OS_C.xml,,,,,,,,,,,,,
GUNDE0292_T2,Chemotherapy + HD-MPA,Yes,,,68,9,,-0.05,,GUNDE0292_OS_CH.xml,"\< 0.05\""""",,,,,,,,,,,,
GUNDE1190_T1,TAM,Yes,,,73,32,,,,GUNDE1190_OS_T.xml,,,,,,,,,,,,,
GUNDE1190_T2,TAM/HD-MPA,Yes,,,78,32,,0.37,,GUNDE1190_OS_TM.xml,,,,,,,,,,,,,
GUNDE1286_T1,Awkly,Yes,,,62,11,,,,GUNDE1286_OS_A.xml,,,,,,,,,,,,,
GUNDE1286_T2,VAC,Yes,,,66,13.1,,0.49,,GUNDE1286_OS_V.xml,,,,,,,,,,,,,
GUNDE1294_T1,Doxorubicin,Yes,,,111,11,,,,GUNDE1294_OS_dox.xml,,,,,,,,,,,,,
GUNDE1294_T2,Doxorubicin + HD-MPA,Yes,,,107,11,,,,GUNDE1294_OS_doxMPA.xml,,,,,,,,,,,,,
HABES0291_T1,LEP,Yes,,,97,10.73,,,,HABES0291_OS_LEP.xml,,,,,,,,4.2,,,,,
HABES0291_T2,HEP,Yes,,,102,10.27,,,,HABES0291_OS_HEP.xml,,,,,,,,7,,,,,
HAINE0469_T1,Fluoxymesterone,Yes,,,21,,,,,,only one curve; doesnt look like any type,,,,,,,,,,,,
HAINE0469_T2,Fluoxymesterone plus ethinyl estradiol,Yes,,,20,,,,,,,,,,,,,,,,,,
HAINS0297_T1,CMF,Yes,,,64,16,,,,HAINS0297_OS_C.xml,,,,,,,,,,,,,
HAINS0297_T2,NFL,Yes,,,64,19,,0.48,,HAINS0297_OS_N.xml,,,,,,,,,,,,,
HAMBE0411_T1,Combination Arm (H+D),Yes,Yes,,53,30.5,,,,HAMBE0411_OS_C.xml,,,,,,,,9.4,,,HAMBE0411_PFS_C.xml,,
HAMBE0411_T2,Sequential Arm (H -> D),Yes,Yes,,46,19.7,"HR 1.49 [0.91, 2.47] p=0.12",,,HAMBE0411_OS_S.xml,,,,,,,,3.9,,,HAMBE0411_PFS_S.xml,,
HARBE0117_T1,PLD,Yes,Yes,,105,23.3,"HR 1.12 [0.79, 1.58] p=0.53",,,HARBE0117_OS_P.xml,,6,"HR 1.08 [0.76, 1.54] p=0.67",,HARBE0117_TTP_P.xml,,,,,,,,
HARBE0117_T2,Capecitabine,Yes,Yes,,105,26.8,,,,HARBE0117_OS_C.xml,,6.1,,,HARBE0117_TTP_C.xml,,,,,,,,
HARBE0316_T1,Afatinib group,Yes,Yes,,332,20.5,"HR 1.48 [1.12, 1.95] p=0.0048",,,HARBE0316_OS_A.xml,,,,,,,,5.5,,,HARBE0316_PFS_A.xml,,
HARBE0316_T2,Trastuzumab group,Yes,Yes,,168,28.6,,,,HARBE0316_OS_T.xml,,,,,,,,5.6,,,HARBE0316_PFS_T.xml,,
HARPE0799_T1,CMF,Yes,Yes,,48,11,,,45,HARPE0799_OS_C.xml,,,,,,,,,,,HARPE0799_PFS_C.xml,,
HARPE0799_T2,MM,Yes,Yes,,47,12,,0.9,41,HARPE0799_OS_M.xml,,,,,,,,,,,HARPE0799_PFS_M.xml,,
HARRI0102_T1,TLC D-99,Yes,Yes,,108,16,,,,HARRI0102_OS_D.xml,,3.8,,,HARRI0102_TTP_D.xml,,,,,,,,
HARRI0102_T2,Doxorubicin,Yes,Yes,,116,20,"HR 0.76 [0.56, 1.04] p=0.09",,,HARRI0102_OS_Do.xml,,4.3,,,HARRI0102_TTP_Do.xml,,,,,,,,
HARVE0713_T1,C,Yes,,,42,12.8,,,,,,,,,,,,3.1,,,,,
HARVE0713_T2,CCy,Yes,,,40,13.2,,0.72,,,,,,,,,,6.9,,,,,
HARVE1106_T1,60 mg/m2,Yes,,,149,10.6,,,125,HARVE1106_OS_60mg.xml,,3,,,,,,,,,,,
HARVE1106_T2,75 mg/m2,Yes,,,190,10.3,,,152,HARVE1106_OS_75mg.xml,,3.5,,,,,,,,,,,
HARVE1106_T3,100 mg/m2,Yes,,,185,12.3,,,149,HARVE1106_OS_100mg.xml,,3.9,,,,,,,,,,,
HATSC0212_T1,ET,Yes,Yes,,143,26,,,,HATSC0212_OS_E.xml,,,,,,,,10.8,,,HATSC0212_PFS_E.xml,,
HATSC0212_T2,TEX,Yes,Yes,,144,29.7,"HR 0.84 [0.63, 1.11] p=0.22",,,HATSC0212_OS_T.xml,,,,,,,,12.4,,,HATSC0212_PFS_T.xml,,
HAUSM1295_T1,EV,Yes,,,129,14.7,,,,,,5.4,,,,,,,,,,,
HAUSM1295_T2,MV,Yes,,,126,13.3,,,,,,5.1,,,,,,,,,,,
HAYES1095_T1,TAM,Yes,Yes,,215,31.67,,,,HAYES1095_OS_TA.xml,,5.83,,,HAYES1095_TTP_TA.xml,,,,,,,,
HAYES1095_T2,TOR60,Yes,Yes,,221,38.17,"HR 0.96 [0.70, 1.32]",,,HAYES1095_OS_T.xml,Flipped hazard ratios,5.6,,,HAYES1095_TTP_T.xml,,,,,,,,
HAYES1095_T3,TOR200,Yes,Yes,,212,30.13,"HR 1.23 [0.91, 1.67]",,,HAYES1095_OS_TO.xml,Flipped hazard ratios,5.57,,,HAYES1095_TTP_TO.xml,,,,,,,,
HEERY1115_T1,Docetaxel and PANVAC,Yes,,,25,,,,,,,,,,,,,7.9,,,HEERY1115_PFS_DP.xml,,
HEERY1115_T2,Docetaxel Alone,Yes,,,23,,,,,,,,,,,,,3.9,,,HEERY1115_PFS_D.xml,,
HEIDE0290_T1,AC,Yes,,,51,,,,,,,,,,,,,,,,,,
HEIDE0290_T2,EC,Yes,,,66,,,,,,,,,,,,,,,,,,
HEIDE0290_T3,NC,Yes,,,62,,,,,,,,,,,,,,,,,,
HEIDN1102_T1,FEC,Yes,Yes,,126,15.8,,0.7,,HEIDN1102_OS_F.xml,"Follow-up range [0.99, 73.68]",6.15,,,HEIDN1102_TTP_F.xml,,,,,,,,
HEIDN1102_T2,Mitoxantrone,Yes,Yes,,132,14.1,,,,HEIDN1102_OS_M.xml,,4.4,,,HEIDN1102_TTP_M.xml,,,,,,,,
HEINO0185_T1,Tamoxifen group,Yes,,,49,29.5,,,,HEINO0185_OS_TAM.xml,,13,,,,,,,,,,,
HEINO0185_T2,Tamoxifen plus nandrolone decanoate group,Yes,,,49,24.8,,,,HEINO0185_OS_TND.xml,,12,,,,,,,,,,,
HENDE0589_T1,Mitoxantrone,Yes,Yes,,165,9.1,,0.38,,HENDE0589_OS_M.xml,,,,,HENDE0589_TTP_M.xml,,,,,,,,
HENDE0589_T2,Doxorubicin,Yes,Yes,,160,8.93,,,,HENDE0589_OS_D.xml,,,,,HENDE0589_TTP_D.xml,,,,,,,,
HOLME1186_T1,Single,Yes,,,39,,,,,,,,,,,,,,,,,,
HOLME1186_T2,Daily x 5,Yes,,,37,,,,,,,,,,,,,,,,,,
HOOGS0776_T1,Intermittent combination,Yes,,,98,14,,,,HOOGS0776_OS_I.xml,,,,,,,,,,,,,
HOOGS0776_T2,Weekly combination,Yes,,,106,14,,,,HOOGS0776_OS_W.xml,,,,,,,,,,,,,
HOOGS0776_T3,Adriamycin,Yes,,,79,11,,,,HOOGS0776_OS_A.xml,,,,,,,,,,,,,
HORI0901_T1,Method A,Yes,Yes,,48,26.9,,0.748,,HORI0901_OS_A.xml,,11.6,,,HORI0901_TTP_A.xml,,,,,,,,
HORI0901_T2,Method B,Yes,Yes,,45,24.9,,,,HORI0901_OS_B.xml,,10.1,,,HORI0901_TTP_B.xml,,,,,,,,
HORTO0289_T1,Doxorubicin infusion,Yes,,,21,10,,,,,,,,,,,,,,,,,
HORTO0289_T2,Epirubicin infusion,Yes,,,27,9,,,,,,,,,,,,,,,,,
HORTO0289_T3,Epirubicin bolus,Yes,,,23,7,,,,,,,,,,,,,,,,,
HORTO1116_T1,Ribociclib Group,Yes,,,334,,"HR 0.746 [0.517, 1.078] p=0.059",,,,,,,,,,,,,,HORTO1116_PFS_R.xml,,
HORTO1116_T2,Placebo Group,Yes,,,334,,,,,,,,,,,,,14.7,,,HORTO1116_PFS_P.xml,,
HOWEL0504_T1,Fulvestrant,Yes,,,313,36.9,"HR 1.29 [1.01, 1.64] p=0.04",,,,,6.8,,,HOWEL0504_TTP_T.xml,,,,,,HOWEL0504_PFS_T.xml,,
HOWEL0504_T2,Tamoxifen,Yes,,,274,38.7,,,,,,8.3,,,HOWEL0504_TTP_F.xml,,,,,,HOWEL0504_PFS_F.xml,,
HOWEL0802_T1,Fulvestrant 250 mg,Yes,,,222,26.4,"HR 0.98 [0.84, 1.15] p=0.809",,,,Survival data from HOWEL0705; HR combined with another large study -- this explains why the confidence interval is smaller than would be expected given the number of patients in this study,5.5,,,HOWEL0802_TTP_F.xml,,,,,,HOWEL0802_PFS_F.xml,,
HOWEL0802_T2,Anastrozole,Yes,,,229,24.2,,,,,Survival data from HOWEL0705; HR combined with another large study -- this explains why the confidence interval is smaller than would be expected given the number of patients in this study,5.1,,,HOWEL0802_TTP_A.xml,,,,,,HOWEL0802_PFS_A.xml,,
HU0415_T1,Paclitaxel plus gemcitabine,Yes,,,118,18.3,,,,,,,,,,,,6.47,,,,,
HU0415_T2,Cisplatin plus gemcitabine,Yes,,,118,22.4,"HR 0.902 [0.605, 1.344] p=0.611",,,,,,,,,,,7.73,,,,,
HULTB0596_T1,MPA,Yes,,,100,21.4,,,,,,,,,,,,,,,,,
HULTB0596_T2,AG,Yes,,,100,21.4,,,,,,,,,,,,,,,,,
HUOBE0212_T1,Arm A: HER2+ (Let alone),Yes,,A,31,,,,,,,3.3,,,HUOBE0212_TTP_A.xml,,,,,,,,
HUOBE0212_T2,Arm B: HER2+ (Let + Tra),Yes,,A,26,,,,,,,14.1,,,HUOBE0212_TTP_B.xml,,,,,,,,
HURVI0313_T1,HT,Yes,,,70,,,,,,,,,,,,,9.2,,,HURVI0313_PFS_H.xml,,
HURVI0313_T2,T-DM1,Yes,,,67,,,,,,,,,,,,,14.2,,,HURVI0313_PFS_T.xml,,
HURVI0715_T1,Everolimus + trastuzumab + paclitaxel,Yes,,,480,48.6,"HR 1.13 [0.90, 1.42]",,,,Survival data from YARDL0217,,,,,,,14.95,,,,,
HURVI0715_T2,Placebo + trastuzumab + paclitaxel,Yes,,,239,50,,,,,Survival data from YARDL0217,,,,,,,14.49,,,,,
HYAMS1013_T1,Cediranib 45 mg/day + fulvestrant LD,Yes,,,31,,,,,,,,,,,,,7.43,,,,,
HYAMS1013_T2,Placebo + fulvestrant,Yes,,,31,,,,,,,,,,,,,3.73,,,,,
IBRAH1111_T1,AS1402 + Letrozole,Yes,,,56,,,,,IBRAH1111_AS14_OS.xml,,,,,,,,,,,,,
IBRAH1111_T2,Letrozole only,Yes,,,54,,,,,IBRAH1111_letro_OS.xml,,,,,,,,,,,,,
ICLI0205_T1,EoP,Yes,Yes,,96,14,,0.039,81.16,ICLI0205_OS_EOP.xml,164/184 died,5.5,,,ICLI0205_TTP_EOP.xml,,,,,,,,
ICLI0205_T2,Paclitaxel,Yes,Yes,,97,9.5,,,83.84,ICLI0205_OS_PAC.xml,,3.9,,,ICLI0205_TTP_PAC.xml,,,,,,,,
INAJI0912_T1,40 mg,Yes,,,33,,,,,,,4.6,,,INAJI0912_TTP_40.xml,,,,,,,,
INAJI0912_T2,80 mg,Yes,,,32,,,,,,,3.7,,,INAJI0912_TTP_80.xml,,,,,,,,
INAJI0912_T3,120 mg,Yes,,,32,,,,,,,3.6,,,INAJI0912_TTP_120.xml,,,,,,,,
INGLE0181_T1,DES,Yes,,,74,,,0.28,20,INGLE0181_OS_TAX.xml,,,,,,,,,,,,,
INGLE0181_T2,Tamoxifen,Yes,,,69,,,,25,INGLE0181_OS_MEG.xml,,,,,,,,,,,,,
INGLE0282_T1,Megestrol Acetate,Yes,,,28,17.33,,0.16,17,INGLE0282_OS_MEG.xml,,,,,,,,,,,,,
INGLE0282_T2,Tamoxifen,Yes,,,27,13.27,,,20,INGLE0282_OS_TAM.xml,,,,,,,,,,,,,
INGLE0399_T1,TAM,Yes,Yes,,68,,"HR 0.98 [0.62, 1.55] p=0.92",,,INGLE0399_OS_TAM.xml,,,,,,,,14.2,,,INGLE0399_PFS_TAM.xml,,
INGLE0399_T2,TAM plus OCT,Yes,Yes,,67,,,,,INGLE0399_os_OCT.xml,,,,,,,,10.3,,,INGLE0399_PFS_OCT.xml,,
INGLE0485_T1,Doxorubicin,Yes,,,74,7.73,,0.87,73,INGLE0485_OS_DOX.xml,,3.73,,,,,,,,,,,
INGLE0485_T2,Doxorubicin + Mitolactol,Yes,,,77,7.5,,,74,INGLE0485_OS_Mi.xml,,3.23,,,,,,,,,,,
INGLE0588_T1,TAM,Yes,Yes,,119,30.1,,,,INGLE0588_OS_TAM.xml,,6.5,,,INGLE0588_TTP_TAM.xml,,,,,,,,
INGLE0588_T2,TAM Plus FLU,Yes,Yes,,118,32.2,"HR 1.04 [0.75, 1.44]",,,INGLE0588_OS_FLU.xml,Converted from 90% CI to 95% CI,11.6,,,INGLE0588_TTP_FLU.xml,,,,,,,,
INGLE0686_T1,TAM,Yes,,,49,21.9,,,34,INGLE0686_OS_TAM.xml,,7.2,,,,,,,,,,,
INGLE0686_T2,TAM + AG + HC,Yes,,,48,27.6,,0.36,33,INGLE0686_OS_AG.xml,,7.6,,,,,,,,,,,
INGLE0791_T1,TAM,Yes,Yes,,159,35,,,,INGLE0791_OS_TAM.xml,,11,,,INGLE0791_TTP_TAM.xml,,,,,,,,
INGLE0791_T2,TAM + PRDLN,Yes,Yes,,161,32,"HR 1.15 [0.83, 1.60]",,,INGLE0791_OS_TP.xml,,10,,,INGLE0791_TTP_TP.xml,,,,,,,,
INGLE0797_T1,Letrozole 0.5 mg/day,Yes,Yes,,46,20.4,,,18,INGLE0797_OS_5.xml,,3.23,,,,,,,,,INGLE0797_PFS_5.xml,,
INGLE0797_T2,Letrozole 2.5 mg/day,Yes,Yes,,45,20.4,,,16,INGLE0797_OS_25.xml,,5.13,,,,,,,,,INGLE0797_PFS_25.xml,,
INGLE1179_T1,Adriamycin,Yes,,,18,7.5,,,,,,2.8,,,,,,,,,,,
INGLE1179_T2,Rubidazone,Yes,,,18,8.5,,0.746,,,,1.9,,,,,,,,,,,
INGLE1289_T1,D,Yes,,,95,8.4,,,,INGLE1289_OS_DVM.xml,,2.7,,,,,,,,,,,
INGLE1289_T2,DVM,Yes,,,90,9.2,"HR 0.84 [0.62, 1.13]",,,INGLE1289_H+D_OS.xml,,4.2,,,,,,,,,,,
INOUE0110_T1,H + D,Yes,Yes,,53,,,,,INOUE0110_OS_H.xml,,,,,,,,14.6,,,INOUE0110_PFS_HD.xml,,
INOUE0110_T2,H -> H + D,Yes,Yes,,54,,"HR 2.72 [1.03, 7.18] p=0.04",,,INOUE0110_S_D.xml,,,,,,,,3.7,,,INOUE0110_PFS_H.xml,,
INOUE0884_T1,ACF,Yes,,,28,20.8,,,,INOUE0884_OS_ACF.xml,,,,,,,,,,,,,
INOUE0884_T2,ACFM,Yes,,,30,13,,,,INOUE0884_OS_ACFM.xml,,,,,,,,,,,,,
IRWIN0880_T1,Combination,Yes,,,45,16.8,,,,,,,,,,,,,,,,,
IRWIN0880_T2,Fixed-rotation,Yes,,,45,18.4,,,,,,,,,,,,,,,,,
ITALI0688_T1,FEC,Yes,,,222,19.7,,,,ITALI0688_OS_FEC.xml,,9.1,,,,,,,,,,,
ITALI0688_T2,FAC,Yes,,,221,20.43,,0.75,,ITALI0688_FAC_OS.xml,,10.47,,,,,,,,,,,
IWATA0613_T1,Exemestane,Yes,,,149,,"HR 1.062 [0.733, 1.539]",,,,,13.8,,,,,,,,,,,
IWATA0613_T2,Anastrozole,Yes,,,149,60.1,,,,,,11.1,,,,,,,,,,,
IZUO1285_T1,MPA,Yes,,,47,,,,,,,,,,,,,,,,,,
IZUO1285_T2,MS,Yes,,,40,,,,,,,,,,,,,,,,,,
JAIN0216_T1,PICN 260 mg/m2,Yes,,,64,,,,,,,,,,,,,5.37,,,JAIN0216_PFS_260.xml,,
JAIN0216_T2,PICN 295 mg/m2,Yes,,,58,,,,,,,,,,,,,8.17,,,JAIN0216_PFS_295.xml,,
JAIN0216_T3,nab-paclitaxel 260 mg/m2,Yes,,,58,,,,,,,,,,,,,7.93,,,,,
JAIN0685_T1,Epirubicin,Yes,,,25,,,,,,,3.9,,,,,,,,,,,
JAIN0685_T2,Doxorubicin,Yes,,,28,,,,,,,5.1,,,,,,,,,,,
JAKOB0986_T1,Regimen A,Yes,Yes,,52,6,,,,JAKOB0986_OS_prednisone.xml,,3,,,JAKOB0986_TTP_A.xml,,,,,,,,
JAKOB0986_T2,Regimen B,Yes,Yes,,48,8.5,,,,JAKOB0986_OS_MPApo.xml,,4,,,JAKOB0986_TTP_B.xml,,,,,,,,
JAKOB0986_T3,Regimen C,Yes,Yes,,52,10,,,,JAKOB0986_OS_MPAim.xml,,5,,,JAKOB0986_TTP_C.xml,,,,,,,,
JANNI0214_T1,"Lapatinib 1,250 mg QD plus vinorelbine 20 mg/m2",Yes,,,75,23.3,,,,,,,,,,,,6.2,,,,,
JANNI0214_T2,"Lapatinib 1,250 mg QD plus capecitabine 2,000 mg/m2",Yes,,,27,20.3,"HR 1.02 [0.50, 2.06]",,,,,,,,,,,6.2,,,,,
JAPAN0278_T1,Mepitiostane,Yes,,,50,,,,,,,,,,,,,,,,,,
JAPAN0278_T2,Fluoxymesterone,Yes,,,48,,,,,,,,,,,,,,,,,,
JASSL0301_T1,AT,Yes,Yes,,128,23.3,,,,JASSL0301_OS_AT.xml,,8.3,,,JASSL0301_TTP_AT.xml,,,,,,,,
JASSL0301_T2,FAC,Yes,Yes,,131,18.3,"HR 1.46 [1.08, 1.97]",,,JASSL0301_FAC_OS.xml,,6.2,,,JASSL0301_TTP_FAC.xml,,,,,,,,
JODRE0591_T1,CMF,Yes,Yes,,60,12,,,,JODRE0591_OS_CMF.xml,,5,,,,,,,,,JODRE0591_PFS_CMF.xml,,
JODRE0591_T2,MMM,Yes,Yes,,60,16,,,,JODRE0591_OS_MMM.xml,,6,,,,,,,,,JODRE0591_PFS_MMM.xml,,
JOENS0510_T1,Docetaxel,Yes,,,115,28,,,,JOENS0510_OS_DOC.xml,,11.7,,,,,,,,,,,
JOENS0510_T2,Docetaxel alternating with gemcitabine,Yes,,,122,27,"HR 1.11 [0.75, 1.64] p=0.60",,,JOENS0510_ALT_OS.xml,,11.3,,,,,,,,,,,
JOHNS0404_T1,Idoxifene,Yes,,,30,18.6,,,,,,2.6,,,,,,,,,,,
JOHNS0404_T2,Tamoxifen,Yes,,,26,21.3,,,,,,2.8,,,,,,,,,,,
JOHNS0708_T1,Placebo + letrozole,Yes,,,40,,,,,JOHNS0708_OS_PLA.xml,,10.8,,,,,,,,,,,
JOHNS0708_T2,Tipifarnib + letrozole,Yes,,,81,27.6,,,,JOHNS0708_TIP_OS.xml,,5.6,,,,,,,,,,,
JOHNS0913_T1,Fulvestrant plus anastrozole,Yes,,,243,20.2,"HR 0.95 [0.76, 1.17] p=0.61",,,,,,,,,,,4.4,,,,,
JOHNS0913_T2,Fulvestrant plus placebo,Yes,,,231,19.4,"HR 1.05 [0.84, 1.29] p=0.68",,,,,,,,,,,4.8,,,,,
JOHNS0913_T3,Exemestane,Yes,,,249,21.6,,,,,,,,,,,,3.4,,,,,
JOHNS1109_T1,Letrozole + Placebo,Yes,Yes,,644,,,,,JOHNS1109_OS_Let.xml,,,,,,,,10.8,,,JOHNS1109_PFS_LP.xml,,
JOHNS1109_T2,Letrozole + Lapatinib,Yes,Yes,,642,,"HR 0.74 [0.5, 1.1] p=0.113",,,JOHNS1109_lap_OS.xml,,,,,,,,11.9,,,JOHNS1109_PFS_LL.xml,,
JONAT0295_T1,Goserelin alone,Yes,,,159,29.63,,,99,JONAT0295_OS_Z.xml,,5.37,,,,,,,,,,,
JONAT0295_T2,Goserelin plus tamoxifen,Yes,,,159,32.67,,,99,JONAT0295_OS_ZN.xml,,6.53,,,,,,,,,,,
JONAT0396_T1,Anastrozole 1 mg/day,Yes,,,135,,,,21,,,4.4,,,JONAT0396_TTP_1mg.xml,,,,,,,,
JONAT0396_T2,Anastrozole 10 mg/day,Yes,,,118,14.8,,,22,,,5.2,,,JONAT0396_TTP_10mg.xml,,,,,,,,
JONAT0396_T3,Megestrol acetate 40 mg four times daily,Yes,,,125,,,,28,,,4,,,JONAT0396_TTP_MGA.xml,,,,,,,,
JONAT1013_T1,Lonaprisan 25 mg/day,Yes,,,34,,,,,,,,,,,,,,,,,,
JONAT1013_T2,Lonaprisan 100 mg/day,Yes,,,34,,,,,,,,,,,,,,,,,,
JONES0805_T1,Docetaxel,Yes,Yes,,222,15.4,,,,JONES0805_DOC_OS.xml,,5.7,,,JONES0805_DOC_TTP.xml,,,,,,,,
JONES0805_T2,Paclitaxel,Yes,Yes,,222,12.7,"HR 1.41 [1.15, 1.73] p=0.03",,,JONES0805_PAC_OS.xml,,3.6,,,JONES0805_PAC_TTP.xml,,,,,,,,
JONES1095_T1,NVB,Yes,,,115,8.17,,0.034,,JONES1095_OS_NVB.xml,Cox PH model p-value,,,,,,,,,,,,
JONES1095_T2,ALK,Yes,,,64,7.23,,,,JONES1095_ALK_OS.xml,,,,,,,,,,,,,
KATSU0709_T1,AC,Yes,,,146,22.6,,,125,KATSU0709_OS_AC.xml,,,,,,,,6.6,,,,,
KATSU0709_T2,D,Yes,,,147,25.7,,0.18,117,KATSU0709_D_OS.xml,Convert from 1-sided to 2-sided p-values,,,,,,,7,,,,,
KATSU0709_T3,AC-D,Yes,,,146,25,,0.16,120,KATSU0709_AC-D_OS.xml,Convert from 1-sided to 2-sided p-values,,,,,,,7.1,,,,,
KAUFM0215_T1,Eribulin,Yes,,,554,15.9,"HR 0.88 [0.77, 1.00] p=0.056",,,,,,,,,,,4.1,,,,,
KAUFM0215_T2,Capecitabine,Yes,,,548,14.5,,,,,,,,,,,,4.2,,,,,
KAUFM0400_T1,EXE,Yes,Yes,,366,,,0.039,100,KAUFM0400_OS_EXE.xml,,4.74,,,KAUFM0400_TTP_EXE.xml,,,,,,,,
KAUFM0400_T2,MA,Yes,Yes,,403,28.79,,,130,KAUFM0400_MA_OS.xml,,3.87,,,KAUFM0400_TTP_MA.xml,,,,,,,,
KAUFM1109_T1,Trastuzumab + Anastrozole,Yes,Yes,,103,28.5,,0.325,58,KAUFM1109_OS_TRA.xml,,4.8,,,KAUFM1109_TTP_TA.xml,,,4.8,,,KAUFM1109_PFS_TA.xml,,
KAUFM1109_T2,Anastrozole Alone,Yes,Yes,,104,23.9,,,64,KAUFM1109_ANA_OS.xml,,2.4,,,KAUFM1109_TTP_A.xml,,,2.4,,,KAUFM1109_PFS_A.xml,,
KELLE1004_T1,PLD,Yes,,,150,11,"HR 1.05 [0.82, 1.33] p=0.71",,,,,,,,,,,2.9,,,KELLE1004_PFS_PLD.xml,,
KELLE1004_T2,Control,Yes,,,151,9,,,,,,,,,,,,2.5,,,KELLE1004_PFS_CON.xml,,
KELLO1187_T1,TAM,Yes,,,67,,,,,KELLO1187_OS_TAM.xml,Survival only from day of diagnosis and day of metastasis,,,,,,,,,,,,
KELLO1187_T2,NAN,Yes,,,60,,,,,KELLO1187_NAN_OS.xml,Survival only from day of diagnosis and day of metastasis,,,,,,,,,,,,
KENNE0175_T1,DES,Yes,,,21,25,,,,,,,,,,,,,,,,,
KENNE0268_T1,Methenolone Enanthate,Yes,,,27,,,,,,,,,,,,,,,,,,
KENNE0268_T2,Testosterone propionate,Yes,,,13,,,,,,,6,,,,,,,,,,,
KHOO0806_T1,GP1,Yes,,,72,,,,,,,7.5,,,KHOO0806_TTP_GP1.xml,,,,,,,,
KHOO0806_T2,GP2,Yes,,,68,,,,,,,7,,,KHOO0806_TTP_GP2.xml,,,,,,,,
KHOO0806_T3,GD,Yes,,,68,,,,,KHOO0806_OS_GP.xml,,7.4,,,,,,,,,,,
KIANG1185_T1,"ER+, Regimen A",Yes,,A,19,29,,,17,KIANG1185_OS_+E.xml,Estrogen,,,,,,,,,,,,
KIANG1185_T2,"ER+, Regimen C",Yes,,A,21,72,,0.05,14,KIANG1185_OS_-D.xml,Dio...,,,,,,,,,,,,
KIANG1185_T3,"ER?, Regimen A",Yes,,B,17,31.95,,,,KIANG1185_OS_?E.xml,Estrogen,,,,,,,,,,,,
KIANG1185_T4,"ER?, Regimen C",Yes,,B,24,35.84,,0.61,,KIANG1185_OS_?D.xml,Dio...,,,,,,,,,,,,
KIANG1185_T5,"ER-, Regimen B",Yes,,C,14,14.03,,0.41,,KIANG1185_OS_-E.xml,Estrogen,,,,,,,,,,,,
KIANG1185_T6,"ER-, Regimen C",Yes,,C,17,16.75,,,,KIANG1185_OS_-A.xml,Alone,,,,,,,,,,,,
KIM0814_T1,TSU-68 plus docetaxel,Yes,,,38,29,HR 0.8 p=0.42,,,,"Removed the CI due to asymmetry; it appear to have been a typo, and likely should have been [0.5, 1.3]",,,,,,,6.8,,,,,
KIM0814_T2,Docetaxel,Yes,,,39,26,,,,,,,,,,,,8.1,,,,,
KIM1017_T1,Ipatasertib plus paclitaxel,Yes,,,62,,,,,,,,,,,,,6.2,"HR 0.60 [0.37, 0.98] p=0.037",,KIM1017_PFS_I.xml,,
KIM1017_T2,Placebo plus paclitaxel,Yes,,,62,,,,,,,,,,,,,4.9,,,KIM1017_PFS_P.xml,,
KLEEB1297_T1,"Anastrozole, 1 mg once daily",Yes,,,29,,,,,,,,,,,,,,,,,,
KLEEB1297_T2,"Formestane, 250 mg every 2 weeks",Yes,,,31,,,,,,,,,,,,,,,,,,
KLEFS0180_T1,VAC with levamisole,Yes,,A,48,,,0.05,,KLEFS0180_OS_V_V.xml,,,,,,,,,,,,,
KLEFS0180_T2,VAC control,Yes,,A,53,,,,,KLEFS0180_OS_V_P.xml,,,,,,,,,,,,,
KLEFS0180_T3,CVMF with levamisole,Yes,,B,25,,,,,KLEFS0180_OS_CL.xml,,,,,,,,,,,,,
KLEFS0180_T4,CVMF,Yes,,B,19,,,,,KLEFS0180_OS_C_C.xml,,,,,,,,,,,,,
KLIJN0600_T1,LHRH-A,Yes,,,54,30,"HR 1.95 [1.23, 3.10]",,,,,,,,,,,6.3,,,,,
KLIJN0600_T2,TAM,Yes,,,54,34.8,"HR 1.63 [1.03, 2.59]",,,,,,,,,,,5.6,,,,,
KLIJN0600_T3,LHRH-A + TAM,Yes,,,53,44.4,,,,,,,,,,,,9.7,,,,,
KNIGH0179_T1,5-week schedule,Yes,,,20,7,,,,,,,,,,,,,,,,,
KNIGH0179_T2,3-week schedule,Yes,,,16,6.07,,,,,,,,,,,,,,,,,
KOLAR0285_T1,CAP,Yes,,,61,,,,20,,,,,,,,,,,,,,
KOLAR0285_T2,CMFVP,Yes,,,62,,,,34,,,,,,,,,,,,,,
KOLAR0289_T1,CAP,Yes,,,68,13,,0.1,58,KOLAR0289_OS_F.xml,,,,,,,,,,,,,
KOLAR0289_T2,FAC,Yes,,,74,9,,,68,KOLAR0289_OS_C.xml,,,,,,,,,,,,,
KOYAM0599_T1,Arm I,Yes,,,37,18.46,,,,KOYAM0599_OS_I.xml,,,,,,,,,,,,,
KOYAM0599_T2,Arm II,Yes,,,32,23.57,,0.4361,,KOYAM0599_OS_II.xml,,,,,,,,,,,,,
KROOK0485_T1,CFP,Yes,,,66,18.13,,0.08,49.5,KROOK0485_OS_C.xml,"\Over 75% of patients had died\""""",9.57,,,,,,,,,,,
KROOK0485_T2,CFP + tamoxifen,Yes,,,59,13.13,,,44.25,KROOK0485_OS_CT.xml,"\Over 75% of patients had died\""""",5.27,,,,,,,,,,,
KROP0316_T1,Group A,Yes,,,22,,,,,,,,,,,,,7.4,,,KROP0316_PFS_A.xml,,
KROP0316_T2,Group B,Yes,,,22,,,,,,,,,,,,,,,,KROP0316_PFS_B.xml,,
KROP0614_T1,Trastuzumab Emtansine,Yes,Yes,,404,22.7,,,,KROP0614_OS_T.xml,,,,,,,,6.2,,,KROP0614_PFS_T.xml,,
KROP0616_T1,Part 1: Pictilisib plus fulvestrant,Yes,,A,89,,,,,,,,,,,,,6.6,,,KROP0616_PFS_A_Pi.xml,,
KROP0616_T2,Part 1: Placebo plus fulvestrant,Yes,,A,79,,,,,,,,,,,,,5.1,,,KROP0616_PFS_A_P.xml,,
KROP0616_T3,Part 2: Pictilisib plus fulvestrant,Yes,,B,41,,,,,,,,,,,,,5.4,,,KROP0616_PFS_B_Pi.xml,,
KROP0616_T4,Part 2: Placebo plus fulvestrant,Yes,,B,20,,,,,,,,,,,,,10,,,KROP0616_PFS_B_P.xml,,
KUMAR0484_T1,Low Dose,Yes,,,24,,,,,,,,,,,,,,,,,,
KUMAR0484_T2,High Dose,Yes,,,26,,,,,,,,,,,,,,,,,,
KUMMA0616_T1,C Alone,Yes,,,18,,,,,,,,,,,,,1.9,,,KUMMA0616_PFS_A.xml,,
KUMMA0616_T2,V+C Combination,Yes,,,21,,,,,,,,,,,,,2.1,,,KUMMA0616_PFS_C.xml,,p=0.034
LALIS0711_T1,Dose-escalated epirubicin / paclitaxel,Yes,,,51,16,,,,,,,,,,,,6,,,,,
LALIS0711_T2,Dose-dense epirubicin / paclitaxel,Yes,,,55,14,,,,,,,,,,,,7,,,,,
LAM1214_T1,Paclitaxel and bevacizumab (AT) group,Yes,,,156,23.1,,,,,,,,,,,,8.4,,,,,
LAM1214_T2,Paclitaxel and bevacizumab plus capecitabine (ATX) group,Yes,,,156,24.2,"HR 0.92 [0.72, 1.19] p=0.53",,,,,,,,,,,11.2,,,,,
LANG0213_T1,Bevacizumab plus paclitaxel,Yes,Yes,,285,30.2,,,,LANG0213_OS_BP.xml,,,,,,,,10.9,,,LANG0213_PFS_BP.xml,,
LANG0213_T2,Bevacizumab plus capecitabine,Yes,Yes,,279,26.1,"HR 1.06 [0.80, 1.40]",,,LANG0213_OS_BC.xml,Weird confidence intervals from non-inferiority design; this one looks normal and is from the top of Figure 3,,,,,,,8.1,,,LANG0213_PFS_BC.xml,,
LANGR1105_T1,EP,Yes,Yes,,353,13,"HR 1.02 [0.87, 1.19] p=0.8",,,LANGR1105_OS_EP.xml,,,,,,,,7,,,LANGR1105_PFS_EP.xml,,
LANGR1105_T2,EC,Yes,Yes,,352,14,,,,LANGR1105_OS_EC.xml,,,,,,,,7.1,,,LANGR1105_PFS_EC.xml,,
LASAL0304_T1,Insulin + Methotrexate,Yes,,,10,,,,,,,,,,,,,,,,,,
LASAL0304_T2,Methotrexate,Yes,,,10,,,,,,,,,,,,,,,,,,
LASAL0304_T3,Insulin,Yes,,,10,,,,,,,,,,,,,,,,,,
LAWTO0293_T1,Doxorubicin,Yes,,,28,6.4,,,,LAWTO0293_OS_D.xml,,,,,,,,,,,,,
LAWTO0293_T2,Epirubicin,Yes,,,28,9.14,"HR 0.57 [0.33, 0.98]",,,LAWTO0293_OS_E.xml,HR computed from O and E,,,,,,,,,,,,
LAWTO0293_T3,Mitozantrone,Yes,,,31,7.77,"HR 0.75 [0.43, 1.31]",,,LAWTO0293_OS_M.xml,HR computed from O and E,,,,,,,,,,,,
LEE0186_T1,"No previous tamoxifen administrations, 5 mg twice a day",Yes,,,15,,,,,,,,,,,,,,,,,,
LEE0186_T2,"No previous tamoxifen administrations, 10 mg twice a day",Yes,,,19,,,,,,,,,,,,,,,,,,
LEE0186_T3,"No previous tamoxifen administrations, 20 mg twice a day",Yes,,,18,,,,,,,,,,,,,,,,,,
LEGHA1179_T1,HOM,Yes,,,27,,,,,,,,,,,,,,,,,,
LEGHA1179_T2,HMM,Yes,,,21,,,,,,,,,,,,,,,,,,
LEO1010_T1,Fulvestrant 500 mg,Yes,Yes,,361,26.4,"HR 0.84 [0.69, 1.03] p=0.091",,,LEO1010_OS_500.xml,,,,,,,,6.5,,,LEO1010_PFS_500.xml,,
LEO1010_T2,Fulvestrant 250 mg,Yes,Yes,,374,22.3,,,,LEO1010_OS_250.xml,,,,,,,,5.5,,,LEO1010_PFS_250.xml,,
LEONA0787_T1,VMP,Yes,,,59,11,,0.86,41.3,,70% have died,,,,,,,,,,,,
LEONA0787_T2,VAP,Yes,,,56,11,,,39.2,,70% have died,,,,,,,,,,,,
LIN0107_T1,Docetaxel arm,Yes,Yes,,50,22.7,,0.63,24,LIN0107_OS_D.xml,,9.8,,,LIN0107_TTP_D.xml,,,,,,,,
LIN0107_T2,Paclitaxel arm,Yes,Yes,,51,22.4,,,30,LIN0107_OS_P.xml,,6.5,,,LIN0107_TTP_P.xml,,,,,,,,
LIN1211_T1,Lapatinib + capecitabine,Yes,,,13,,,,,,,,,,,,,,,,,,
LIN1211_T2,Lapatinib + topotecan,Yes,,,9,,,,,,,,,,,,,,,,,,
LIPPM0184_T1,CAMF,Yes,,,53,17,,,40,,,12,,,LIPPM0184_TTP_C.xml,,,,,,,,
LIPPM0184_T2,CAMFTP,Yes,,,55,19,,0.291,38,,,16,,,LIPPM0184_TTP_CTP.xml,,,,,,,,
LIPTO0187_T1,Estrace,Yes,,,21,18.87,,0.19,,LIPTO0187_OS_S.xml,,,,,,,,,,,,,
LIPTO0187_T2,Placebo,Yes,,,14,14.09,,,,LIPTO0187_OS_P.xml,,,,,,,,,,,,,
LIPTO0882_T1,Tamoxifen,Yes,,,39,,,,,,,,,,,,,,,,,,
LIPTO0882_T2,Aminoglutethimide,Yes,,,36,,,,,,,,,,,,,,,,,,
LISSO0202_T1,Taxotere,Yes,,,16,,,,,,,,,,,,,,,,,,
LISSO0202_T2,Taxotere + bromocriptine,Yes,,,14,,,,,,,,,,,,,,,,,,
LLOMB0112_T1,Exemestane Arm,Yes,,,51,19.9,"HR 1.33 [0.78, 2.25] p=0.296",,,,,6.1,,,,,,,,,,,
LLOMB0112_T2,Anastrozole Arm,Yes,,,52,48.3,,,,,,12.1,,,,,,,,,,,
LLOMB0607_T1,P600,Yes,,,47,,,,,,,4.2,,,,,,4.2,,,,,
LLOMB0607_T2,P900,Yes,,,45,21.4,"HR 0.87 [0.44, 1.72] p=0.687",,,,,4.6,,,,,,4.1,,,,,
LLOYD0179_T1,AC,Yes,,,36,16.5,,,,LLOYD0179_OS_C.xml,,,,,,,,,,,,,
LLOYD0179_T2,AC + Cal,Yes,,,20,23.5,,0.05,,LLOYD0179_OS_CC.xml,,,,,,,,,,,,,
LOKIC1277_T1,MA,Yes,,,20,,,,,,,,,,,,,,,,,,
LOKIC1277_T2,MAC,Yes,,,20,,,,,,,,,,,,,,,,,,
LOPEZ0189_T1,FAC,Yes,,,46,16.44,,,,LOPEZ0189_OS_FAC.xml,,,,,,,,,,,,,
LOPEZ0189_T2,FEC,Yes,,,48,13.48,,,,LOPEZ0189_OS_FEC.xml,,,,,,,,,,,,,
LOPEZ1283_T1,FAC + HD-MPA i.m.,Yes,,,39,30,,,,LOPEZ1283_OS_im.xml,,,,,,,,,,,,,
LOPEZ1283_T2,FAC + HD-MPA p.o.,Yes,,,37,22,,,,LOPEZ1283_OS_po.xml,,,,,,,,,,,,,
LOPEZ1289_T1,Doxorubicin,Yes,Yes,,37,20,,0.09,,LOPEZ1289_OS_D.xml,,4,,,LOPEZ1289_TTP_D.xml,,,,,,,,
LOPEZ1289_T2,Idarubicin,Yes,Yes,,34,14,,,,LOPEZ1289_OS_I.xml,,3,,,LOPEZ1289_TTP_I.xml,,,,,,,,
LORTH0112_T1,Arm A (standard schedule),Yes,,,66,22.1,,,33.66,,Events in 51% of patients,,,,,,,9.3,,,LORTH0112_PFS_A.xml,,
LORTH0112_T2,Arm B (weekday schedule),Yes,,,64,26.7,,0.31,32.64,,Events in 51% of patients,,,,,,,12,,,LORTH0112_PFS_B.xml,,
LORUS1114_T1,Arm A,Yes,,,117,30.57,,0.107,,,,9.57,,,,,,,,,,,
LORUS1114_T2,Arm B,Yes,,,116,28.47,,,,,,7.93,,,,,,,,,,,
LUCK0115_T1,TBX,Yes,,,111,21.6,"HR 1.10 [0.729, 1.65] p=0.653",,,,,,,,,,,9.9,,,,,
LUCK0115_T2,TB,Yes,,,116,18.9,,,,,,,,,,,,11.3,,,,,
LUCK0613_T1,Capecitabine + paclitaxel (XP),Yes,,,170,22,"HR 1.027 [0.740, 1.424]",,,,,,,,,,,10.4,,,,,
LUCK0613_T2,Epirubicin + paclitaxel (EP),Yes,,,170,26.1,,,,,,,,,,,,9.2,,,,,
LUNDG1189_T1,AG,Yes,,,76,22.4,,0.2,,LUNDG1189_OS_AG.xml,,,,,,,,,,,,,
LUNDG1189_T2,MA,Yes,,,74,16.3,,,,LUNDG1189_OS_MA.xml,,,,,,,,,,,,,
LYMAN0504_T1,AT,Yes,,,45,14,,,44,LYMAN0504_OS_AT.xml,,,,,,,,,,,,,
LYMAN0504_T2,AC,Yes,,,46,27,,,33,LYMAN0504_OS_AC.xml,,,,,,,,,,,,,
MACKE0115_T1,RAM Plus DOC,Yes,,,759,27.3,"HR 1.01 [0.83, 1.23] p=0.915",,,,,9.7,,,,,,,,,,,
MACKE0115_T2,PBO Plus DOC,Yes,,,385,27.2,,,,,,8.2,,,,,,,,,,,
MANN0985_T1,PALA,Yes,,,20,,,,,,,,,,,,,,,,,,
MANN0985_T2,PALA + 5-FU,Yes,,,29,,,,,,,,,,,,,,,,,,
MANN0985_T3,5-FU,Yes,,,14,,,,,,,,,,,,,,,,,,
MARSC0589_T1,CFP,Yes,,,166,15.2,,,,MARSC0589_OS_CMFP.xml,,4.7,,,,,,,,,,,
MARSC0589_T2,CMFP,Yes,,,170,14.9,"HR 1.02 [0.79, 1.32] p=0.88",,,MARSC0589_OS_CFP.xml,,6.2,,,,,,,,,,,
MARTI0215_T1,"Arm A, Cint",Yes,,,95,27.3,"HR 1.0 [0.7, 1.4] p=0.9",,,,,,,,MARTI0215_TTP_A.xml,,,8.7,,,,,
MARTI0215_T2,"Arm B, Ccont",Yes,,,97,23.3,,,,,,,,,MARTI0215_TTP_B.xml,,,6.8,,,,,
MARTI0217_T1,Buparlisib + paclitaxel,Yes,,,207,,,,,,,,,,,,,8,"HR 1.18 [0.82, 1.68]",,MARTI0217_PFS_BP.xml,,
MARTI0217_T2,Placebo + paclitaxel,Yes,,,209,,,,,,,,,,,,,9.2,,,MARTI0217_PFS_PP.xml,,
MARTI0307_T1,Gemcitabine plus vinorelbine,Yes,,,125,15.9,,,,,,,,,,,,6,,,MARTI0307_PFS_GV.xml,,
MARTI0307_T2,Vinorelbine,Yes,,,126,16.4,,,,,,,,,,,,4,,,MARTI0307_PFS_V.xml,,
MARTI0315_T1,ET,Yes,,,184,51.8,"HR 0.87 [0.58, 1.32] p=0.518",,,,,,,,,,,14.4,,,,,
MARTI0315_T2,ET-B,Yes,,,190,52.1,,,,,,,,,,,,19.3,,,,,
MARTI0411_T1,Motesanib,Yes,,,91,,,,,,,,,,,,,9.5,,,MARTI0411_PFS_M.xml,,
MARTI0411_T2,Placebo,Yes,,,94,,,,,,,,,,,,,9,,,MARTI0411_PFS_P.xml,,
MARTI0411_T3,Bevacizumab,Yes,,,97,,,,,,,,,,,,,11.5,,,MARTI0411_PFS_B.xml,,
MARTI1213_T1,Neratinib,Yes,,,117,19.74,"HR 1.25 [0.83, 1.86] p=0.280",,,,,,,,,,,4.53,,,,,
MARTI1213_T2,Lapatinib plus capecitabine,Yes,,,116,23.62,,,,,,,,,,,,6.83,,,,,
MARTO0590_T1,IDA,Yes,,,41,9.59,,,24,MARTO0590_OS_IDA.xml,,,,,,,,,,,,,
MARTO0590_T2,ADRIA,Yes,,,22,12.01,,0.452,11,MARTO0590_OS_AD.xml,,,,,,,,,,,,,
MARTY0705_T1,Trastuzumab + Docetaxel,Yes,,,92,31.2,,0.0325,,MARTY0705_OS_TD.xml,,11.7,,,,,,,,,,,
MARTY0705_T2,Docetaxel Alone,Yes,,,94,22.7,,,,MARTY0705_OS_D.xml,,6.1,,,,,,,,,,,
MATEL0485_T1,Estrogen,Yes,,,24,,,,,,,,,,,,,,,,,,
MATEL0485_T2,Tamoxifen,Yes,,,19,,,,,,,,,,,,,,,,,,
MATTS1079_T1,VAC,Yes,,,31,23,,,,MATTS1079_OS_VAC.xml,,,,,,,,,,,,,
MATTS1079_T2,VACM,Yes,,,33,,,,,MATTS1079_OS_VACM.xml,,,,,,,,,,,,,
MAVRO0110_T1,DE,Yes,Yes,,136,37.6,,0.744,63,MAVRO0110_OS_DE.xml,,10.6,,,MAVRO0110_TTP_DE.xml,,,,,,,,
MAVRO0110_T2,DC,Yes,Yes,,136,35.7,,,65,MAVRO0110_OS_DC.xml,,11,,,MAVRO0110_TTP_DC.xml,,,,,,,,
MAYER1210_T1,PB,Yes,,,23,,,,,,,,,,,,,,,,MAYER1210_PFS_PB.xml,,
MAYER1210_T2,PBS,Yes,,,23,,,,,,,,,,,,,,,,MAYER1210_PFS_PBS.xml,,
MEHTA0812_T1,Anastrozole alone,Yes,Yes,,345,41.3,,,,MEHTA0812_OS_A.xml,,,,,,,,13.5,,,MEHTA0812_PFS_A.xml,,
MEHTA0812_T2,Anastrozole and Fulvestrant,Yes,Yes,,349,47.7,"HR 0.81 [0.65, 1.00] p=0.049",,,MEHTA0812_OS_AF.xml,,,,,,,,15,,,MEHTA0812_PFS_AF.xml,,
MILES0117_T1,Placebo-paclitaxel,Yes,Yes,,242,25.8,,,,MILES0117_OS_P.xml,,,,,,,,8.8,,,MILES0117_PFS_P.xml,,
MILES0117_T2,Bevacizumab + paclitaxel,Yes,Yes,,239,,"HR 0.81 [0.61, 1.08] p=0.1563",,,MILES0117_OS_BP.xml,,,,,,,,11,"HR 0.68 [0.51, 0.91] p=0.0007",,MILES0117_PFS_BP.xml,,
MILES0710_T1,Placebo + Docetaxel,Yes,,,241,31.9,,,,,,,,,,,,8.2,,,MILES0710_PFS_P.xml,,
MILES0710_T2,7.5 mg/kg + Docetaxel,Yes,,,248,30.8,"HR 1.05 [0.81, 1.36] p=0.72",,,,,,,,,,,9,,,MILES0710_PFS_7.5.xml,,
MILES0710_T3,15 mg/kg + Docetaxel,Yes,,,247,30.2,"HR 1.03 [0.80, 1.33] p=0.85",,,,"Fixed a likely typo --- the CI was reported with a lower bound of 0.7, but in fact it is symmetric if that is instead 0.8",,,,,,,10,,,MILES0710_PFS_15.xml,,
MILLA0101_T1,Toremifene,Yes,,,106,15.4,"HR 0.97 [0.74, 1.29]",,,MILLA0101_OS_TOR.xml,,11.9,,,,,,,,,,,
MILLA0101_T2,Tamoxifen,Yes,,,111,12.3,,,,MILLA0101_TAM_OS.xml,,9.2,,,,,,,,,,,
MILLA0603_T1,Anastrozole,Yes,,,121,17.4,"HR 0.64 [0.47, 0.86] p=0.003",,,MILLA0603_OS_ANA.xml,,,,,,,,,,,,,
MILLA0603_T2,Tamoxifen,Yes,,,117,16,,,,MILLA0603_TAM_OS.xml,,,,,,,,,,,,,
MILLE0896_T1,0.6 mg tid,Yes,,,18,,,,,,,,,,,,,,,,,,
MILLE0896_T2,1 mg bid,Yes,,,19,,,,,,,,,,,,,,,,,,
MILLE0896_T3,2 mg bid,Yes,,,19,,,,,,,,,,,,,,,,,,
MILLN1207_T1,Paclitaxel plus Bevacizumab,Yes,Yes,,347,26.7,"HR 0.88 [0.736, 1.052] p=0.16",,,MILLN1207_OS_PB.xml,Computed HR CI from HR and p-value,,,,,,,11.8,,,MILLN1207_PFS_PB.xml,,
MILLN1207_T2,Paclitaxel,Yes,Yes,,326,25.2,,,,MILLN1207_OS_P.xml,,,,,,,,5.9,,,MILLN1207_PFS_P.xml,,
MILLO0205_T1,Capecitabine,Yes,Yes,,230,14.5,,,87.4,MILLO0205_OS_CAP.xml,38% of patients had died,,,,,,,4.17,,,MILLO0205_PFS_CAP.xml,,
MILLO0205_T2,Capecitabine + Bevacizumab,Yes,Yes,,232,15.1,,,88.16,MILLO0205_OS_CAPBV.xml,38% of patients had died,,,,,,,4.86,,,MILLO0205_PFS_CAPBV.xml,,
MILST0485_T1,TAM,Yes,,,35,,,,,,,,,,,,,,,,,,
MILST0485_T2,TAG,Yes,,,31,,,,,,,,,,,,,,,,,,
MITA0614_T1,Dinaciclib,Yes,,,15,,,,,,,,,,,,,2.73,,,,,
MITA0614_T2,Capecitabine,Yes,,,15,,,,,,,,,,,,,4.17,,,,,
MOULD0210_T1,3-Hour,Yes,Yes,,107,14.2,,,,MOULD0210_OS_3-HOUR.XML,,,,,,,,3.8,,,MOULD0210_PFS_3.xml,,
MOULD0210_T2,96-Hour,Yes,Yes,,107,12.7,"HR 1.11 [0.80, 1.53] p=0.55",,,MOULD0210_96-HOUR.xml,,,,,,,,5,,,MOULD0210_PFS_96.xml,,
MOURI0177b_T1,Single drug,Yes,,,27,,,,,,,,,,,,,,,,,,
MOURI0177b_T2,Multiple drug,Yes,,,28,,,,,,,,,,,,,,,,,,
MOURI0180_T1,TAM,Yes,,,65,,,,,,,,,,,,,,,,,,
MOURI0180_T2,TAM + DES,Yes,,,57,,,,,,,,,,,,,,,,,,
MOURI0501_T1,Letrozole,Yes,,,455,34,,0.53,,,Survival update from MOURI0603,9.4,,,MOURI0501_TTP_L.xml,,,,,,,,
MOURI0501_T2,Tamoxifen,Yes,,,455,30,,,,,Survival update from MOURI0603,6,,,MOURI0501_TTP_T.xml,,,,,,,,
MOURI1280_T1,CMF,Yes,,,120,19,,,90,,,7,,,MOURI1280_TTP_CMF.xml,,,,,,,,
MOURI1280_T2,CMF + T,Yes,,,125,24,,0.006,90,,,14,,,MOURI1280_TTP_CMFT.xml,,,,,,,,
MOURIb1280_T1,TAM,Yes,,,46,,,,,,,,,,,,,,,,,,
MOURIb1280_T2,TAM + MPA,Yes,,,55,,,,,,,,,,,,,,,,,,
MROSS0193_T1,EPI,Yes,,,25,7.4,,,,MROSS0193_OS_EPI.xml,,,,,,,,,,,,,
MROSS0193_T2,EPI + VPL,Yes,,,26,8.9,,,,MROSS0193_OS_EPIVPL.xml,,,,,,,,,,,,,
MUSOL0217_T1,Fulvestrant + dovitinib,Yes,Yes,,47,,"HR 0.81 [0.39, 1.65]",,,MUSOL0217_OS_FD.xml,,,,,,,,5.5,"HR 0.68 [0.41, 1.14]",,MUSOL0217_PFS_FD.xml,,
MUSOL0217_T2,Fulvestrant + placebo,Yes,Yes,,50,25.9,,,,MUSOL0217_OS_FP.xml,,,,,,,,5.5,,,MUSOL0217_PFS_FP.xml,,
MUSS0385_T1,Megestrol Acetate,Yes,Yes,,69,25.7,,,47,MUSS0385_OS_M.xml,,7.7,,,MUSS0385_TTP_M.xml,,,,,,,,
MUSS0385_T2,Tamoxifen,Yes,Yes,,67,36,,0.12,37,MUSS0385_OS_T.xml,,7.7,,,MUSS0385_TTP_T.xml,,,,,,,,
MUSS0894_T1,Tamoxifen,Yes,,,91,23.8,,,75,MUSS0894_OS_MPA.xml,,,,,,,,,,,,,
MUSS0894_T2,MPA,Yes,,,91,33,,0.09,70,MUSS0894_STA_OS.xml,,,,,,,,,,,,,
MUSS1190_T1,Standard-dose,Yes,,,86,16.5,,,50,MUSS1190_OS_STA.xml,,,,,,,,,,,,,
MUSS1190_T2,High-dose,Yes,,,84,22.4,,0.04,39,MUSS1190_HIGH_OS.xml,,,,,,,,,,,,,
MUSS1277_T1,3 Drugs,Yes,,,38,,,,,,,,,,,,,,,,,,
MUSS1277_T2,5 Drugs,Yes,,,34,,,,,,,,,,,,,,,,,,
MUSS1282_T1,CMF,Yes,,,49,13.1,,,17,MUSS1282_os_cmf.xml,,,,,,,,,,,,,
MUSS1282_T2,VAC,Yes,,,51,10.9,,0.53,15,MUSS1282_OS_VAC.xml,,,,,,,,,,,,,
NABHD0696_T1,A,Yes,,,235,11.7,,0.321,135,NABHD0696_OS_A.xml,,4.2,,,,,,,,,,,
NABHD0696_T2,B,Yes,,,236,10.5,,,143,NABHD0696_OS_B.xml,,3,,,,,,,,,,,
NABHO0599_T1,Docetaxel,Yes,,,203,11.4,,0.0097,137,NABHO0599_os_doc.xml,,4.4,,,,,,,,,,,
NABHO0599_T2,MV,Yes,,,189,8.7,,,138,NABHO0599_os_mv.xml,,2.6,,,,,,,,,,,
NABHO1100_T1,Anastrozole 1 mg,Yes,,,170,,,,,,,11.1,,,NABHO1100_TTP_A.xml,,,,,,,,
NABHO1100_T2,Tamoxifen 20 mg,Yes,,,182,,,,,,,5.6,,,NABHO1100_TTP_T.xml,,,,,,,,
NABHT0303_T1,AC,Yes,,,215,21.7,,,176,,,7.4,,,NABHT0303_TTP_AC.xml,,,,,,,,
NABHT0303_T2,AT,Yes,,,214,22.5,,0.26,165,,,8.7,,,NABHT0303_TTP_AT.xml,,,,,,,,
NAMER0601_T1,FAC or FEC,Yes,Yes,,138,20,,0.27,,NAMER0601_FAC_OS.xml,,,,,,,,7,,,NAMER0601_PFS_F.xml,,
NAMER0601_T2,MV,Yes,Yes,,142,17,,,,NAMER0601_OS_MV.xml,,,,,,,,7,,,NAMER0601_PFS_MV.xml,,
NEIDH0586_T1,Doxorubicin,Yes,,,41,,,,,,,4.67,,,,,,,,,,,
NEIDH0586_T2,Mitoxantrone,Yes,,,49,,,,,,,3.63,,,,,,,,,,,
NEMOT0582_T1,CFP,Yes,Yes,,18,14.12,,,15,NEMOT0582_OS_CFP.xml,,8.57,,,NEMOT0582_TTP_CFP.xml,,,,,,,,
NEMOT0582_T2,CAF,Yes,Yes,,46,14.12,,,40,NEMOT0582_OS_CAF.xml,,,,,NEMOT0582_TTP_CAF.xml,,,,,,,,
NEMOT0582_T3,CA,Yes,Yes,,42,17.14,,,36,NEMOT0582_OS_CA.xml,,10.59,,,NEMOT0582_TTP_CA.xml,,,,,,,,
NEMOT0582_T4,CFP-CA,Yes,Yes,,20,19.16,,,16,NEMOT0582_OS_CFPCA.xml,,10.59,,,NEMOT0582_TTP_CFPCA.xml,,,,,,,,
NICHO0578_T1,TZT,Yes,,,17,3.4,,,,,,,,,,,,,,,,,
NICHO0578_T2,PRZF,Yes,,,17,3.7,,,,,,,,,,,,,,,,,
NIELS0600_T1,Epirubicin,Yes,Yes,,81,15.2,,,,NIELS0600_OS_E.xml,,8.6,,,NIELS0600_TTP_E.xml,,,,,,,,
NIELS0600_T2,Epirubicin + cisplatin,Yes,Yes,,74,20.6,,0.41,,NIELS0600_OS_EC.xml,,14.4,,,NIELS0600_TTP_EC.xml,,,,,,,,
NIELS0790_T1,Epirubicin,Yes,,,76,12,,,,NIELS0790_OS_E.xml,,6,,,,,,,,,,,
NIELS0790_T2,Epirubicin + vindesine,Yes,,,67,12,,,,NIELS0790_OS_EV.xml,,6,,,,,,,,,,,
NIELS1211_T1,Gemcitabine + Docetaxel,Yes,Yes,,170,19.7,"HR 0.94 [0.75, 1.18] p=0.57",,,NIELS1211_OS_GD.xml,,10.3,,,NIELS1211_TTP_GD.xml,,,,,,,,
NIELS1211_T2,Docetaxel,Yes,Yes,,167,17.9,,,,NIELS1211_OS_D.xml,,8.3,,,NIELS1211_TTP_D.xml,,,,,,,,
NOAUT0385_T1,CMF,Yes,,,82,,,,,,,,,,,,,,,,,,
NOAUT0385_T2,CMF+T,Yes,,,71,,,,,,,,,,,,,,,,,,
NOAUT0682_T1,CMFV,Yes,,,108,,,,,,,,,,,,,,,,,,
NOAUT0682_T2,CD,Yes,,,110,,,,,,,,,,,,,,,,,,
NOOIJ0303_T1,Continuation of CMF,Yes,Yes,,96,14,,,,NOOIJ0303_OS_C.xml,,5.2,,,,,,,,,NOOIJ0303_PFS_C.xml,,
NOOIJ0303_T2,No further treatment,Yes,Yes,,100,14.4,,0.77,,NOOIJ0303_OS_D.xml,,3.5,,,,,,,,,NOOIJ0303_PFS_D.xml,,
NORRS0600_T1,Arm 1,Yes,,,151,13.8,,,106,NORRS0600_OS_1.xml,,6.2,,,,,,,,,,,
NORRS0600_T2,Arm 2,Yes,,,149,14.4,,0.4,105,NORRS0600_OS_2.xml,,6.1,,,,,,,,,,,
OBRIE0304_T1,PLD,Yes,Yes,,254,21,,,,OBRIE0304_OS_P.xml,,,,,,,,6.9,,,OBRIE0304_PFS_P.xml,,
OBRIE0304_T2,Doxorubicin,Yes,Yes,,255,22,"HR 0.94 [0.74, 1.19]",,,OBRIE0304_OS_D.xml,,,,,,,,7.8,,,OBRIE0304_PFS_D.xml,,
OSBOR0311_T1,Tamoxifen + gefitinib,Yes,,,153,,,,,,TODO: search for follow-up survival analyses,,,,,,,10.9,,,OSBOR0311_PFS_GT.xml,,
OSBOR0311_T2,Tamoxifen + placebo,Yes,,,136,,,,,,TODO: search for follow-up survival analyses,,,,,,,8.8,,,OSBOR0311_PFS_PT.xml,,
OSBOR0702_T1,Fulvestrant 250 mg,Yes,,,206,,,,,,TODO: search for follow-up survival analyses,5.4,,,OSBOR0702_TTP_F.xml,,,,,,,,
OSBOR0702_T2,Anastrozole 1 mg/d,Yes,,,194,,,,,,TODO: search for follow-up survival analyses,3.4,,,OSBOR0702_TTP_A.xml,,,,,,,,
OSHAU0111_T1,Gemcitabine-Carboplatin and Iniparib,Yes,Yes,,61,12.3,"HR 0.57 [0.36, 0.90] p=0.01",,,OSHAU0111_OS_GI.xml,,,,,,,,5.9,,,OSHAU0111_PFS_GI.xml,,
OSHAU0111_T2,Gemcitabine-Carboplatin Alone,Yes,Yes,,62,7.7,,,,OSHAU0111_OS_GA.xml,,,,,,,,3.6,,,OSHAU0111_PFS_GA.xml,,
OSHAU0116_T1,E,Yes,,,102,,,,,,,,,,,,,3.7,,,OSHAU0116_PFS_E.xml,,
OSHAU0116_T2,AA,Yes,,,89,,,,,,,,,,,,,3.7,,,OSHAU0116_PFS_AA.xml,,
OSHAU0116_T3,AAE,Yes,,,106,,,,,,,,,,,,,4.5,,,OSHAU0116_PFS_AAE.xml,,
OSHAU0602_T1,Capecitabine / Docetaxel,Yes,Yes,,255,14.5,"HR 0.775 [0.634, 0.947] p=0.0126",,,OSHAU0602_OS_C.xml,,6.1,,,OSHAU0602_TTP_C.xml,,,,,,,,
OSHAU0602_T2,Docetaxel,Yes,Yes,,256,11.5,,,,OSHAU0602_OS_D.xml,,4.2,,,OSHAU0602_TTP_D.xml,,,,,,,,
OSHAU0901_T1,Capecitabine,Yes,Yes,,61,19.6,,,,OSHAU0901_OS_C.xml,,4.1,,,OSHAU0901_TTP_C.xml,,,,,,,,
OSHAU0901_T2,CMF,Yes,Yes,,32,17.2,,,,OSHAU0901_OS_CM.xml,,3,,,OSHAU0901_TTP_CM.xml,,,,,,,,
OSHAU1214_T1,Gemcitabine and Carboplatin,Yes,,,258,11.1,,,,,,,,,,,,4.1,,,,,
OSHAU1214_T2,"Gemcitabine, Carboplatin, and Iniparib",Yes,,,261,12.2,"HR 0.85 [0.69, 1.04] p=0.1114",,,,,,,,,,,5.1,,,,,
PACIL0506_T1,ED,Yes,Yes,,26,18,,,15,PACIL0506_OS_ED.xml,Converted from 1-sided to 2-sided p-value,9,,,,,,,,,PACIL0506_OS_ED.xml,,
PACIL0506_T2,D,Yes,Yes,,25,21,,0.7188,15,PACIL0506_OS_D.xml,Converted from 1-sided to 2-sided p-value,11,,,,,,,,,PACIL0506_OS_D.xml,,
PACIN0500_T1,FEC,Yes,,,79,19,,,,,No KM for each arm individually,9,,,,,,,,,,,
PACIN0500_T2,EM,Yes,,,81,19,,,,,No KM for each arm individually,9,,,,,,,,,,,
PACIN0500_T3,LFEC,Yes,,,74,21,,,,,No KM for each arm individually,10,,,,,,,,,,,
PACIN0500_T4,LEM,Yes,,,74,21,,,,,No KM for each arm individually,10,,,,,,,,,,,
PAGAN0217_T1,Arm A,Yes,Yes,,86,35.6,,0.55,,PAGAN0217_OS_A.xml,,3.7,HR 2.1,,PAGAN0217_TTP_A.xml,,,,,,,,
PAGAN0217_T2,Arm B,Yes,Yes,,87,36.3,,,,PAGAN0217_OS_B.xml,,10.3,,,PAGAN0217_TTP_B.xml,,,,,,,,
PAJK0408_T1,Capecitabine,Yes,,,23,9.3,,,,,,,,,,,,2.8,,,,,
PAJK0408_T2,Vinorelbine,Yes,,,24,11,,,,,,,,,,,,2.6,,,,,
PALLI0512_T1,VG,Yes,Yes,,74,20.4,,,,PALLI0512_OS_VG.xml,,,,,,,,5.4,,,PALLI0512_PFS_VG.xml,,
PALLI0512_T2,Cap,Yes,Yes,,74,22.4,,0.319,,PALLI0512_OS_C.xml,,,,,,,,5.2,,,PALLI0512_PFS_C.xml,,
PALMI1112_T1,Docetaxel,Yes,Yes,,18,7.93,,0.388,,PALMI1112_OS_D.xml,,2.43,,,PALMI1112_TTP_D.xml,,,,,,,,
PALMI1112_T2,Vinorelbine,Yes,Yes,,18,4.95,,,,PALMI1112_OS_V.xml,,1.77,,,PALMI1112_TTP_V.xml,,,,,,,,
PANNU0180_T1,MAP/1,Yes,,,21,,,,,,11+ months MOS,,,,,,,,,,,,
PANNU0180_T2,TMX/1,Yes,,,20,,,,,,11+ months MOS,,,,,,,,,,,,
PANNU0479_T1,MAP/1500,Yes,,,50,,,0.04263,,PANNU0479_OS_1500.xml,,,,,,,,,,,,,
PANNU0479_T2,MAP/500,Yes,,,50,20.9,,,,PANNU0479_OS_500.xml,,,,,,,,,,,,,
PANNU0884b_T1,CMF,Yes,,,23,18,,,,PANNU0884b_OS_C.xml,,,,,,,,,,,,,
PANNU0884b_T2,R 14,Yes,,,23,14,,0.552,,PANNU0884b_OS_R.xml,,,,,,,,,,,,,
PAPAD0309_T1,Docetaxel,Yes,Yes,,30,28,,0.41,,PAPAD0309_OS_D.xml,,5.8,,,PAPAD0309_TTP_D.xml,,,,,,,,
PAPAD0309_T2,Docetaxel + gemcitabine,Yes,Yes,,39,14,,,,PAPAD0309_OS_DG.xml,,6.3,,,PAPAD0309_TTP_DG.xml,,,,,,,,
PARID0303_T,Alternating regimen (ATATATAT),Yes,,,51,20,,,,PARID0903_OS_A.xml,,9.1,,,,,,,,,,,
PARID0903_T1,Exemestane,Yes,,,61,,,,,,,,,,,,,,,,,,
PARID0903_T2,Tamoxifen,Yes,,,59,,,,,,,,,,,,,,,,,,
PARID0986_T1,IM arm,Yes,,,41,7,,,,,,,,,,,,,,,,,
PARID0986_T2,Oral arm,Yes,,,37,11,,,,,,,,,,,,,,,,,
PARIT0200_T1,Paclitaxel,Yes,Yes,,166,15.6,,,,PARIT0200_OS_P.xml,,,,,,,,3.9,,,PARIT0200_PFS_P.xml,,
PARIT0200_T2,Doxorubicin,Yes,Yes,,165,18.3,,0.3813,,PARIT0200_OS_D.xml,,,,,,,,7.5,,,PARIT0200_PFS_D.xml,,
PARK0513_T1,Maintenance,Yes,Yes,,116,32.3,"HR 0.65 [0.42, 0.99] p=0.047",,,PARK0513_OS_M.xml,,,,,,,,7.5,,,PARK0513_PFS_M.xml,,
PARK0513_T2,Observation,Yes,Yes,,115,23.5,,,,PARK0513_OS_O.xml,,,,,,,,3.8,,,PARK0513_PFS_O.xml,,
PARK1010_T1,GV arm,Yes,,,41,10.6,,0.436,38,PARK1010_OS_G.xml,,,,,,,,,,,,,
PARK1010_T2,G -> V arm,Yes,,,40,8.9,,,38,PARK1010_OS_S.xml,,,,,,,,,,,,,
PARK1117_T1,EG,Yes,Yes,,59,21.2,,,,PARK1117_OS_E.xml,,,,,,,,9.6,,,PARK1117_PFS_E.xml,,
PARK1117_T2,PG,Yes,Yes,,59,,"HR 0.57 [0.23, 1.45] p=0.240",,,PARK1117_OS_P.xml,,,,,,,,12.6,"HR 0.84 [0.53, 1.33] p=0.457",,PARK1117_PFS_P.xml,,
PARNE0503_T1,CAF Alone,Yes,,,120,20.7,,,111,PARNE0503_OS_C.xml,,,,,,,,,,,,,
PARNE0503_T2,CAF + LV,Yes,,,121,20.7,,0.8681,110,PARNE0503_OS_CL.xml,,,,,,,,,,,,,
PARVI0585_T1,DC regimen,Yes,,,47,,,,,,,,,,,,,,,,,,
PARVI0585_T2,CMFVP regimen,Yes,,,55,,,,,,,,,,,,,,,,,,
PATER0180_T1,CMF,Yes,,,45,,,,,,No KM with two groups in full population,,,,,,,,,,,,
PATER0180_T2,CMF + Levamisole,Yes,,,45,21,,,,,No KM with two groups in full population,,,,,,,,,,,,
PAVES0395_T1,FEC,Yes,Yes,,78,19,,0.343,54,PAVES0395_OS_FE.xml,,8.5,,,PAVES0395_TTP_FE.xml,,,,,,,,
PAVES0395_T2,FNC,Yes,Yes,,74,15.5,,,56,PAVES0395_OS_FN.xml,,7.5,,,PAVES0395_TTP_FN.xml,,,,,,,,
PEREZ0117_T1,Trastuzumab + Taxane,Yes,,,365,,,,,,,,,,,,,13.7,,,PEREZ0117_PFS_TT.xml,,
PEREZ0117_T2,T-DM1,Yes,,,367,,"HR 0.86 [0.64, 1.16]",,,,,,,,,,,14.1,"HR 0.91 [0.73, 1.13] p=0.31",,PEREZ0117_PFS_T.xml,,
PEREZ0117_T3,T-DM1 + Pertuzumab,Yes,,,363,,"HR 0.82 [0.61, 1.11]",,,,,,,,,,,15.2,"HR 0.87 [0.69, 1.08] p=0.14",,PEREZ0117_PFS_TP.xml,,
PEREZ0704_T1,Irinotecan Weekly,Yes,,,52,9.7,,,,PEREZ0704_weekly_OS.xml,,,,,,,,2.8,,,,,
PEREZ0704_T2,Irinotecan Every 3 Weeks,Yes,,,51,8.6,,,,PEREZ0704_every3weeks_OS.xml,,,,,,,,1.9,,,,,
PEREZ0794_T1,Formestane,Yes,,,203,34.73,,,,PEREZ0794_OS_F.xml,,7.1,,,,,,,,,,,
PEREZ0794_T2,Tamoxifen,Yes,,,206,38.07,,0.73,,PEREZ0794_OS_T.xml,,9.8,,,,,,,,,,,
PEREZ1115_T1,Etirinotecan pegol,Yes,Yes,,429,12.4,,,,PEREZ1115_OS_E.xml,,,,,,,,2.4,,,PEREZ1115_PFS_E.xml,,
PEREZ1205_T1,Every 3 Weeks,Yes,,,43,27.6,,,23,PEREZ1205_every3weeks_OS.xml,,,,,,,,9.9,,,,,
PEREZ1205_T2,Weekly,Yes,,,48,38.4,,,21,PEREZ1205_weekly_OS.xml,,,,,,,,14.7,,,,,
PEREZ1291_T1,Doxorubicin,Yes,,,69,12,,0.47,,PEREZ1291_OS_D.xml,,,,,,,,,,,,,
PEREZ1291_T2,Epirubicin,Yes,,,72,10,,,,PEREZ1291_OS_E.xml,,,,,,,,,,,,,
PERIT0391_T1,FEC,Yes,,,31,,,,,,,8.13,,,,,,,,,,,
PERIT0391_T2,FNC,Yes,,,29,,,,,,,2.87,,,,,,,,,,,
PERRY1087_T1,TCAF,Yes,,,188,20.6,,,157,PERRY1087_OS_TCAF.xml,,,,,,,,,,,,,
PERRY1087_T2,CAF,Yes,,,191,19.9,,0.76,164,PERRY1087_OS_CAF.xml,,,,,,,,,,,,,
PFEIF0596_T1,Treatment A,Yes,,,123,25.7,,,,,,18.1,,,,,,,,,,,
PFEIF0596_T2,Treatment B,Yes,,,123,26.6,,0.28,,,,18.4,,,,,,,,,,,
PIERG0495_T1,Group I,Yes,,,131,23,,,,PIERG0495_OS_A.xml,,,,,,,,,,,,,
PIERG0495_T2,Group II,Yes,,,127,21,,,,PIERG0495_OS_B.xml,,,,,,,,,,,,,
PIVOT0515_T1,Lapatinib + Capecitabine,Yes,,,271,22.7,"HR 1.34 [0.95, 1.90] p=0.095",,,,,,,,,,,6.6,,,,,
PIVOT0515_T2,Trastuzumab + Capecitabine,Yes,,,269,27.3,,,,,,,,,,,,8.1,,,,,
POWLE0684_T1,TAD,Yes,Yes,,111,10,,,,POWLE0684_OS_TAD.xml,,,,,POWLE0684_TTP_TAD.xml,,,,,,,,
POWLE0684_T2,T,Yes,Yes,,111,10,,,,POWLE0684_OS_T.xml,,,,,POWLE0684_TTP_T.xml,,,,,,,,
POWLE0891_T1,3M,Yes,,,106,8,,,,POWLE0891_OS_3M.xml,,,,,,,,,,,,,
POWLE0891_T2,VAC,Yes,,,105,10,,,,POWLE0891_OS_VAC.xml,,,,,,,,,,,,,
PRIES0577_T2,Cytotoxic,Yes,,,45,10.7,,,,PRIES0577_OS_CYT.xml,,,,,,,,,,,,,
PRIES0975_T1,Two drug group,Yes,,,25,,,,,,,,,,,,,,,,,,
PRIES0975_T2,Four drug group,Yes,,,25,,,,,,,,,,,,,,,,,,
PRITC0910_T1,AD,Yes,,,47,,,,,PRITC0910_OS_AD.xml,,3.1,,,,,,,,,,,
PRITC0910_T2,LD,Yes,,,51,,,,,PRITC0910_ld_OS.xml,,6.1,,,,,,,,,,,
PRITC0910_T3,HD,Yes,,,46,,,,,PRITC0910_hd_OS.xml,,6,,,,,,,,,,,
PRONZ1193_T1,Arm A,Yes,,,41,,,,,,,,,,,,,,,,,,
PRONZ1193_T2,Arm B,Yes,,,39,,,,,,,,,,,,,,,,,,
PYRHO0297_T1,Toremifene,Yes,,,214,33,,,123,PYRHO0297_OS_TOR.xml,,7.3,,,,,,,,,,,
PYRHO0297_T2,Tamoxifen,Yes,,,201,38.7,,0.645,115,PYRHO0297_TAM_OS.xml,,10.2,,,,,,,,,,,
RAATS0192_T1,1 mg/d,Yes,,,38,17.5,,,,RAATS0192_OS_1mg.xml,,,,,,,,,,,,,
RAATS0192_T2,4 mg/d,Yes,,,42,,,0.17,,RAATS0192_4mg_OS.xml,,,,,,,,,,,,,
RAMIR0375_T1,4-Drug,Yes,,,52,13.2,,,,RAMIR0375_OS_4drug.xml,,,,,,,,,,,,,
RAMIR0375_T2,5-Drug,Yes,,,48,12.2,,,,RAMIR0375_OS_5drug.xml,,,,,,,,,,,,,
RANAD0613_T1,CP175,Yes,,,64,,,,,RANAD0613_OS_CP175.xml,,,,,,,,,,,,,
RANAD0613_T2,NP220,Yes,,,66,,,,,RANAD0613_NP220_OS.xml,,,,,,,,,,,,,
RANAD0613_T3,NP300,Yes,,,65,,,,,RANAD0613_NP300_OS.xml,,,,,,,,,,,,,
RAUSC0194_T1,20 mg,Yes,,,101,,,,,RAUSC0194_OS_20mg.xml,,5.6,,,,,,,,,,,
RAUSC0194_T2,40 mg,Yes,,,108,,,,,RAUSC0194_40mg_OS.xml,,8.3,,,,,,,,,,,
RAUSC0194_T3,100 mg,Yes,,,122,,,,,RAUSC0194_100mg_OS.xml,,6.4,,,,,,,,,,,
REYNO0104_T1,DPPE + DOX,Yes,,,153,23.6,"HR 0.66 [0.48, 0.91] p=0.021",,,,,,,,,,,5.9,,,,,
REYNO0104_T2,DOX,Yes,,,150,15.6,,,,,,,,,,,,6,,,,,
RICCA0995_T1,FEC-75,Yes,,,35,13,,,,,,10,,,,,,,,,,,
RICCA0995_T2,FEC-100,Yes,,,32,22,,0.09,,,,11,,,,,,,,,,,
RICHA0592_T1,75 mg/m2 every 3 weeks,Yes,,,28,8,,,,RICHA0592_OS_75mg.xml,,4,,,,,,,,,,,
RICHA0592_T2,25 mg/m2 weekly,Yes,,,31,8,,0.25,,RICHA0592_25mg_OS.xml,,5,,,,,,,,,,,
RIVER0408_T1,Every-3-week treatment arm,Yes,,,62,18.3,,0.34,36,RIVER0408_OS_every.xml,,,,,,,,5.7,,,RIVER0408_PFS_3W.xml,,
RIVER0408_T2,Weekly treatment arm,Yes,,,63,18.6,,,39,RIVER0408_weekly_OS.xml,,,,,,,,5.5,,,RIVER0408_PFS_W.xml,,
RIXE1109_T1,Arm A: 50 mg (continuous),Yes,,,70,13.17,,,,RIXE1109_OS_arma.xml,,,,,,,,2.03,,,RIXE1109_PFS_A.xml,,
RIXE1109_T2,Arm B: 150 mg (continuous),Yes,,,72,12.13,,,,RIXE1109_armb_OS.xml,,,,,,,,1.87,,,RIXE1109_PFS_B.xml,,
RIXE1109_T3,Arm C: 450 mg (15 day on/7 day off),Yes,,,56,16.1,,,,RIXE1109_armc_OS.xml,,,,,,,,1.93,,,RIXE1109_PFS_C.xml,,
ROBER0313_T1,Placebo group,Yes,,,50,,,,,ROBER0313_OS_pla.xml,,5.7,,,,,,5.7,,,ROBER0313_PFS_P.xml,,
ROBER0313_T2,Ganitumab group,Yes,,,106,22.2,"HR 1.78 [1.27, 2.50] p=0.025",,,ROBER0313_gan_OS.xml,,3.9,,,,,,3.9,,,ROBER0313_PFS_G.xml,,
ROBER0411_T1,Sunitinib + Paclitaxel,Yes,,,242,17.6,"HR 1.82 [1.16, 2.86] p=0.008",,,ROBER0411_OS_sun.xml,,,,,,,,7.4,,,ROBER0411_PFS_SP.xml,,
ROBER0411_T2,Bevacizumab + Paclitaxel,Yes,,,243,,,,,ROBER0411_OS_bev.xml,,,,,,,,9.2,,,ROBER0411_PFS_BP.xml,,
ROBER0606_T1,TPC,Yes,,,98,35.7,"HR 0.90 [0.46, 1.77] p=0.76",,,ROBER0606_TCP_OS.xml,,,,,,,,10.7,,,ROBER0606_PFS_TPC.xml,,
ROBER0606_T2,TP,Yes,,,98,32.2,,,,ROBER0606_TP_OS.xml,,,,,,,,7.1,,,ROBER0606_PFS_TP.xml,,
ROBER0909_T1,Fulvestrant HD,Yes,,,101,54.1,"HR 0.70 [0.50, 0.98] p=0.04",,,ROBER0909_FUL_OS.xml,updated survival info from ROBER1112 and ELLIS1115,23.4,,,,,,,,,,,
ROBER0909_T2,Anastrozole 1 mg,Yes,,,103,48.4,,,,ROBER0909_ANA_OS.xml,updated survival info from ROBER1112 and ELLIS1115,13.1,,,,,,,,,,,
ROBSO0817_T,Olaparib group,Yes,,,205,19.3,,,,,,,,,,,,7,,,,,
ROBUS0693_T1,Regimen A (500 mg),Yes,,,52,20,,,,,Computed from O and E noting that O for 500 mg should be 25.5 (it's a typo),10.5,,,,,,,,,,,
ROBUS0693_T2,Regimen B (1000 mg),Yes,,,54,22,"HR 1.084 [0.632, 1.857]",,,,Computed from O and E noting that O for 500 mg should be 25.5 (it's a typo),14.5,,,,,,,,,,,
ROCHL1016_T1,Arm A,Yes,,,,,,,,ROCHL1016_PFS_A.xml,,,,,,,,10.3,,,,,p=0.83
ROCHL1016_T2,Arm B,Yes,,,,,,,,ROCHL1016_PFS_B.xml,,,,,,,,8.5,,,,,
ROMER0387_T2,Arm B,Yes,,,40,27.5,,,,ROMER0387_OS_arma.xml,,,,,,,,,,,,,
RORTH0180_T1,Treatment group I,Yes,,,65,,,,,RORTH0180_a_OS.xml,,3.74,,,,,,,,,,,
RORTH0180_T2,Treatment group II,Yes,,,69,,,,,RORTH0180_B_OS.xml,,3.43,,,,,,,,,,,
RORTH0180_T3,Treatment group III,Yes,,,67,,,,,RORTH0180_C_OS.xml,,2.51,,,,,,,,,,,
ROSAT0211_T1,Myocet / paclitaxel,Yes,,,30,24,,,,,,12,,,,,,,,,,,
ROSAT0211_T2,Myocet / docetaxel,Yes,,,24,18,"HR 1.3 [0.7, 2.4] p=0.34",,,,,9,,,,,,,,,,,
ROSE0500_T1,TAM,Yes,,,97,22,,,95,ROSE0500_OS_TAM.xml,,9.2,,,,,,,,,,,
ROSE0500_T2,TAM + AG + H,Yes,,,87,24.1,,,85,ROSE0500_OS_TAH.xml,,7.7,,,,,,,,,,,
ROSE0500_T3,TAM + FLU,Yes,,,86,21.1,,,83,ROSE0500_OS_TF.xml,,9.2,,,,,,,,,,,
ROSE1103_T1,Letrozole,Yes,,,356,22,"HR 0.95 [0.774, 1.166] p=0.624",,,ROSE1103_OS_Let.xml,Computed CI from HR and p-value,5.7,,,,,,,,,,,
ROSE1103_T2,Anastrozole,Yes,,,356,20.3,,,,ROSE1103_Ana_OS.xml,,5.7,,,,,,,,,,,
ROSNE0387_T1,CFP-CFPMV-CA,Yes,,,46,16.6,,,32.95,ROSNE0387_OS_arm1.xml,101/141 died,,,,,,,,,,,,
ROSNE0387_T2,CFPMV-CA-CFP,Yes,,,48,17.6,,,34.38,ROSNE0387_OS_arm2.xml,101/141 died,,,,,,,,,,,,
ROSNE0387_T3,CA-CFP-CFPMV,Yes,,,47,12.3,,,33.67,ROSNE0387_OS_arm3.xml,101/141 died,,,,,,,,,,,,
ROSSO1193_T2,Lonidamine,Yes,,,111,,,,,,,,,,,,,10,,,,,
ROSSO1193_T3,Observation,Yes,,,104,,,,,,,,,,,,,6,,,,,
ROZEN0484_T1,Carminomycin,Yes,,,29,8,,,24,ROZEN0484_OS_carminomycin.xml,,,,,,,,,,,,,
ROZEN0484_T2,4'-Epidoxorubicin,Yes,,,34,8,,,27,ROZEN0484_OS_epi.xml,,,,,,,,,,,,,
RUBEN1078_T1,Placebo group,Yes,,,33,15,,0.29,,RUBEN1078_OS_PLA.xml,,,,,,,,,,,,,
RUBEN1078_T2,Progestogen group,Yes,,,36,8,,,,RUBEN1078_OS_PRO.xml,,,,,,,,,,,,,
RUBEN1275_T1,Group C,Yes,,,49,,"HR 1.15 [0.73, 1.82]",,,RUBEN1275_OS_C.xml,Cox model,,,,,,,,,,,,
RUBEN1275_T2,Group 4D,Yes,,,50,,,,,RUBEN1275_OS_4D.xml,,,,,,,,,,,,,
RUFF0909_T1,DZ,Yes,,,83,27.8,,0.99,36,,,,,,,,,7.2,,,RUFF0909_PFS_DZ.xml,,
RUFF0909_T2,DP,Yes,,,86,22.2,,,38,,,,,,,,,8.3,,,RUFF0909_PFS_DP.xml,,
RUGO0117_T1,Proposed Biosimilar + Taxane,Yes,,,230,,"HR 0.61 [0.36, 1.04] p=0.07",,,,,11.1,,,,,,11.1,,,,,
RUGO0117_T2,Trastuzumab + Taxane,Yes,,,228,,,,,,,11.1,,,,,,11.1,,,,,
RUGO0611_T1,Axitinib + Docetaxel,Yes,,,111,,,,,,,8.1,,,RUGO0611_TTP_AD.xml,,,,,,,,
RUGO0611_T2,Placebo + Docetaxel,Yes,,,56,,,,,,,7.1,,,RUGO0611_TTP_PD.xml,,,,,,,,
RUGO0613_T2,Ixabepilone + bevacizumab (Arm B),Yes,,,45,,,,,,,,,,,,,11.9,,,,,
RUGO0613_T3,Paclitaxel + bevacizumab (Arm C),Yes,,,32,,,,,,,,,,,,,13.5,,,,,
RUGO0715_T1,Paclitaxel,Yes,,,283,26.5,,,,,,,,,,,,11,,,,,
RUGO0715_T2,Nab-Paclitaxel,Yes,,,271,23.5,"HR 1.17 [0.92, 1.47]",,,,,,,,,,,9.3,,,,,
RUGO0715_T3,Ixabepilone,Yes,,,245,23.6,"HR 1.31 [1.03, 1.66]",,,,,,,,,,,7.4,,,,,
RUGO0613_T1,Ixabepilone + bevacizumab (Arm A),Yes,,,46,,,,,,,,,,,,,9.6,,,,,
RUSSE0797_T1,MA,Yes,,,75,26,"HR 0.95 [0.69, 1.29]",,,RUSSE0797_OS_MA.xml,,,,,,,,,,,,,
RUSSE0797_T2,AG,Yes,,,80,27,"HR 0.98 [0.72, 1.33]",,,RUSSE0797_OS_AG.xml,,,,,,,,,,,,,
RUSSE0797_T3,MA+AG,Yes,,,80,26,,,,RUSSE0797_OS_MAAG.xml,,,,,,,,,,,,,
SALIM0480_T1,CMF group,Yes,,,34,,,,,,,,,,,,,,,,,,
SALIM0480_T2,CAMP group,Yes,,,37,,,,,,,,,,,,,,,,,,
SAMON0994_T1,AG,Yes,,,28,,,,,,,,,,,,,,,,,,
SAMON0994_T2,MPA,Yes,,,29,,,,,,,,,,,,,,,,,,
SAMON0994_T3,AG+MPA,Yes,,,28,,,,,,,,,,,,,,,,,,
SCHEL0482_T1,Intermittent,Yes,,,35,,,,,,,4,,,,,,,,,,,
SCHEL0482_T2,Infusion,Yes,,,31,,,,,,,5,,,,,,,,,,,
SCHMI0105_T2,AT,Yes,Yes,,45,23.4,,,,SCHMI0105_OS_AT.xml,,10.6,,,SCHMI0105_TTP_AT.xml,,,,,,,,
SCHMI0210_T1,Low-dose adecatumumab,Yes,,,56,,,,,,,1.54,,,SCHMI0210_TTP_L.xml,,,,,,,,
SCHMI0210_T2,High-dose adecatumumab,Yes,,,56,,,,,,,1.71,,,SCHMI0210_TTP_H.xml,,,,,,,,
SCHOT0816_T1,"Dasatinib, 100 mg daily",Yes,Yes,,43,23.3,"HR 0.88 [0.53, 1.44] p=0.61",,,SCHOT0816_OS_100.xml,,,,,,,,2.4,,,SCHOT0816_PFS_100.xml,,
SCHOT0816_T2,"Dasatinib, 70 mg bid",Yes,Yes,,42,23.3,,,,SCHOT0816_OS_70.xml,,,,,,,,3.57,"HR 1.04 [0.66, 1.65]",,SCHOT0816_PFS_70.xml,,
SCHRO0611_T1,"Weekly docetaxel, Arm A",Yes,,,79,7.86,,,,SCHRO0611_OS_W.xml,,,,,,,,4.55,,,,,
SCHRO0611_T2,"3-weekly docetaxel, Arm B",Yes,,,77,9.94,"HR 0.73 [0.525, 1.016] p=0.062",,,SCHRO0611_OS_3W.xml,Computed CI from HR and p-value,,,,,,,5.11,,,,,
SCHWA0513_T1,Sorafenib + GEM/CAP,Yes,,,81,13.4,"HR 1.01 [0.71, 1.44] p=0.95",,,,,3.4,,,,,,,,,,,
SCHWA0513_T2,Placebo + GEM/CAP,Yes,,,79,11.4,,,,,,2.7,,,,,,,,,,,
SEGAL0385_T1,CMFP,Yes,,,208,10.4,,,,SEGAL0385_OS_CMFP.xml,,,,,,,,,,,,,
SEGAL0385_T2,CMFPV,Yes,,,219,10.1,,0.63,,SEGAL0385_OS_CMFPV.xml,,,,,,,,,,,,,
SEIDM0408_T1,CALGB 9840 3-Weekly,Yes,,,104,,,,,,TODO: track down online appendix,,,,SEIDM0408_TTP_3W.xml,,,,,,,,
SEIDM0408_T2,CALGB 9840 Weekly,Yes,,,182,,,,,,TODO: track down online appendix,,,,SEIDM0408_TTP_W.xml,,,,,,,,
SEIDM0408_T3,CALGB 9840 3-Weekly + Trastuzumab,Yes,,,123,,,,,,TODO: track down online appendix,,,,SEIDM0408_TTP_3WT.xml,,,,,,,,
SEIDM0408_T4,CALGB 9840 Weekly + Trastuzumab,Yes,,,168,,,,,,TODO: track down online appendix,,,,SEIDM0408_TTP_WT.xml,,,,,,,,
SEIDM0511_T1,GD,Yes,Yes,,237,23,,,,SEIDM0511_OS_GD.xml,,9.3,,,,,,,,,SEIDM0511_PFS_GD.xml,,
SEIDM0511_T2,CD,Yes,Yes,,226,23.3,"HR 1.031 [0.830, 1.280] p=0.785",,,SEIDM0511_OS_CD.xml,,8.9,,,,,,,,,SEIDM0511_PFS_CD.xml,,
SEIDM0813_T1,"Arm A, nab-P 260 mg/m2 q3w + Bevacizumab",Yes,,,75,21.3,,,,SEIDM0813_OS_armA.xml,pval given for A vs. C only,8,,,,,,7.7,,,,,
SEIDM0813_T2,"Arm B, nab-P 260 mg/m2 q2w + Bevacizumab",Yes,,,54,19,,,,SEIDM0813_OS_armB.xml,pval given for A vs. C only,5.8,,,,,,5.8,,,,,
SEIDM0813_T3,"Arm C, nab-P 130 mg/m2 weekly + Bevacizumab",Yes,,,79,23.7,,,,SEIDM0813_OS_armC.xml,pval given for A vs. C only,9,,,,,,8.8,,,,,
SJOST0899_T1,Docetaxel,Yes,Yes,,143,10.4,,,92.8,SJOST0899_OS_D.xml,183/282 alive at time of analysis,6.3,,,SJOST0899_TTP_D.xml,,,,,,,,
SJOST0899_T2,MF,Yes,Yes,,139,11,,0.79,90.2,SJOST0899_OS_M.xml,,3,,,SJOST0899_TTP_M.xml,,,,,,,,
SLAMO0301_T1,"An Anthracycline, Cyclophosphamide, and Trastuzumab",Yes,Yes,A,143,26.8,"HR 0.82 [0.61, 1.09] p=0.16",,,SLAMO0301_OS_A_A.xml,,7.8,,,,,,,,,SLAMO0301_PFS_A_A.xml,,
SLAMO0301_T2,An Anthracycline and Cyclophosphamide Alone,Yes,Yes,A,138,21.4,,,,SLAMO0301_OS_A_AA.xml,,6.1,,,,,,,,,SLAMO0301_PFS_A_AA.xml,,
SLAMO0301_T3,Paclitaxel and Trastuzumab,Yes,Yes,B,92,22.1,"HR 0.80 [0.56, 1.11] p=0.17",,,SLAMO0301_OS_B_P.xml,,6.9,,,,,,,,,SLAMO0301_PFS_B_P.xml,,
SLAMO0301_T4,Paclitaxel Alone,Yes,Yes,B,96,18.4,,,,SLAMO0301_OS_B_PA.xml,,3,,,,,,,,,SLAMO0301_PFS_B_PA.xml,,
SLEDG0100_T1,CAF,Yes,,,113,30,,0.834,93,SLEDG0100_OS_CAF.xml,,,,,,,,,,,,,
SLEDG0100_T2,CAFTH,Yes,,,114,29.3,,,93,SLEDG0100_OS_C.xml,,,,,,,,,,,,,
SLEDG0203_T1,A,Yes,,,224,19.1,,,192,SLEDG0203_OS_D.xml,,,,,,,,,,,,,
SLEDG0203_T2,T,Yes,,,229,22.5,,0.6,202,SLEDG0203_OS_P.xml,,,,,,,,,,,,,
SLEDG0203_T3,A+T,Yes,,,230,22.4,,0.82,197,SLEDG0203_OS_DP.xml,,,,,,,,,,,,,
SLEDG0917_T1,Abemaciclib + Fulvestrant,Yes,,,446,,,,,,,,,,,,,16.4,"HR 0.553 [0.449, 0.681]",,SLEDG0917_PFS_AF.xml,,
SLEDG0917_T2,Placebo + Fulvestrant,Yes,,,223,,,,,,,,,,,,,9.3,,,SLEDG0917_PFS_PF.xml,,
SMALL0283_T1,CAF,Yes,,,184,13.4,,,87,SMALL0283_OS_CAF.xml,"\p < 0.1\""""",,,,,,,,,,,,
SMALL0283_T2,CMFVP,Yes,,,178,11.1,,,97,SMALL0283_OS_CMFVP.xml,,,,,,,,,,,,,
SMALL1176_T1,Schedule A,Yes,,,35,11.2,,,30,SMALL1176_OS_A.xml,,,,,,,,,,,,,
SMALL1176_T2,Schedule B,Yes,,,33,11.2,,,28,SMALL1176_OS_B.xml,,,,,,,,,,,,,
SMALL1176_T3,Schedule C,Yes,,,34,5.1,,,27,SMALL1176_OS_C.xml,,,,,,,,,,,,,
SMITH0180_T2,Vincristine / ADR,Yes,,,14,,,,,,,,,,,,,,,,,,
SMITH0180_T3,Vindesine / ADR,Yes,,,11,,,,,,,,,,,,,,,,,,
SMITH1113_T1,Ixabepilone weekly for 3 weeks,Yes,,,85,13.9,,,55,,,,,,,,,2.9,,,,,
SMITH1113_T2,Ixabepilone every 3 weeks,Yes,,,91,16.1,,0.11,48,,,,,,,,,5.3,,,,,
SMITH1181_T1,Tamoxifen,Yes,,,60,,,,,SMITH1181_OS_TAM.xml,,,,,,,,,,,,,
SMITH1181_T2,Aminoglutethimide,Yes,,,57,18.8,,,,SMITH1181_OS_AG.xml,,,,,,,,,,,,,
SMORE0314_T1,PLD,Yes,,,40,13.8,,,,,,,,,,,,5.6,,,,,
SMORE0314_T2,Capecitabine,Yes,,,38,16.8,"HR 0.87 [0.53, 1.44] p=0.59",,,,,,,,,,,7.7,,,,,
SPARA0710_T1,Ixabepilone Plus Capecitabine,Yes,Yes,,595,16.4,"HR 0.9 [0.78, 1.03] p=0.1162",,,SPARA0710_OS_IC.xml,,,,,,,,6.2,,,SPARA0710_PFS_IC.xml,,
SPARA0710_T2,Capecitabine,Yes,Yes,,603,15.6,,,,SPARA0710_OS_C.xml,,,,,,,,4.4,,,SPARA0710_PFS_C.xml,,
SPARA0909_T1,Docetaxel ,Yes,Yes,,373,20.6,,,,SPARA0909_OS_D.xml,,7,,,SPARA0909_TTP_D.xml,,,,,,SPARA0909_PFS_D.xml,,
SPARA0909_T2,PLD + Docetaxel,Yes,Yes,,377,20.5,"HR 1.02 [0.86, 1.22] p=0.81",,,SPARA0909_OS_PD.xml,,9.8,,,SPARA0909_TTP_PD.xml,,,,,,SPARA0909_PFS_PD.xml,,
SPARA1204_T1,Marimastat,Yes,Yes,,114,24.7,,,,SPARA1204_OS_M.xml,,,,,,,,4.7,,,SPARA1204_PFS_M.xml,,
SPARA1204_T2,Placebo,Yes,Yes,,65,26.6,"HR 1.03 [0.73, 1.46] p=0.86",,,SPARA1204_OS_P.xml,,,,,,,,3.1,,,SPARA1204_PFS_P.xml,,
SPITT0887_T1,Single combination,Yes,,,131,14,,0.62,,SPITT0887_OS_S.xml,,,,,,,,,,,,,
SPITT0887_T2,Alternating combinations,Yes,,,131,15,,,,SPITT0887_OS_A.xml,,,,,,,,,,,,,
SPOON0591_T1,Conventional dose,Yes,,,92,,,,,,,,,,,,,,,,,,
SPOON0591_T2,Loading dose,Yes,,,87,,,0.39,,,,,,,,,,,,,,,
STEIN1292_T1,3M,Yes,,,51,9,,,,,,,,,,,,,,,,,
STEIN1292_T2,2M,Yes,,,54,10.5,,,,,,,,,,,,,,,,,
STEMM0310_T1,q1w,Yes,Yes,,48,22.7,,0.24,,STEMM0310_OS_q1.xml,,5.4,,,STEMM0310_TTP_q1.xml,,,,,,,,
STEMM0310_T2,q3w,Yes,Yes,,54,15.8,,,,STEMM0310_OS_q3.xml,,6.3,,,STEMM0310_TTP_q3.xml,,,,,,,,
STEMM0310b_T1,q1w,Yes,Yes,,43,20.5,,,,STEMM0310b_OS_q1.xml,,6.2,,,STEMM0310b_TTP_q1.xml,,,,,,,,
STEMM0310b_T2,q3w,Yes,Yes,,42,28.7,,0.98,,STEMM0310b_OS_q3.xml,,10.3,,,STEMM0310b_TTP_q3.xml,,,,,,,,
STEMM0311_T1,Gemcitabine and Vinorelbine,Yes,,,46,17.5,,,,STEMM0311_OS_GemVin.xml,,,,,,,,5.7,,,,,
STEMM0311_T2,Gemcitabine and Cisplatin,Yes,,,45,13,,,,STEMM0311_OS_GemCis.xml,,,,,,,,6.9,,,,,
STEMM0311_T3,Gemcitabine and Capecitabine,Yes,,,50,19.4,,,,STEMM0311_OS_GemCap.xml,,,,,,,,8.3,,,,,
STENB0193_T1,TOR,Yes,,,31,14.4,,,,STENB0193_OS_TO.xml,,,,,,,,,,,,,
STENB0193_T2,TAM,Yes,,,31,26.7,,0.16,,STENB0193_OS_TA.xml,,,,,,,,,,,,,
STEWA0597_T1,CAF,Yes,,,128,15.2,,0.0033,119,STEWA0597_OS_CA.xml,,5.3,,,,,,,,,,,
STEWA0597_T2,CNF,Yes,,,121,10.9,,,120,STEWA0597_OS_CN.xml,,3.2,,,,,,,,,,,
STEWA1282_T1,T,Yes,,,72,12,,,,STEWA1282_OS_T.xml,,,,,,,,,,,,,
STEWA1282_T2,T + P,Yes,,,73,21,,0.025,,STEWA1282_OS_TP.xml,,,,,,,,,,,,,
STOCK1011_T1,Intermittent capecitabine,Yes,,,107,22,,,,,HR info reported as A+B vs. C and A vs. B,,,,,,,6,,,,,
STOCK1011_T2,Continuous capecitabine,Yes,Yes,,107,22,,,,STOCK1011_OS_C.xml,HR info reported as A+B vs. C and A vs. B,,,,,,,6,,,STOCK1011_PFS_C.xml,,
STOCK1011_T3,CMF,Yes,Yes,,109,18,,,,STOCK1011_OS_CM.xml,HR info reported as A+B vs. C and A vs. B,,,,,,,6,,,STOCK1011_PFS_CM.xml,,
SWAIN0988_T1,Tamoxifen / fluoxymesterone,Yes,,,29,12.6,,,,,,2.9,,,SWAIN0988_TTP_TF.xml,,,,,,,,
SWAIN0988_T2,Tamoxifen / danazol,Yes,,,34,16.9,,0.64,,,,3.8,,,SWAIN0988_TTP_TD.xml,,,,,,,,
TABER0904_T1,Weekly docetaxel,Yes,,,41,29.1,,,,TABER0904_OS_weekly.xml,,5.7,,,,,,,,,,,
TABER0904_T2,3-weekly docetaxel,Yes,,,41,20.1,,,,TABER0904_OS_3weekly.xml,,5.3,,,,,,,,,,,
TAKAS0116_T1,S-1 group,Yes,,,306,35,,,,TAKAS0116_OS_S.xml,,,,,,,,9.6,,,,,
TALBO0502_T1,Intermittent capecitabine,Yes,,,22,7.6,,,,,,3,,,,,,,,,,,
TALBO0502_T2,Paclitaxel,Yes,,,19,9.4,,,,,,3.1,,,,,,,,,,,
TALLE0870_T1,Delta-Testololactone,Yes,,,24,11,,,24,TALLE0870_OS_del.xml,,,,,,,,,,,,,
TALLE0870_T2,NSC-77622,Yes,,,23,6.5,,,22,TALLE0870_OS_deluteval.xml,,,,,,,,,,,,,
TAMUR0517_T1,Nab-paclitaxel,Yes,Yes,,98,42.4,,0.19,,TAMUR0517_OS_N.xml,,,,,,,,9.8,,,TAMUR0517_PFS_N.xml,,
TAMUR0517_T2,Docetaxel,Yes,Yes,,99,34,,,,TAMUR0517_OS_D.xml,,,,,,,,11.2,,,TAMUR0517_PFS_D.xml,,p=0.363
TANNO0988_T1,Lower Dose,Yes,,,67,12.8,,,51.89,TANNO0988_OS_l.xml,103/133 died,,,,,,,,,,,,
TANNO0988_T2,Higher Dose,Yes,,,66,15.6,,0.026,51.11,TANNO0988_OS_h.xml,103/133 died,,,,,,,,,,,,
TASHI0894_T1,UFT,Yes,,,28,47,,,,TASHI0894_OS_UFT.xml,,,,,,,,,,,,,
TASHI0894_T2,FT,Yes,,,28,34,,,,TASHI0894_OS_FT.xml,,,,,,,,,,,,,
TASHI0995_T1,MMV,Yes,,,21,8.1,,,,TASHI0995_OS_MMV.xml,,,,,,,,,,,,,
TASHI0995_T2,MMVM,Yes,,,40,8.1,,,,TASHI0995_OS_MMVM.xml,,,,,,,,,,,,,
TASHI0995_T3,MMVP,Yes,,,41,10.3,,,,TASHI0995_OS_MMVP.xml,,,,,,,,,,,,,
TAYLO0398_T1,Goserelin,Yes,,,69,37,,,,TAYLO0398_OS_G.xml,,,,,,,,,,,,,
TAYLO0486_T1,CMF,Yes,,,86,20.9,,,73,TAYLO0486_OS_C.xml,,,,,,,,,,,,,
TAYLO0486_T2,Tamoxifen,Yes,,,95,23.3,,0.2,78,TAYLO0486_OS_T.xml,,,,,,,,,,,,,
THOMA1107_T1,Ixabepilone Plus Capecitabine,Yes,,,369,,,,,,,,,,,,,5.8,,,THOMA1107_PFS_I.xml,,
THOMA1107_T2,Capecitabine,Yes,,,368,,,,,,,,,,,,,4.2,,,THOMA1107_PFS_C.xml,,
THURL0697_T1,Formestane,Yes,,,91,,,,,,,,,,,,,,,,,,
THURL0697_T2,MGA,Yes,,,86,,,,,,,,,,,,,,,,,,
THURL0796_T1,TAM,Yes,,,107,39.5,,,,THURL0796_OS_T.xml,,,,,,,,,,,,,
THURL0796_T2,Fadrozole,Yes,,,105,35.6,"HR 0.91 [0.63, 1.32] p=0.63",,,THURL0796_OS_F.xml,,,,,,,,,,,,,
TOLCH0299_T1,BR96-doxorubicin,Yes,,,9,,,,,,,,,,,,,,,,,,
TOLCH0299_T2,Doxorubicin,Yes,,,9,,,,,,,,,,,,,,,,,,
TOMIN0103_T1,Letrozole-treated,Yes,,,78,,,0.345,,,,7.03,,,TOMIN0103_TTP_L.xml,,,,,,,,
TOMIN0103_T2,Fadrozole-treated,Yes,,,76,,,,,,,3.77,,,TOMIN0103_TTP_F.xml,,,,,,,,
TOMIN0403_T1,0.3 mg/day,Yes,,,20,,,,,,,3.5,,,,,,,,,,,
TOMIN0403_T2,1.0 mg/day,Yes,,,20,,,,,,,3.27,,,,,,,,,,,
TOMIN0403_T3,3.0 mg/day,Yes,,,19,,,,,,,4.6,,,,,,,,,,,
TOMIN0403_T4,10.0 mg/day,Yes,,,20,,,,,,,2.03,,,,,,,,,,,
TOMIN0403_T5,30.0 mg/day,Yes,,,19,,,,,,,7.77,,,,,,,,,,,
TOMIN0489_T1,Group A,Yes,,,44,20.6,,,,TOMIN0489_OS_A.xml,,,,,,,,,,,,,
TOMIN0489_T2,Group B,Yes,,,34,14.3,,,,TOMIN0489_OS_B.xml,,,,,,,,,,,,,
TOMIN0794_T1,Arm I,Yes,,,96,19.23,,,,TOMIN0794_OS_I.xml,,,,,,,,,,,,,
TOMIN0794_T2,Arm II,Yes,,,103,22.12,,0.21,,TOMIN0794_OS_II.xml,,,,,,,,,,,,,
TORME0282_T1,DA,Yes,,,55,9,,,,,,,,,,,,,,,,,
TORME0282_T2,DAT,Yes,,,67,11.33,,0.18,,,,,,,,,,,,,,,
TORME0684_T1,CMFVP-C,Yes,,,86,16,,,75,TORME0684_OS_A.xml,,,,,,,,,,,,,
TORME0684_T2,CMFVP-I,Yes,,,109,13,,,99,TORME0684_OS_B.xml,,,,,,,,,,,,,
TORME0684_T3,CAFVP,Yes,,,107,19,,,85,TORME0684_OS_C.xml,,,,,,,,,,,,,
TORMG0283_T1,"Group A, CMF",Yes,,A,47,12.5,,,43,TORMG0283_OS_CMF.xml,,,,,,,,,,,,,
TORMG0283_T2,"Group A, CMF/AV",Yes,,A,50,17.8,,,41,TORMG0283_OS_CMFAV.xml,,,,,,,,,,,,,
TORMG0283_T3,"Group A, CMFP",Yes,,A,47,18,,,,,,,,,,,,,,,,,
TORMG0283_T4,"Group B, CMFP",Yes,,B,135,19.4,,,86,TORMG0283_OS_CMFP.xml,,,,,,,,,,,,,
TORMG0283_T5,"Group B, CMFP/AV",Yes,,B,176,16.3,,,118,TORMG0283_OS_CMFPAV.xml,,,,,,,,,,,,,
TREDA0215_T1,Ixabepilone,Yes,,,40,,,,,,,,,,,,,4.1,,,,,
TREDA0215_T2,Ixabepilone With Cetuximab,Yes,,,39,,,,,,,,,,,,,4.1,,,,,
TREDA0616_T1,Taxane + BEV,Yes,,,59,,,,,,,,,,,,,8.1,,,TREDA0616_PFS_T.xml,,
TREDA0616_T2,Exemestane + BEV,Yes,,,58,,,,,,,,,,,,,7.6,,,TREDA0616_PFS_E.xml,,
TRYFO0116_T1,Anastrozole/gefitinib,Yes,,,36,,,,,,,,,,,,,,,,TRYFO0116_PFS_G.xml,,
TRYFO0116_T2,Anastrozole/placebo,Yes,,,35,,,,,,,,,,,,,,,,TRYFO0116_PFS_P.xml,,
TRYFO0617_T1,CMF,Yes,,,19,19.25,,,,,,,,,,,,4.8,,,TRYFO0617_PFS_C.xml,,
TRYFO0617_T2,CMF + Trastuzumab,Yes,,,70,24.5,,,,,,,,,,,,9.4,,,TRYFO0617_PFS_T.xml,,
TURNE0715_T1,Palbociclib-Fulvestrant,Yes,,,347,,,,,,TODO: continue checking for an update with OS information,,,,,,,9.5,,,,,
TURNE0715_T2,Placebo-Fulvestrant,Yes,,,174,,,,,,TODO: continue checking for an update with OS information,,,,,,,4.6,,,,,
UNTCH0310_T1,HEC-60,Yes,,,60,,,,,,,12.5,,,UNTCH0310_TTP_60.xml,,,,,,,,
UNTCH0310_T2,HEC-90,Yes,,,60,,,,,,,10.1,,,UNTCH0310_TTP_90.xml,,,,,,,,
URRUT0917_T1,Arm A: Trastuzumab + Capecitabine,Yes,,,218,28.1,,,,URRUT0917_OS_A.xml,,9,,,,,,9,,,,,
URRUT0917_T2,Arm B: Pertuzumab + Trastuzumab + Capecitabine,Yes,,,228,36.1,"HR 0.68 [0.51, 0.90]",,,URRUT0917_OS_B.xml,,11.6,,,,,,11.1,"HR 0.82 [0.65, 1.02] p=0.0731",,,,
VAHDA0317_T1,RAM+CAP,Yes,,,52,15.73,"HR 1.374 [0.82, 2.30] p=0.2260",,,,,,,,VAHDA0317_PFS_R.xml,,,5.16,HR 0.691 p=0.1315,,,,
VAHDA0317_T2,ICR+CAP,Yes,,,49,14.49,"HR 1.295 [0.77, 2.16] p=0.3244",,,,,,,,VAHDA0317_PFS_I.xml,,,1.7,HR 1.480 p=0.0851,,,,
VAHDA0317_T3,CAP,Yes,,,49,16.71,,,,,,,,,VAHDA0317_PFS_C.xml,,,4.43,,,,,
VAHDA0713_T1,Eribulin,Yes,,,51,,,,,,,,,,,,,3.47,,,,,
VAHDA0713_T2,Ixabepilone,Yes,,,50,,,,,,,,,,,,,3.17,,,,,
VALER0111_T1,TH,Yes,Yes,,131,37.1,,,92,VALER0111_OS_TH.xml,,11.07,,,,,,,,,VALER0111_PFS_TH.xml,,
VALER0111_T2,TCH,Yes,Yes,,132,37.4,,0.99,90,VALER0111_OS_TCH.xml,,10.35,,,,,,,,,VALER0111_PFS_TCH.xml,,
VALLE0393_T1,Arm A,Yes,,,89,25,,,,VALLE0393_OS_A.xml,,,,,,,,,,,,,
VALLE0393_T2,Arm B,Yes,,,92,29,,0.8,,VALLE0393_OS_B.xml,,,,,,,,,,,,,
VANOO0586_T1,Carminomycin,Yes,,,25,7,,,22,VANOO0586_OS_C.xml,,2.1,,,,,,,,,,,
VANOO0586_T2,Doxorubicin,Yes,,,31,12,,0.285,24,VANOO0586_OS_D.xml,,7,,,,,,,,,,,
VANTO0300_T1,FEC day 1+8,Yes,,,52,15.9,,,,,,11.5,,,,,,,,,,,
VANTO0300_T2,FEC day 1,Yes,,,52,14.4,,,,,,10.4,,,,,,,,,,,
VANVE0786_T1,MPA,Yes,,,61,20,,,,VANVE0786_OS_MPA.xml,,,,,,,,,,,,,
VANVE0786_T2,TAM,Yes,,,68,26,,,,VANVE0786_OS_TAM.xml,,,,,,,,,,,,,
VAUGH0588_T1,AD,Yes,,,59,8.5,,,57,,,4.2,,,VAUGH0588_TTP_A.xml,,,,,,,,
VAUGH0588_T2,VAD,Yes,,,56,9.8,,0.53,53,,,5.1,,,VAUGH0588_TTP_V.xml,,,,,,,,
VENTU0400_T1,Arm A,Yes,,,33,9.5,,,,,,,,,,,,,,,,,
VENTU0400_T2,Arm B,Yes,,,33,9,,,,,,,,,,,,,,,,,
VENTU0400_T3,Arm C,Yes,,,33,9,,,,,,,,,,,,,,,,,
VERMA1112_T1,Lapatinib plus Capecitabine,Yes,Yes,,488,25.9,,,,VERMA1112_OS_L.xml,,,,,,,,6.4,,,VERMA1112_PFS_L.xml,,
VERMA1112_T2,T-DM1,Yes,Yes,,490,29.9,"HR 0.75 [0.64, 0.88]",,,VERMA1112_OS_T.xml,"\p < 0.001\""""",,,,,,,9.6,,,VERMA1112_PFS_T.xml,,
VERMO0493_T1,Iproplatin,Yes,,,30,,,,,,,,,,,,,,,,,,
VERMO0493_T2,Carboplatin,Yes,,,32,,,,,,,,,,,,,,,,,,
VICI0411_T1,Arm A (EV),Yes,,,54,34.6,,,,VICI0411_OS_EV.xml,,,,,,,,10.7,,,,,
VICI0411_T2,Arm B (PLD/V),Yes,,,50,24.8,,,,VICI0411_OS_PLDV.xml,,,,,,,,8.8,,,,,
VICI1211_T1,DG,Yes,,,36,26,,,,VICI1211_OS_DG.xml,,,,,,,,10.9,,,,,
VICI1211_T2,DC,Yes,,,36,28,,,,VICI1211_OS_DC.xml,,,,,,,,10,,,,,
VILAD1285_T1,A,Yes,,,38,22.5,,,,VILAD1285_OS_A.xml,,,,,,,,,,,,,
VILAD1285_T2,B,Yes,,,40,24.7,,,,VILAD1285_OS_B.xml,,,,,,,,,,,,,
VILAD1285_T3,C,Yes,,,39,21.7,,,,VILAD1285_OS_C.xml,,,,,,,,,,,,,
VILLA0197_T1,UFT,Yes,,,31,,,,,,,2.8,,,,,,,,,,,
VILLA0197_T2,5-FU,Yes,,,31,,,,,,,2.22,,,,,,,,,,,
VOGEL0202_T1,Trastuzumab 2 mg/kg,Yes,,,59,22.9,,,33.64,VOGEL0202_OS_2mg.xml,65/114 deaths,3.5,,,,,,,,,,,
VOGEL0202_T2,Trastuzumab 4 mg/kg,Yes,,,55,25.8,,,31.36,VOGEL0202_OS_4mg.xml,,3.8,,,,,,,,,,,
VONMI0309_T1,Capecitabine alone,Yes,,,78,20.4,,,,,,5.6,,,,,,,,,VONMI0309_PFS_C.xml,,
VONMI0309_T2,Capecitabine Plus Trastuzumab,Yes,,,78,25.5,"HR 0.763 [0.477, 1.220] p=0.2570",,,,,8.2,,,,,,,,,VONMI0309_PFS_CT.xml,,
VONMI0905_T1,BMF,Yes,,,162,,,,,,,8.2,,,VONMI0905_TTP_B.xml,,,,,,,,
VONMI0905_T2,CMF,Yes,,,162,,,,,,,6.7,,,VONMI0905_TTP_C.xml,,,,,,,,
VUYLS1116_T1,Pictilisib + paclitaxel,Yes,,,91,,,,,,,,,,,,,8.2,"HR 0.95 [0.62, 1.46] p=0.83",,VUYLS1116_PFS_PIC.xml,,
VUYLS1116_T2,Placebo + paclitaxel,Yes,,,92,,,,,,,,,,,,,7.8,,,VUYLS1116_PFS_PLA.xml,,
WALTE0192_T1,Arm 1 (Standard),Yes,,,34,6.07,,,,,,2.57,,,,,,,,,,,
WALTE0192_T2,Arm 2 (Low Dose),Yes,,,33,6.07,,,,,,2.8,,,,,,,,,,,
WANG0815_T1,Arm A (no ESOM),Yes,,,32,19.2,,,,,HR analysis combines arms B and C,8.7,,,WANG0815_TTP_NO.xml,,,,,,,,
WANG0815_T2,Arm B (lower dose ESOM),Yes,,,31,39.3,,,,,HR analysis combines arms B and C,9.4,,,WANG0815_TTP_YES.xml,,,,,,,,
WANG0815_T3,Arm C (higher dose ESOM),Yes,,,31,26.1,,,,,HR analysis combines arms B and C,9.7,,,,,,,,,,,
WARD0173_T1,L,Yes,,,33,,,,,,,,,,,,,,,,,,
WARD0173_T2,H,Yes,,,35,,,,,,,,,,,,,,,,,,
WELT0216_T1,Arm A: CAP/BEV,Yes,,,297,25.1,,,,,,,,,,,,8.8,,,WELT0216_PFS_A.xml,,
WELT0216_T2,Arm B: CAP/BEV/VIN,Yes,,,295,27.2,"HR 0.85 [0.70, 1.03] p=0.104",,,,,,,,,,,9.6,,,WELT0216_PFS_B.xml,,
WILDI0910_T1,Arm A (Sunitinib),Yes,Yes,,36,12,,0.749,18,WILDI0910_OS_A.xml,,,,,,,,2.8,,,WILDI0910_PFS_A.xml,,
WILDI0910_T2,Arm B (No therapy),Yes,Yes,,19,18.9,,,7,WILDI0910_OS_B.xml,,,,,,,,3.1,,,WILDI0910_PFS_B.xml,,
WILLE0390_T1,MA,Yes,,,50,20,,,,WILLE0390_OS_MA.xml,,,,,,,,15,,,,,
WILLE0390_T2,MPA,Yes,,,48,16,,,,WILLE0390_OS_MPA.xml,,,,,,,,10,,,,,
WILLI0295_T1,Trilostane,Yes,,,63,,,,,,,,,,,,,,,,,,
WILLI0295_T2,Aminoglutethimide,Yes,,,49,,,,,,,,,,,,,,,,,,
WILS0985_T1,Combination,Yes,,,74,22,,,33,WILS0985_OS_C.xml,,17,,,,,,,,,,,
WILS0985_T2,Alternating,Yes,,,71,24,,,31,WILS0985_OS_A.xml,,17,,,,,,,,,,,
WINER0604_T1,Paclitaxel 175 mg/m2,Yes,,,158,11,,,148,WINER0604_OS_T175.xml,,3.9,,,,,,,,,,,
WINER0604_T2,Paclitaxel 210 mg/m2,Yes,,,156,12,,,147,WINER0604_OS_T210.xml,,4.1,,,,,,,,,,,
WINER0604_T3,Paclitaxel 250 mg/m2,Yes,,,155,14,,,138,WINER0604_OS_T250.xml,,4.9,,,,,,,,,,,
WISHA0994_T1,Placebo,Yes,,,106,13.77,,,,WISHA0994_OS_P.xml,,,,,,,,7,,,,,
WISHA0994_T2,Quinidine,Yes,,,107,10.97,"HR 1.20 [0.88, 1.63] p=0.247",,,WISHA0994_OS_Q.xml,,,,,,,,7,,,,,
WOLFF0113_T1,Letrozole Plus Temsirolimus,Yes,Yes,,555,,"HR 0.89 [0.65, 1.23] p=0.50",,,WOLFF0113_OS_T.xml,,,,,,,,8.9,,,WOLFF0113_PFS_T.xml,,
WOLFF0113_T2,Letrozole Plus Placebo,Yes,Yes,,555,,,,,WOLFF0113_OS_P.xml,,,,,,,,9,,,WOLFF0113_PFS_P.xml,,
XU0111_T1,Fulvestrant 250 mg,Yes,,,121,,,,,,,3.67,,,XU0111_TTP_F.xml,,,,,,,,
XU0111_T2,Anastrozole,Yes,,,113,,,,,,,5.3,,,XU0111_TTP_A.xml,,,,,,,,
XU0711_T1,Gemcitabine / paclitaxel,Yes,,,49,15.5,,,,XU0711_OS_GPAC.xml,,5,,,,,,4.8,,,,,
XU0711_T2,Gemcitabine / carboplatin,Yes,,,47,22.8,"HR 0.81 [0.44, 1.50] p=0.504",,,XU0711_OS_GCAR.xml,,4.3,,,,,,4.3,,,,,
XU0711_T3,Gemcitabine / cisplatin,Yes,,,51,20.1,"HR 1.49 [0.82, 2.73] p=0.194",,,XU0711_OS_GCIS.xml,,4.8,,,,,,4.8,,,,,
YAMAM0217_T1,XT,Yes,Yes,,82,33.8,"HR 0.89 [0.52, 1.53] p=0.68",,,YAMAM0217_OS_X.xml,,,,,,,,10.5,"HR 0.62 [0.40, 0.97] p=0.03",,YAMAM0217_PFS_X.xml,,
YAMAM0217_T2,T -> X,Yes,Yes,,81,28.8,,,,YAMAM0217_OS_Y.xml,,,,,,,,9.8,,,YAMAM0217_PFS_Y.xml,,
YAMAM0513_T1,TOR120,Yes,,,46,32.3,"HR 0.60 [0.26, 1.39] p=0.22",,,,,,,,,,,7.3,,,,,
YAMAM0513_T2,EXE,Yes,,,45,21.9,,,,,,,,,,,,3.7,,,,,
YAMAM0615_T1,S-1,Yes,,,65,32.2,"HR 1.32 [0.7, 2.48] p=0.39",,,,,,,,,,,15.6,,,,,
YAMAM0615_T2,Capecitabine,Yes,,,71,42.5,,,,,,,,,,,,14.4,,,,,
YAP0981_T1,Continuous infusion,Yes,,,25,,,,,,,2.8,,,YAP0981_TTP_C.xml,,,,,,,,
YAP0981_T2,Bolus injection,Yes,,,26,,,,,,,1.4,,,YAP0981_TTP_B.xml,,,,,,,,
YARDL0415_T1,GV,Yes,,,83,7.5,,,,,,,,,,,,2.3,,,,,
YARDL0613_T1,Exemestane Plus Ertinostat,Yes,,,64,28.1,"HR 0.59 [0.36, 0.97] p=0.036",,,,,,,,,,,4.3,,,,,
YARDL0613_T2,Exemestane Plus Placebo,Yes,,,66,19.8,,,,,,,,,,,,2.3,,,,,
YARDL1109_T1,Liposomal doxorubicin,Yes,Yes,,50,16.2,,0.3423,,YARDL1109_OS_L.xml,,,,,,,,6.5,,,YARDL1109_PFS_L.xml,,
YARDL1109_T2,Weekly docetaxel,Yes,Yes,,52,15.4,,,,YARDL1109_OS_D.xml,,,,,,,,5.5,,,YARDL1109_PFS_D.xml,,
YARDL1115_T1,"Arm 1, everolimus",Yes,,,56,17.5,"HR 1.25 [0.76, 2.04] p=0.38",,,,,,,,,,,9.1,,,YARDL1115_PFS_E.xml,,
YARDL1115_T2,"Arm 2, placebo",Yes,,,57,19.6,,,,,,,,,,,,7.1,,,YARDL1115_PFS_P.xml,,
YARDL1216_T1,Ramucirumab With Eribulin,Yes,,,71,13.5,"HR 0.91 [0.59, 1.41] p=0.68",,,,,,,,,,,4.4,"HR 0.83 [0.56, 1.23] p=0.35",,,,
YARDL1216_T2,Eribulin,Yes,,,70,11.5,,,,,,,,,,,,4.1,,,,,
YAU0185_T1,Vincristine,Yes,,,19,,,,,,,,,,,,,,,,,,
YAU0185_T2,Vinblastine,Yes,,,31,,,,,,,,,,,,,,,,,,
YAU0185_T3,Vindesine CI,Yes,,,41,,,,,,,,,,,,,,,,,,
YAU0185_T4,Vindesine IB,Yes,,,40,,,,,,,,,,,,,,,,,,
YOSEF0693_T1,SMF,Yes,,,83,11.27,,,,YOSEF0693_OS_SMF.xml,,,,,,,,,,,,,
YOSEF0693_T2,CMF,Yes,,,70,10.8,,,,YOSEF0693_OS_CMF.xml,,,,,,,,,,,,,
ZAMAN0715_T1,Fulvestrant + Selumetinib,Yes,,,23,22.9,,,11,ZAMAN0715_OS_FS.xml,,,,,,,,3.7,,,,,
ZAMAN0715_T2,Fulvestrant + Placebo,Yes,,,22,19.4,,,9,ZAMAN0715_OS_FP.xml,,,,,,,,5.6,,,,,
ZEKAN1284_T1,VAC,Yes,,,23,10.9,,,15,,,6,,,,,,,,,ZEKAN1284_PFS_V.xml,,
ZEKAN1284_T2,CF,Yes,,,26,14.5,,0.49,12,,,3.5,,,,,,,,,ZEKAN1284_PFS_C.xml,,
ZHANG0317_T1,Utidelone plus capecitabine,Yes,Yes,,270,16.13,"HR 0.63 [0.45, 0.88] p=0.0059",,,ZHANG0317_OS_U.xml,,,,,,,,8.44,,,ZHANG0317_PFS_U.xml,,
ZHANG0317_T2,Capecitabine alone,Yes,Yes,,135,12.78,,,,ZHANG0317_OS_C.xml,,,,,,,,4.27,,,ZHANG0317_PFS_C.xml,,
ZHANGB0816_T1,Fulvestrant 500 mg,Yes,,,111,,,,,,,,,,,,,8,"HR 0.75 [0.54, 1.03] p=0.078",,ZHANGB0816_PFS_500.xml,,
ZHANGB0816_T2,Fulvestrant 250 mg,Yes,,,110,,,,,,,,,,,,,4,,,ZHANGB0816_PFS_250.xml,,
ZIELZ0305_T1,GET,Yes,,,124,29.5,,0.61,49.6,,60% of events censored,9.1,,,,,,,,,,,
ZIELZ0305_T2,FEC,Yes,,,135,24.9,,,54,,,9,,,,,,,,,,,